Dietary fatty acids and risk factors for coronary heart disease : controlled studies in healthy volunteers by Zock, P.L.
DIETARY FATTY ACIDS AND RISK FACTORS 
FOR CORONARY HEART DISEASE: 
CONTROLLED STUDIES IN HEALTHY VOLUNTEERS 
Peter L. Zock 
Ontvangen 
1 6 JAN. 1995 
UB-CARDEX 
CENTRALE LAND BO UWC ATALOG US 
0000 0546 8554 ^ Oc| ^ I 
Promotoren: dr. J.G.A.J. Hautvast 
Hoogleraar in de leer van de voeding en de voedselbereiding 
dr. M.B. Katan 
Universitair hoofddocent aan de Vakgroep Humane Voeding 
Bijzonder hoogleraar in de voedingsleer van de mens 
aan de Katholieke Universiteit Nijmegen 
puo?^ ( ms 
Peter L. Zock 
DIETARY FATTY ACIDS AND RISK FACTORS 
FOR CORONARY HEART DISEASE: 
CONTROLLED STUDIES IN HEALTHY VOLUNTEERS 
Proefschrift 
ter verkrijging van de graad van doctor 
in de landbouw- en milieuwetenschappen 
op gezag van de rector magnificus, 
dr. C.M. Karssen, 
in het openbaar te verdedigen 
op woensdag 11 januari 1995 
des namiddags te vier uur in de Aula 
van de Landbouwuniversiteit te Wageningen 
O JOllbl 
These studies were supported by a grant from the Foundation for Nutrition and 
Health Sciences, and by a PhD-fellowship to Peter L. Zock from the Netherlands 
Postgraduate School of Human Nutrition. 
Financial support by the Netherlands Heart Foundation and 
the Wageningen Agricultural University for the publication of 
this thesis is gratefully acknowledged. 
CIP-GEGEVENS KONINKLIJKE BIBLIOTHEEK, DEN HAAG 
Zock, Peter L. 
Dietary fatty acids and risk factors for coronary heart disease: 
controlled studies in healthy volunteers / 
Peter L. Zock. - [S.1.: s.n.] 
Thesis Wageningen. - With ref. - With summary in Dutch. 
ISBN 90-5485-328-X 
Subject headings: coronary heart disease, fatty acids, lipoproteins 
Cover design: The Lemon House, Advertising & Final Art, Amersfoort 
Illustrations: Loet van Moll, Illustraties, Arnhem 
Lay-out: Peter Zock 
Printing: Grafisch Service Centrum Van Gils B.V. Wageningen 
1995 Zock. No part of this publication may be reproduced, stored in any retrieval system, 
or transmitted in any form by any means, electronical, mechanical, photocopying, recording, 
or otherwise, without the permission of the author, or, when appropriate, of the publishers 
of the publication. 
BIBLIOTHEEK 
LANDBCHJ VVU NIVERSITEH 
WAGENINGEN 
fjUO^O |g>3S 
Stellingen 
1. Enkelvoudig onverzadigde frans-vetzuren hebben vergeleken met cis-
onverzadigde vetzuren een ongunstige uitwerking op de serumlipoproteïnen. 
Dit proefschrift 
2. De vetzuursamenstelling van voedingsvet heeft geen grote invloed op de 
bloeddruk. 
Dit proefschrift; proefschrift Ronald Mensink, Landbouwuniversiteit, 7990 
3. Trans-vetzuren zijn een van de weinige voedingsdeterminanten van het 
lipoproteïne(a)-gehalte in het bloed. 
Dit proefschrift 
9. 
10. 
Of het gebruik van stearinezuur als alternatief voor fra/7S-vetzuren 
bij het harder maken van vetten gezondheidsvoordelen oplevert, is nog 
onvoldoende onderzocht. 
Dit proefschrift 
Doordat myristinezuur ten opzichte van palmitinezuur zowel het HDL als 
het LDL cholesterolgehalte verhoogt, is het niet duidelijk welk van deze 
vetzuren het meeste risico voor coronaire hartziekte met zich meebrengt. 
Dit proefschrift 
Het veranderen van de positie van een vetzuur binnen het 
triglyceridenmolecuul maakt weinig verschil uit voor de uitwerking 
van voedingsvetten op de bloedlipiden bij de mens. 
Dit proefschrift 
Ondanks het algemeen heersende idee dat het drinken van veel koffie 
ongezond is, is consumptie van papier-gefilterde koffie onschadelijk. 
Het is een wijdverbreide misvatting dat Darwins evolutietheorie gaat 
over een gericht proces dat leidt tot grotere complexiteit en uiteindelijk 
tot zelfbewuste intelligentie. 
Stephen J Gould, Interview door Wim Kayzer, VPRO TV, 1993 
Het aanprijzen en verkopen van zogenaamde 'natuurprodukten' met 
behulp van ongegronde gezondheidsclaims en het verzwijgen van mogelijke 
bijwerkingen, zoals dat door sommige zaken voor alternatieve voeding 
wordt gedaan, is een zuivere vorm van kwakzalverij. 
P-waardes worden vaak misbruikt om het denkproces bij het accepteren of 
verwerpen van hypotheses over te slaan. 
1 1 . Succes bij het volgen van een hogere opleiding wordt slechts in geringe 
mate door het IQ (datgene wat een intelligentietest meet) voorspeld. 
12. Boven de 80 jaar is een matig verhoogd serumcholesterolgehalte eerder 
een teken van goede gezondheid dan een risico-indicator voor coronaire 
hartziekte. 
Bernard Forette et al. Lancet 1989; i.868-870. 
13. De hoeveelheid onzin die commentatoren bij het verslaan van 
sportwedstrijden uitkramen, is omgekeerd evenredig met hun 
taalvaardigheid. 
14. De voedselschaarste die tot ondervoeding en hoge kindersterfte in sommige 
delen van de derde wereld leidt, is meestal een direct gevolg van oorlog. 
15. Het feit dat mensen door te eten dagelijks ongeveer 600 m2 darmepitheel 
aan 1,5 kg produkten van agrarische oorsprong blootstellen, onderstreept 
het belang van de Vakgroep Humane Voeding binnen de Faculteit der 
Landbouw- en Milieuwetenschappen. 
Stellingen behorend bij het proefschrift 
Dietary fatty acids and risk factors for coronary heart disease: 
controlled studies in healthy volunteers 
Peter L. Zock 
Wageningen, 11 januari 1995 
Aan mijn ouders 
The unique design of these studies was based on the belief that nutritional 
experiments can be carried out as precisely in man as in animals. 
Edward H. Ahrens, Jr., et al. The Lancet 1957; i: p.6976. 
Abstract 
Dietary fatty acids and risk factors for coronary heart disease: 
controlled studies in healthy volunteers 
PhD Thesis by Peter L. Zock, Department of Human Nutrition, Wageningen 
Agricultural University, Wageningen, The Netherlands. January 11, 1995. 
High levels of LDL cholesterol, blood pressure and Lp(a), and low levels of HDL 
cholesterol increase the risk for coronary heart disease (CHD). This thesis describes 
the effects of dietary fatty acids on these risk factors. In each of three trials we fed 
diets wi th tailored fatty acid composition to about 60 healthy men and women. 
Each diet within a trial was supplied to every volunteer for 3 weeks. 
In the first study we compared the effects of monounsaturated trans fatty 
acids with those of linoleic acid, the fatty acid from which trans fatty acids are 
formed upon partial hydrogénation, and with those of stearic acid, a product of 
complete hydrogénation of linoleic acid. Relative to linoleic acid, both trans fatty 
acids and stearic acid raised LDL and lowered HDL cholesterol. Thus, partial as well 
as complete hydrogénation of linoleic acid produces fatty acids that unfavorably 
affect serum lipids relative to linoleic acid itself. Trans fatty acids and stearic acid 
did not influence blood pressure, but trans fatty acids modestly raised Lp(a). 
The second study addressed the relative cholesterol-raising potentials of two 
specific saturates, myristic and palmitic acid. Relative to oleic acid, myristic acid 
was about 1.5 times as cholesterol-raising as palmitic acid, due to increases in 
both LDL and HDL cholesterol. The differences between myristic and palmitic acid 
were statistically significant. However, both saturates caused high LDL cholesterol 
levels and raise the LDL to HDL cholesterol ratio. 
In the third study we examined the effect of the positional distribution of fatty 
acids within dietary triglycerides. Two diets had identical total fatty acid 
composition, but a major contrast in fatty acid configuration. Total, LDL, and HDL 
cholesterol levels were the same on both diets. The position of the dietary fatty 
acids was partly reflected in fasting plasma lipids, but the fatty acid configuration 
had no important effect on lipoprotein levels. 
In conclusion, monounsaturated trans fatty acids and the saturates myristic 
and palmitic acid have adverse effects on the serum lipoprotein risk profile for 
CHD. People at high risk for CHD should replace the hard fats in their diets by 
carbohydrates or unsaturated oils. 
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Chapter 1 
Background and scope 
Coronary heart disease (CHD) is a major health problem in Western societies. 
In 1992, about 85,000 people in the Netherlands were hospitalized because of the 
disease, and it was the primary cause of more than 20,000 deaths [1]. The 
predominant clinical symptoms of CHD are angina, myocardial infarction, and 
sudden cardiac death [2]. The disease is characterized by an insufficient blood 
supply to the heart muscle. Its main cause is atherosclerosis, a combination of 
changes in the endothelium and smooth muscle of coronary arteries involving 
accumulation of lipids, fibrous lesions and ultimately impaired blood flow [3]. 
Several risk factors for CHD have been defined, including high blood cholesterol 
levels and blood pressure, smoking, obesity, diabetes and physical inactivity. The 
studies described in this thesis focus primarily on the influence of dietary fatty 
acids on the serum cholesterol concentration and its distribution over low density 
(LDL) and high density lipoproteins (HDL) in healthy men and women. In addition, 
effects of certain fatty acids on blood pressure and on the plasma lipoprotein(a) 
concentration, another risk factor for CHD, are addressed. 
This introduction gives a brief overview of epidemiologic studies on the 
relation of serum lipoprotein cholesterol, lipoprotein(a), and blood pressure with 
CHD, and the involvement of diet. In addition, the possible adverse effects of low 
or lowered cholesterol levels are discussed. The rationale of the studies and an 
outline of the thesis are given at the end of this chapter. 
Serum total or LDL cholesterol and coronary heart disease 
A large body of epidemiologic data indicates a direct relation between the level 
of total or LDL cholesterol and the incidence of CHD. The evidence includes within-
population studies [4-7] as well as cross-cultural comparisons [8,9]. Cohort studies 
within populations consistently show an association between blood cholesterol 
levels and CHD rates, this association is continuous throughout the entire range of 
cholesterol levels in the population [4]. An analysis of surveys which measured 
cholesterol levels in 17 different countries indicates that the variation in serum total 
and LDL cholesterol may explain four-fifths of the cross-cultural variation in CHD 
mortality [9]. Also, differences between populations in saturated fat and 
cholesterol intake are related with differences in CHD mortality rates [10,11]. It 
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should be mentioned, however, that the strength of associations observed in cross-
cultural studies depends on the populations included in the analysis, e.g [12], and 
that comparisons can easily be confounded by other life-style factors that 
accompany differences in fat consumption. Nevertheless, the reductions in 
cholesterol that have been achieved in the past years in some Western countries, 
mainly through changes in the diet, are associated with a decrease in CHD 
mortality [9]. 
The strongest evidence for a link between total or LDL cholesterol levels and 
CHD comes from randomized clinical trials. Such studies have shown that lowering 
cholesterol levels can reduce CHD incidence in persons without evidence of prior 
CHD (primary prevention trials) [13,14]. Trials in patients with angiographically 
defined symptoms (secondary prevention trials) have revealed that cholesterol 
lowering by diet [15-20] or drug therapy [21-23] can slow progression of 
atherosclerosis in both men and women and that even regression of the 
atherosclerotic process may be accomplished. Meta-analyses that pool the results 
of prevention trials also demonstrate that dietary therapy alone is effective in 
reducing CHD rates [24-29]. 
Clinical trials of relatively short-term duration indicate that each 1 % reduction 
in the total cholesterol level results in about a 2% reduction in CHD incidence 
[25,29,30]. Observational studies suggest that the reduction in CHD risk with long-
term cholesterol lowering may be substantially greater [29,31], especially when 
underestimation of the association due to individual variability in cholesterol levels 
(regression dilution bias) is taken into account [32]. In summary, high LDL or total 
cholesterol levels have proven to be powerful risk factors for CHD. 
Low cholesterol levels and total mortality 
The evidence that cholesterol lowering prevents CHD is the corner stone of the 
public health policy to controlling high blood cholesterol. However, doubts have 
been voiced as to whether cholesterol lowering yields benefit in terms of reduced 
total mortality, and it has been proposed that low or lowered cholesterol levels may 
be a significant risk factor for non-CHD mortality [26,33-36]. Different types of 
epidemiologic studies provide evidence on the total mortality issue. 
13 
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Observational studies 
Ecological comparisons show that populations with lower cholesterol levels 
generally have lower age-adjusted mortality, mainly the results of less CHD, than 
populations with high cholesterol levels [9,10,37]. These population studies are 
suggestive, but confounding due to certain differences in life-style cannot be 
excluded. 
Other observational information is derived from within-population cohort 
studies. In the 30-year follow-up of the Framingham Heart Study [38], young 
persons with the lowest serum cholesterol concentrations at entry were found to 
have lower total mortality rates at midlife than those with high initial 
concentrations. Similar findings were reported for the men in the Johns Hopkins 
Precursors Study [39], who were followed for 30.5 years. Jacobs et al. [40] 
recently reviewed a large number of cohort studies. They reported that men in the 
range of 4.14 to 5.15 mmol/L had a lower total mortality rate than men with higher 
cholesterol levels. However, the relation between cholesterol level and total 
mortality appeared to be J-shaped; higher total mortality occurred with elevated 
levels of cholesterol, but was also noted in men with very low total cholesterol 
levels [40]. The Multiple Risk Factor Intervention Trial (MRFIT) constituted two 
thirds of the total number of men in this review. A more detailed analysis of the 
large MRFIT follow-up study revealed that there was no trend for an increase in 
total mortality until the cholesterol concentration fell below 3.62 mmol/L, and a 
significant increase was noted only in the very small portion of men with levels 
lower than 3.10 mmol/L [41]. The pooled cohort data in the review by Jacobs and 
others [40] showed a statistical significant increase in total deaths at very low 
cholesterol levels for a variety of conditions, including some cancers (e.g. lung but 
not colon), respiratory disease, liver disease, hemorrhagic stroke, and trauma. It is 
conceivable is that some of these disorders lower serum cholesterol; in that case 
a low level at entry may be only a marker of increased risk and not the cause of 
excess mortality. A systematic review of the 10 largest cohort studies also reports 
increased mortality from various causes at low cholesterol levels [42]. Only 
hemorrhagic stroke was significantly associated with low cholesterol, however, 
increased hemorrhagic risk was clearly outweighed by a lower CHD mortality. 
Moreover, a higher non-CHD death rate at low cholesterol levels was limited to 
community cohorts; the association was absent in the cohorts of employed men. 
The chance of including subjects with pre-existing disease is higher in community 
cohorts than in cohorts of employed, generally healthy persons. This supports that 
14 
General introduction 
underlying illness may decrease serum cholesterol levels and confound the relation 
between low cholesterol and excess mortality [42]. Low cholesterol levels could 
also be associated with other characteristics that place people at a higher risk, 
such as heavy alcohol use or socioeconomic status [7,43]. 
Clinical trials 
Randomized prevention trials have been designed to detect effects of 
cholesterol lowering on CHD incidence or recurrence, and because of their 
relatively small size and duration they are of limited value in assessing non-CHD or 
total mortality [44]. In addition, the treated subjects in the secondary prevention 
trials do not have low enough cholesterol levels to confirm or refute the excess 
non-CHD deaths at very low levels. Nevertheless, several meta-analysis of 
cholesterol lowering trials [26,33,35] show an increase in combined non-CHD 
deaths in the treated subjects, comprising small, non-significant increases in 
mortality from a variety of diseases. The diverse causes of death make it difficult 
to postulate a biological mechanism by which cholesterol lowering in itself 
produces specific adverse effects that increase risk. The lack of a plausible 
mechanism weakens the notion that low cholesterol levels may cause higher total 
mortality. 
Meta-analyses of prevention trials have found increased non-CHD mortality in 
studies using drugs but not in those using dietary therapy [26,27,42]. The exact 
nature of any adverse side-effects of drugs and, if they are real, whether they are 
confined to one class of drugs or extend to all cholesterol lowering drugs remains 
to be established. A recent review of non-drug prevention trials shows that dietary 
interventions, with or without additional advice to quit smoking and/or to increase 
physical exercise, reduce CHD risk as well as total death rates [28]. Thus, there is 
no indication that lowering cholesterol by diet increases non-CHD or total mortality. 
Conclusion 
At present, the evidence that blood cholesterol lowering reduces mortality and 
morbidity is much more consistent and reliable than the evidence that certain 
cholesterol lowering drugs may increase non-CHD death rate, which may be an 
association based on confounding. Even if total mortality accompanying cholesterol 
reduction in is unchanged, substantial benefit will still be gained by a reduction in 
CHD morbidity. In any case, the available evidence suggests that dietary treatment 
of elevated total and LDL cholesterol levels is totally safe. 
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Other risk factors for coronary heart disease 
HDL cholesterol and triglycerides 
Studies in high-risk populations consistently show that low HDL cholesterol 
levels are associated with an increased CHD risk, independent of LDL cholesterol 
and other risk factors [31,45]. Data from the largest prospective studies in the 
United States indicate that for every 0.026 mmol/L (1 mg/dL) decrease in HDL 
cholesterol, the risk for CHD is increased by 2% to 3% [46,47], after adjustment 
for other risk factors. Similar results were found for men and women. None of the 
large-scale primary and secondary prevention trials was designed specifically to 
test the hypothesis that raising HDL cholesterol concentrations reduces risk. Thus 
it may be difficult to discriminate the relative contributions of LDL lowering and 
HDL raising to CHD risk reduction. Nevertheless, several trials show an 
independent contribution of increased HDL cholesterol to the overall reduction in 
CHD incidence [22,47,48]. Also, people with genetically deficient HDL have a high 
risk of premature CHD, in spite of low LDL cholesterol levels [49]. Taken together, 
the available information on HDL cholesterol and CHD provides considerable 
support for a causal relationship. However, to date there is no definitive evidence 
that manipulation of HDL levels modifies susceptibility for CHD. Although plausible, 
the beneficial effect of raising HDL by diet remains to be established. 
Observational studies show that people with high fasting triglyceride levels 
have an enhanced CHD-risk [31,50]. However, high triglyceride concentrations go 
together with other risk factors such as obesity, diabetes, low HDL levels, and lack 
of physical activity. In multivariate analyses of cohort studies, triglycerides often 
lose their ability to predict CHD when these factors are taken into account [50,51 ] . 
Therefore, it is unclear whether a high level of triglycerides causes CHD by itself 
or serves mainly as an indicator of other risk factors, such as low HDL cholesterol 
levels. Some investigators suggest that postprandial rather than fasting 
triglycerides may be atherogenic [52,53], but the evidence on this point is still 
limited. 
Lipoprotein (a) 
Lipoprotein(a) (Lp(a)) is a plasma lipoprotein whose structure and composition 
closely resembles that of LDL, but with an additional molecule of apolipoprotein(a), 
a large glycoprotein showing sequence homology to plasminogen [54]. Levels of 
Lp(a) in the blood are largely genetically determined [54,55]. The interest in this 
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lipoprotein has recently been increased because of accumulating evidence that 
elevated Lp(a) concentrations are an independent risk factor for CHD, e.g. [56-60]. 
However, most of the studies are based on cross-sectional observations. The few 
prospective studies that have been published show either a higher risk of CHD in 
subjects with high Lp(a) levels [58,61] or no association [62-64]. These latter 
studies do not negate a role of Lp(a) in atherogenesis, but it is obvious that more 
large prospective studies are needed to confirm that high Lp(a) levels are causally 
related to CHD. Despite structural resemblance, the influence of diet on Lp(a) 
concentrations seems different from that on LDL cholesterol. Unlike LDL, Lp(a) 
levels are generally insensitive to dietary changes [60]. However, relatively little 
study on dietary determinants of Lp(a) have been done. 
Blood pressure 
High blood pressure is an established risk factor for CHD [65]; the higher the 
blood pressure, the greater the risk for CHD [66-68]. In several trials of relatively 
short-term duration, treatment of hypertension could not be shown to reduce CHD 
[69]. A recent overview of randomized trials, however, shows that lowering blood 
pressure significantly reduces the CHD incidence [70]. Thus, the relation between 
blood pressure and CHD appears to be causal. The majority of epidemiologic 
studies used diastolic blood pressure to characterize the blood pressure of an 
individual, irrespective of other parameters, such as systolic pressure. Therefore, 
diastolic rather than systolic blood pressure is generally regarded as an independent 
risk factor of CHD. In both observational studies and trials, however, differences 
between groups in diastolic pressure are much the same as differences in systolic 
pressure [68,70]. Thus, it is conceivable that high levels of both systolic and 
diastolic blood pressure are indicators of increased CHD risk. Several [71-74], but 
not all [75-78] studies on dietary fat and blood pressure suggest that the quantity 
and quality of fat consumption may modulate systolic and diastolic blood pressure. 
Dietary fat and serum lipoprotein cholesterol 
A host of metabolic studies conducted in the past 35 years shows that total 
and lipoprotein cholesterol levels can be influenced by fat intake [79-81]. Dietary 
fat largely consists of a mixture of triglycerides. The constituent fatty acids are 
usually classified according to their number of double bonds. We distinguish 
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saturated (zero double bonds), monounsaturated (one double bond), and 
polyunsaturated fatty acids (more than one double bond). The main 
monounsaturate in the diet is oleic acid (c/s-C18:1n-9) and the main polyunsaturate 
is linoleic acid (c/s,c/s-C18:2n-6). A recent meta-analysis of 27 well-controlled 
dietary trials summarizes the effect of the 3 classes of fatty acids on serum 
lipoprotein cholesterol [81]. Replacement of carbohydrates by fat raises HDL 
cholesterol; saturated fatty acids being the most potent and linoleic acid the least. 
Increasing dietary fat intake at the expense of carbohydrates also lowers the 
fasting triglyceride levels; saturates, oleic acid, and linoleic acid all produce this 
effect to about the same extent. Effects on LDL cholesterol are markedly different, 
with saturated fatty acids strongly raising LDL, and linoleic acid modestly lowering 
it. Oleic acid also has a slight LDL cholesterol lowering effect relative to 
carbohydrates. The influence of the different fatty acids on total cholesterol largely 
resemble those on LDL [81]. Thus, changing the fatty acid composition of the diet 
provides a useful tool to favorably modify the lipoprotein risk profile for CHD. 
Rationale of the studies and outline of the thesis 
Dietary fatty acids may differ from each other in three aspects other than the 
number of double bonds, namely, 1. the configuration of the double bonds (cis or 
trans), 2. the number of carbon atoms (chain length), and 3. the position of the 
fatty acid on the glycerol molecule (triglyceride configuration). The present thesis 
addresses the influence of these aspects on serum lipoprotein cholesterol and other 
CHD risk factors. The effects of various fatty acids were investigated by means of 
strictly controlled trials, in which we supplied conventional solid food diets with 
specific fatty acid compositions to large groups of healthy men and women. Our 
studies focussed on the most common fatty acids in human diets. The medium 
chain fatty acids (C6:0, C8:0, and C10:0) and the n-3 polyunsaturated fatty acids 
(C18:3n-3, C20:5n-3, and C22:6n-3) are beyond the scope of this thesis. 
7. Configuration of double bonds: monounsaturated trans fatty acids 
Most natural fats and oils have their double bonds in the cis configuration. 
Monounsaturated trans fatty acids (positional isomers of trans-C\8:1) are formed 
during hydrogénation of linoleic acid, either by bacteria in ruminant animals or by 
processing in oil-hardening factories. High-linoleic-acid vegetable oils are partially 
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hydrogenated by the edible oil industry to produce solid and stable fats. Certain 
types of margarine and shortenings are especially high in trans fatty acids. Interest 
in the health effects of these fatty acids has been increased since Mensink and 
Katan [82] reported that monounsaturated trans fatty acids raise LDL and lower 
HDL cholesterol relative to their cis isomer oleic acid. It has been proposed that 
stearic acid (C18:0), a saturate known to be 'neutral' in its effect on lipoprotein 
levels, might offer a favorable alternative to trans fatty acids for the production of 
solid and semi-solid fats. 
In the first study we compared monounsaturated trans fatty acids with linoleic 
acid, the parent fatty acid from which trans fatty acids are formed upon partial 
hydrogénation, and with stearic acid, a product of complete hydrogénation of 
linoleic acid. Chapter 2 addresses the effects on HDL and LDL cholesterol, and 
Chapter 3 deals with systolic and diastolic blood pressure. The data on Lp(a) were 
combined with those from two previous dietary trials conducted at our department 
and are described in Chapter 4. 
2. Chain length: specific saturated fatty acids 
It is common knowledge that saturated fatty acids with a chain length of 12 
to 16 carbon atoms powerfully raise total and LDL cholesterol. Palmitic acid 
(C16:0) is by far the most abundant saturate in our diet. It occurs in all kinds of 
animal and in most vegetable fats. Palm oil, an important raw material for the 
edible oil industry, has a very high palmitic acid content. A major source of myristic 
acid (C14:0) in Western diets is dairy fat, which is also rich in palmitic acid. Certain 
tropical oils, such as coconut oil and palm kernel oil, are rich in both myristic acid 
and lauric acid (C12:0). Little information is available on the relative 
cholesterolemic effects of these specific saturates. Meta-analyses [80,81 ] indicate 
that myristic acid might be much more potent than palmitic acid. It has been 
suggested that myristic acid could be largely responsible for the cholesterol-raising 
effect of C12-C16 saturates, and that palmitic acid may be neutral [83-85]. 
However, other studies clearly show that palmitic acid has a cholesterol-raising 
potential [86-90]. 
The second study, reported in Chapter 5, addresses the issue of myristic 
versus palmitic acid. In order to quantify their relative potencies, we compared the 
effects of myristic and palmitic acid on LDL and HDL cholesterol with each other 
and with those of oleic acid. 
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3. Triglyceride configuration: positional distribution of fatty acids 
Natural dietary fats and oils differ in the distribution of their constituent fatty 
acid over the three possible attachment sites of the triglyceride molecule. For 
example, palmitic acid in lard is mainly esterified to the sn-2 position of glycerol, 
whereas palm oil contains its palmitic acid predominantly in the s/7-1 and SA7-3 
position. In addition, the fatty acid configuration of food fats can be altered to 
produce confectionary and other fats with better texture or certain desired physical 
properties. Animal experiments have suggested that changes in the fatty acid 
distribution can alter their atherogenicity and cholesterolemic effects [91-93]. 
McGandy and co-workers [94] speculated that the stereospecific position of a fatty 
acid might modulate its effect on cholesterol levels in humans. The influence of 
triglyceride structure on lipid metabolism has been extensively studied in animal 
models (see for review [95]), but at present few human data are available. 
In the third study we compared two dietary fats with equal amounts of 
individual fatty acids but different positional distribution. Chapter 6 describes the 
effects on lipoprotein cholesterol levels and in Chapter 7 we report the influence 
of triglyceride structure on the fatty acid composition and configuration of fasting 
plasma lipids. 
Finally, Chapter 8 summarizes the main results. Our findings are put into 
perspective with studies that have been reported since some chapters of this thesis 
were published. Furthermore, methodologie aspects of our diet studies are 
reviewed. Chapter 8 ends with a concluding paragraph. 
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ABSTRACT 
Aim. The objective of this study was to compare the effects of linoleic acid (cis,cis-
C18:2n-6,n-9) and its hydrogénation products elaidic (fra/7s-C18:1n-9) and stearic 
acid (C18:0) on serum lipoprotein levels in man. 
Methods. Twenty-six men and 30 women, all normolipemic and apparently healthy, 
completed the trial. Three experimental diets were supplied to every subject for 
three weeks each, in random order (multiple cross-over). The Linoleate-diet 
provided 12.0% of total energy intake as linoleic acid, 2.8% as stearic acid, and 
0.1 % as trans fatty acids. The Stearate-diet supplied 3.9 energy % as linoleic acid, 
11.8% stearic acid, and 0.3% trans fatty acids. The 7ira/7S-diet provided 3.8 
energy % as linoleic acid, 3.0% stearic acid, and 7.7% as monounsaturated trans 
fatty acids, largely elaidic acid (rra/7S-C18:1n-9). Other nutrients were constant. 
Fasting blood was sampled at the end of each dietary period. 
Results. Mean (±SD) serum LDL cholesterol was 109 ± 2 4 mg/dL (2.83 ± 0.63 
mmol/L) on the Linoleate-diet. It rose to 116 ± 27 mg/dL (3.00 ± 0.71 mmol/L) 
on the Stearate-diet (change, 7 mg/dL or 0.17 mmol/L, P = 0.0008) and to 119 ± 
25 mg/dL (3.07 ± 0.65 mmol/L) on the Trans-d\e\ (change, 9 mg/dL or 0.24 
mmol/L, P<0.0001) . HDL cholesterol decreased by 2 mg/dL (0.06 mmol/L, 
P<0.0001) on the Stearate-diet and by 4 mg/dL (0.10 mmol/L, P<0.0001) on the 
Trans-d\et, both relative to linoleic acid. 
Conclusion. Our findings show that 7.7% of energy (mean, 24 g/day) of trans fatty 
acids in the diet significantly lowered HDL cholesterol and raised LDL cholesterol 
relative to linoleic acid. Combination with earlier results (Mensink RP, Katan MB. 
N Engl J Med 1990; 323: 439-445.) suggests a linear dose-response relation. 
Replacement of linoleic acid by stearic acid also caused somewhat lower HDL 
cholesterol and higher LDL cholesterol levels. Hydrogénation of linoleic acid to 
either stearic or trans fatty acids produces fatty acids that may increase LDL and 
decrease HDL cholesterol relative to linoleic acid itself. 
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INTRODUCTION 
Monounsaturated trans fatty acids with a length of 18 carbon atoms are 
formed when vegetable oils, rich in linoleic acid, are partially hydrogenated so as 
to produce fats with better texture and stability [1]. Although the intake of these 
trans fatty acids, mainly elaidic acid and its isomers (Fig. 1), is much lower than 
that of saturated fatty acids, it is still considerable in industrialized countries. Their 
estimated average consumption is 3 to 4 % of daily energy intake in the United 
States [2]. 
LINOLEIC ACID ^OH 
< 
r 
TRANS- 018:1 (n-10)/A8 
TRANS-C18:1(n-9)/A9 
(ELAIDIC ACID) 
^ TRANS-C18:1(n-8)/A10 
\ 
,0 
OH 
0 
OH 
0 
O^H 
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- ^ 
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Fig 1. Structure of linoleic acid and of some products of hydrogénation. Partially 
hydrogenated soybean oil usually contains a spectrum of positional trans-C\8A isomers 
with C18:1n-8 (A10) being the most abundant [3]. 
Early studies on the effects of trans fatty acids on blood lipids produced 
conflicting results. Some studies [4-6] suggested that trans fatty acids, as 
compared to their cis isomer oleic acid, elevate serum total cholesterol levels, while 
others [7-9] could not confirm this. In a previous study conducted at our 
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Department it was found that trans monounsaturated fatty acids were 
hypercholesterolemia as compared with oleic acid, and that their effect was about 
half of that of a mixture of saturated fatty acids (C12:0, C14:0, and C16:0) [10]. 
In this study trans fatty acids not only raised the serum level of atherogenic low 
density lipoprotein (LDL) cholesterol, but also lowered high density lipoprotein 
(HDL) cholesterol [10]. However, the amount of trans fatty acids given was quite 
high ( 1 1 % of daily energy intake), and doubts have been voiced as to whether 
these findings could be extrapolated to lower levels of intake [11]. 
A product of further hydrogénation of linoleic acid (Fig. 1) is stearic acid, the 
completely saturated analogue of elaidic acid. Stearic acid has been found not to 
raise the serum cholesterol level relative to carbohydrates and to exert effects on 
serum lipids similar to those of oleic acid [12-15]. Like trans fatty acids and other 
saturated fatty acids, stearic acid is a rigid molecule whose presence adds firmness 
to foods. Although stearic acid has a higher melting point than trans fatty acids or 
palmitic acid (C16:0) and has a waxy nature, a limited increase in the stearic acid 
content at the expense of other saturated fatty acids or trans fatty acids has been 
suggested as a way for the edible-fats industry to produce semi-solid and solid fats 
with less of a cholesterol-raising potential [16]. 
Therefore we compared the effects of trans fatty acids on serum lipoprotein 
and apolipoprotein levels in healthy men and women with those of stearic acid and 
of linoleic acid, the parent fatty acid from which trans fatty acids and stearic acid 
are derived during the hydrogénation of soybean and other linoleic acid-rich oils. 
SUBJECTS AND METHODS 
Subjects 
Out of 110 persons who responded to calls via local newspapers 45 women 
and 42 men were randomly selected for a screening procedure. Two women and 
one man were excluded for medical reasons and two men and two women 
withdrew during the screening. The remaining 80 volunteers, 39 men and 41 
women, had no history of atherosclerotic disease, and all were apparently healthy, 
as indicated by a medical questionnaire. None had anemia, glycosuria, proteinuria, 
or hypertension, and none were taking medications known to affect blood lipids. 
Because only 62 subjects could be enrolled in the trial, 31 men and 31 women 
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were randomly selected to take part. Three men withdrew before the study began. 
The protocol and aims of the study were fully explained to the subjects, who gave 
their written consent. No reward was given, except for the free food in the study 
diets. Approval for the study had been obtained from the Ethics Committee of the 
Department. During the study two men withdrew, one because of personal reasons 
and one because of illness. One woman withdrew because of pregnancy. All 
analyses are based on the 26 men and 30 women who completed the trial. Before 
the beginning of the study diets, the subjects' fasting serum lipid levels ranged 
from 3.31 to 6.66 mmol/L for total cholesterol (mean, 4.84 mmol/L or 187.2 
mg/dL), from 0.87 to 2.04 mmol/L for HDL cholesterol (mean, 1.38 mmol/L or 
53.4 mg/dL), and from 0.39 to 1.58 mmol/L (mean, 0.94 mmol/L or 83.2 mg/dL) 
for triglycerides. The men's age ranged from 19 to 48 years (mean, 25 years), and 
they weighed between 60 and 84 kg (mean, 73 kg). Their body mass index ranged 
from 18.5 to 26.0 kg/m2 (mean, 21.5 kg/m2). The women were between 18 and 
49 years old (mean, 24 years), and weighed between 51 and 80 kg (mean, 63 kg); 
their body mass index ranged from 17.9 to 27.5 kg/m2 (mean, 21.5 kg/m2). 
Thirteen women used oral contraceptives, and 4 men and 4 women smoked. 
Design and statistical analyses. 
The trial ran from January 29 until April 2, 1990. The study had a multiple 
crossover design and consisted of three consecutive periods. Each subject followed 
the three study diets for three weeks each. Our experience agrees with that of 
earlier workers [12,17] in that serum lipid and lipoprotein levels stabilize within two 
weeks after a dietary change [18,19]. One diet was high in linoleic acid 
(Linoleate-diet), one was high in stearic acid (Stearate-diet), and the third was high 
in elaidic acid (7A3A?s-diet). Before the trial, the participants were categorized 
according to sex. Male and female subjects were then divided into six groups so 
that each group had a nearly identical number of subjects from both sexes. Women 
who used oral contraceptives were equally distributed over the six treatment 
sequences. Each group received the diets in different order (Fig. 2). In this way, 
variation due to residual effects of the previous diet or to drift of variables over 
time were eliminated [20]. We attempted to blind the participants as to the 
sequence of their diets, but at the end of the trial it turned out that all subjects had 
recognized the linoleic acid-rich diet, and most of them had also correctly identified 
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Fig 2. Experimental design. 
the trans and stearic acid-rich diets. However, it is highly unlikely that awareness 
of the nature of the treatment could have affected the outcome of the study. 
The data were analyzed with the General Linear Models (GLM) of the 
Statistical Analyses System [21]. When the analyses indicated a significant effect 
of diet (P<0.05) , the Tukey method was used for pairwise comparisons of the 
diets and for calculation of 95 % confidence limits for the differences between two 
diets [21 ]. This method encompasses a downward adjustment of significance limits 
for multiple testing and, as a result, only P-values of less than 0.02 were 
considered significant. 
Diets 
Before the trial started, the participants recorded their habitual diet for two 
working days and one weekend day to allow us to estimate their energy and 
nutrient intake. The food records were coded and the nutrient composition and 
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energy content of the diets were calculated with use of the Netherlands Nutrient 
Data Base [22]. The study diets consisted of conventional solid foods, and menus 
were changed daily during each 3-week cycle. The planned nutrient content of the 
three diets was similar, except for 8% of total energy, which was provided by 
either linoleic acid, stearic acid, or elaidic acid. The linoleate group received a 
commercially available margarine high in linoleic acid (Becel, Van den Bergh foods, 
Rotterdam, The Netherlands). In addition, high-linoleic acid sunflower oil was used 
in the preparation of various dishes. For the Trans-d\et, high-oleic acid sunflower 
oil (Trisun, SVO Enterprises, Wickliffe, OH) was hydrogenated with a sulferized 
nickel catalyst (Pricat 9908, Unichema, Emmerich, Germany) under conditions that 
favored formation of trans rather than saturated fatty acids. This hydrogénation 
procedure was largely similar to that applied for our previous study [10,23]. We 
used this procedure rather than hydrogénation of a linoleic acid-rich oil so as to 
avoid the formation of frans-isomers of C18:2 and to maximize the yield of trans-
C18:1 . Seventy-five parts of the hydrogenated fat were mixed with 25 parts of the 
unaltered oleic acid-rich oil, and used to produce a margarine and a shortening high 
in elaidic acid. Fats for the Stearate-diet were produced by interesterification of a 
mixture of 41 parts of fully hydrogenated high-linoleic acid sunflower oil (Chempri, 
Raamsdonksveer, The Netherlands), 50 parts of high-oleic acid sunflower oil, and 
9 parts of unmodified high-linoleic acid sunflower oil. 
Thus, the basic source of all fatty acids in which the three diets differed was 
sunflower oil. The special margarine and shortenings were developed and 
manufactured by the Unilever Research Laboratory (Vlaardingen, The Netherlands). 
Table 1 gives the fatty acid composition of margarine and oil used in the three 
diets. Positional isomers of monounsaturated C18:1-fatty acids were identified by 
gas-liquid chromatography using a capillary Sil-88 column. 
The diets were formulated at 24 levels of energy intake ranging from 5.5 to 
17.5 M J (1315 to 4185 kcal) per day. All foodstuffs were weighed out for each 
individual subject. On week days at noon, hot meals were served and eaten at the 
department. All other food was supplied daily as a package. Food for the weekend 
and guidelines for its preparation were provided on Fridays. In addition to the food 
supplied, subjects were allowed a limited number of items free from fat and 
cholesterol. The energy intake from these free-choice items was fixed for each 
level of energy intake and ranged from 7 to 13% of total energy intake. Subjects 
were urged not to change their selection of free-choice items throughout the trial. 
They were asked to maintain their usual pattern of physical activity and not to 
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Table 1. Fatty acid composition of the margarine and oil used in the three study diets. 
Fatty Acid 
Saturated 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C16:0) 
Monounsaturated 
C/s-C18:1 
7rens-C18:1 
Polyunsaturated 
Linoleic acid (c/s,c/s-C18:2) 
Trans-C18:2 
Others 
Linoleate-Diet 
18.1 
1.5 
0.6 
7.6 
7.0 
18.8 
18.4 
0.1 
62.5 
61.9 
0.5 
0.5 
Stearate-Diet 
g per 700 g of fatty acid 
52.9 
0.1 
0.1 
5.6 
45.5 
37.4 
37.0 
0.1 
9.5 
9.4 
0.0 
0.2 
Trans-Diet 
12.1 
0.0 
0.0 
3.6 
6.6 
84.2 
43.6a 
40.2b 
2.1 
1.9 
0.2 
1.6 
Commercially available linoleic acid-rich margarine and regular sunflower oil provided 37% of the total fat 
content of the Linoleate-diet, high-stearic acid margarine and shortening provided 48% of the total fat content 
of the Stearate-diet, and high-elaidic acid margarine and shortening provided 44% of the total fat content of 
the Trans-diet. 
a
 Positional cis isomers: C18:1n-4, 0.1 g; C18:1n-5, 0.2 g; C18:1n-6, 0.4 g; C18:1n-7, 1.3 g; C18:1n-9, 
38.5 g; C18:1n-12, 3.1 g. 
* GLC showed three positional isomers, predominantly C18:1n-9 (A9) (elaidic acid) plus traces of C18:1n-8 
(A10) and C18:1n-10 (A8). 
change their smoking habits, consumption of coffee, or use of oral contraceptives. 
The participants recorded in diaries any sign of illness, medication used, the 
selection and use of free-choice items, the amount and type of coffee consumed, 
and any deviations from their diets. Inspection of the diaries did not reveal any 
deviations from the protocol which might have affected the results. Duplicate 
portions of each study diet were collected on each of the 63 trial days for an 
imaginary participant with a daily energy intake of 11 MJ (2630 Kcal), stored at 
- 2 0 °C, and pooled and analyzed after the study. These analyzed values of the 
food supplied were combined with the values for the free-choice items (Table 2). 
Body weights without shoes, jackets, and heavy sweaters were recorded twice 
weekly. The level of energy intake was adjusted when necessary, as indicated by 
weight changes. Over the 63 days of the trial average body weight fell by 0.2 ± 
1.1 kg (range, - 2 . 5 to 2.0 kg). The mean difference in body weight at the end of 
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the dietary periods was 0.1 ± 0.7 kg (range - 1 . 7 to 1.4 kg) between the 
Linoleate-dietand the Stearate-diet, 0.0 ± 0.8 kg (range - 2 . 1 to 1.8 kg) between 
the Linoleate-diet and the Trans-diet, and 0.1 ± 0.7 kg (range - 1 . 8 to 2.4 kg) 
between the Trans-diet and the Stearate-diet. 
Blood sampling and analyses 
Before the trial each participant had been assigned a random number that was 
then used for labeling blood and serum tubes. In this way the laboratory 
technicians were kept unaware of the subjects' diet sequence. Blood samples were 
taken after a 12 hour fast on days 1,18 and 21 (period 1 ), days 39 and 42 (period 
2), and on days 60 and 63 (period 3). All venipunctures of each subject were 
performed by the same technician, in the same location, and at the same time of 
the same day of the week. Serum was obtained by low-speed centrifugation within 
1 h of venepuncture, stored at - 8 0 °C, and analyzed enzymatically for total and 
HDL cholesterol and triglycerides [24,25]. All samples from a particular subject 
were analyzed within the same run. The coefficient of variation within runs was 
1.5% for total cholesterol, 1.6% for HDL cholesterol, and 2.9% for triglycerides. 
Mean bias with regard to the target values of 3 serum pools provided by the 
Centers for Disease Control (Atlanta, G A) [26] was 0.14 mmol/L for total 
cholesterol and 0.04 mmol/L for triglycerides. The mean bias with regard to target 
values of 4 serum pools obtained from the Solomon Park Research Laboratories 
(Kirkland, WA) was 0.09 mmol/L for HDL cholesterol. LDL cholesterol was 
calculated using the Friedewald equation [27]. Apolipoproteins were assayed by 
Dr. M. Sandkamp at the Institut für Klinische Chemie und Laboratoriumsmedizin, 
Münster, Germany (Head: Prof. Dr. G. Assmann), using a turbidimetric method on 
microtitre plates, as described [28]. All samples from the same proband were 
measured on the same day within one series. The coefficient of variation within the 
series was 3.5% for apolipoprotein A-l and 3.6% for apolipoprotein B. The two 
lipoprotein and apolipoprotein values obtained at the end of each dietary period 
were averaged for data analyses. 
For each subject, the fatty acid composition of serum cholesterol esters was 
determined in samples obtained at the end of each dietary period (days 2 1 , 42, and 
63) as described earlier [29], with the following modifications: cholesteryl esters 
and triglycerides were separated with Bond Elute solid phase extraction columns 
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(Analytchem International, Harbor City, CA), the component fatty acids were 
methylated with 4 % (v/v) H2S04 in methanol, and a capillary Sil-88 column was 
used for gas chromatographic analysis. The results are expressed as a proportion 
by weight of all fatty acids detected. 
Table 2. Mean daily intake of nutrients of subjects while on the high-linoleic acid diet, the 
high-stearic acid diet, and the high-trans fatty acid diet. 
Energy/Nutrient 
Energy 
MJ/day 
kcal/day 
Protein (% of energy) 
Fat (% of energy) 
Saturated fatty acids 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C16:0) 
Monounsaturated fatty acids 
C/s-C18:1 
7>a/7s-C18:1 
Polyunsaturated fatty acids 
Linoleic acid (c/s,c/s-C18:2) 
7ra/?s-C18:2 
Carbohydrates (% of energy) 
Alcohol (% of energy) 
Cholesterol (mg/MJ) 
^-Sitosterol (mg/MJ) 
Other plant sterols (mg/MJ) 
Dietary fiber (g/MJ) 
Linoleate-Diet 
12.0 ± 2.8 
2869 ± 670 
12.3 
41.1 
11.0 
0.7 
0.9 
5.8 
2.8 
15.8 
14.7 
0.1 
12.5 
12.0 
0.0 
46.0 
0.9 
33.5 
23.8 
3.0 
3.6 
Stearate-Diet 
11.0 ± 2.7 
2845 ± 646 
12.3 
43.5 
20.1 
0.5 
1.0 
5.7 
11.8 
16.6 
15.4 
0.3 
4.3 
3.9 
0.0 
43.5 
0.9 
32.6 
25.1 
3.9 
3.9 
Trans-D\et 
12.0 ± 2.7 
2869 ± 646 
12.8 
39.7 
3.0 
0.5 
1.0 
4.8 
3.0 
23.3 
14.6 
7.7a 
4.2 
3.8 
0.0 
46.6 
1.0 
33.5 
22.6 
3.0 
4.0 
Values are based on chemical analyses of duplicate diets plus the calculated contribution of free-choice 
items (see Methods). Each value represents the mean of three independent duplicates collected in three 
different periods during which each diet was consumed by one-third of the subjects. Variations between 
periods were negligible. 
a
 Values for total trans fatty acid content as determined by gas-liquid chromatography (GLC) and by infrared 
spectroscopy (IR) were similar: both GLC and IR indicated 20.2 g of trans fatty acids per 100 g of total fatty 
acids in the trans fatty acid diet. 
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RESULTS 
Diets and dietary adherence 
The mean daily intakes of energy and the composition of the three 
experimental diets as determined by chemical analyses of duplicate diets plus 
calculated contribution of free-choice items are given in Table 2. Energy and 
nutrients supplied by the free-choice items (mainly carbohydrates and some alcohol 
and protein) did not differ between the dietary regimes. The intake of protein, 
carbohydrates, alcohol, cholesterol, phytosterols, and fiber did not change 
throughout the study. Total fat intake differed somewhat between the Trans-diet 
and the Stearate-diet (3.8 energy %) due to small differences in the intake of oleic 
acid (c/s-C18:1) and saturated fatty acids (C12:0, C14:0, C16:0), and also due to 
the fact that the difference in stearic acid (C18:0) intake turned out to be 8.8% of 
energy instead of the planned 8%. The percentage of total daily energy from 
linoleic acid decreased from 12.0% on the Linoleate-diet to 3.9% and 3.8% on the 
Stéarate and Trans-diet, respectively. It was replaced by 9.0% stearic acid on the 
Stearate-diet and by 7.6% monounsaturated trans fatty acids on the Trans-diet. 
At an energy intake of 11 MJ (2630 kcal) per day the Trans-diet provided 8.7 g of 
stearic and 22.2 g of trans fatty acids (fraA7s-C18:1) per day, while the 
Stearate-diet supplied 34.2 g of stearic acid and 0.8 grams of trans fatty acids. 
Gas-liquid chromatography revealed 3 positional isomers of fra/7s-C18:1 in the 
trans fatty acid-rich margarine and shortening; predominantly trans-C\ 8:1 n-9 (A9, 
elaidic acid) and minor amounts of fra/7S-C18:1n-10 (A8) and fr9A7S-C18:1n-8 
(A10). 
The fatty acid composition of the serum cholesteryl esters at the end of the 
three dietary periods confirmed the subjects' adherence to the diets (Table 3). In 
54 out of the 56 subjects the proportion of linoleic acid in the cholesteryl esters 
was higher on the Linoleate-diet than on either the Stearate-diet (average change, 
6.60 g/100 g; 95% confidence interval, 5.87 to 7.33) or the Trans-diet (average 
change, 8.17 g/100 g; 95% confidence interval, 7.44 to 8.99). The percentage of 
stearic acid was increased on the Stearate-diet in 55 out of 56 subjects relative to 
the Linoleate-diet (change 0.97 g/100 g; 95% confidence interval, 0.86 to 1.09) 
or to the Trans-diet (change 0.88 g/100 g; 95% confidence interval, 0.76 to 0.99). 
Fifty-four out of the 56 subjects showed a larger proportion of elaidic acid in their 
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Table 3. Fatty acid composition of serum cholesteryl esters at the end of the three dietary 
periods. 
Fatty Acid Linoleate-Diet Stearate-Diet Trans-Diet 
g per 100 g of fatty acid 
C14:0 2.71 ± 0.85 2.29 ± 1.18 2.52 ± 1.05 
C16:0a 8.75 ± 0.55 8.37 ± 0.64 9.10 ± 0.64 
C16:1a 1.72 ± 0.77 1.97 ± 0.72 2.52 ± 0.62 
C18:0 0.77 ± 0 . 1 1 1.74 ± 0 . 3 8 * 0.87 ± 0.29 
C/s-C18:1a 15.06 ± 1.576 20.16 ± 1.44 20.62 ± 1.40 
7ra/7s-C18:1 0.13 ± 0.18 0.12 ± 0.19 0.94 ± 0.300 
C/s,c/s-C18:2a 61.01 ± 3.920 54.41 ± 3.23 52.84 ± 3.35 
C20:4 6.36 ± 1.36 6.79 ± 1.32 6.42 ± 1.05 
Other 3.51 ± 0.98 4.16 ± 0.81 4.17 ± 0.81 
Values are means ± SD. The 26 men and 30 women consumed each diet for 3 weeks each, in random order. 
3
 Significantly different between each of the diets, P<0.02. 
b
 Significantly different from both other diets, P< 0.0001. 
cholestery l esters w h e n on the Trans-d\et than w h e n on the Linoleate-diet (change 
0 .81 g / 1 0 0 g ; 9 5 % conf idence in terva l , 0 . 7 0 to 0.92) or the Stearate-diet (change 
0 .83 g / 1 0 0 g ; 9 5 % conf idence in terval , 0 . 7 2 to 0 .94 ) . Al l these d i f ferences are 
h ighly s ign i f icant (P<0.0001). 
Serum lipids and lipoproteins 
Total and lipoprotein cholesterol and triglycerides 
Table 4 g ives the serum lipid and l ipoprotein levels at the end of each 
exper imenta l d iet per iod. Compared w i t h levels on the l inoleic acid d ie t se rum to ta l 
cholestero l increased by 0 .15 mmol /L or 5.8 mg/dL (P = 0 . 0 0 8 1 ; 9 5 % conf idence 
in terva l , 0 . 0 2 to 0 .27 mmol /L) on the Stearate-diet and by 0 .16 mmo l /L or 6 .2 
mg /dL ( P = 0 . 0 0 4 1 ; 9 5 % conf idence in terva l , 0 . 0 4 to 0 .29 mmol /L) on the 
7>ans-diet. LDL cholestero l rose by 0 .17 mmol /L or 6 .6 mg /dL (P = 0 . 0 0 0 8 ; 9 5 % 
con f idence in terva l , 0 . 05 to 0 .28 mmol/L) on the Stearate-diet and by 0 . 2 4 mmo l /L 
or 9 .3 mg /dL (P<0.0001; 9 5 % conf idence in terval , 0 . 1 2 to 0 .35 mmol /L) on the 
Trans-d\e\; th is latter value w a s not s igni f icant ly greater than the increase on the 
Stearate-d iet . 
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Table 4. Serum lipid and lipoprotein cholesterol levels at the end of the three dietary 
periods. 
Total cholesterol 
Men 
Women 
All 
HDL-cholesterol 
Men 
Women 
All 
LDL-cholesterol 
Men 
Women 
All 
HDL/LDL ratio 
Men 
Women 
All 
Triglycerides 
Men 
Women 
All 
Linoleate-Diet 
4.66 
4.81 
4.74 
1.34 
1.58 
1.47 
2.90 
2.78 
2.83 
0.50 
0.59 
0.55 
0.92 
0.96 
0.95 
± 
± 
+ 
± 
± 
+ 
± 
± 
± 
± 
+ 
± 
± 
± 
± 
0.73 
0.71 
0.72 
0.18 
0.28 
0.27 
0.71 
0.55 
0.63 
0.16 
0.16 
0.16 
0.31 
0.40 
0.36 
Stearate-Diet 
mmol 
4.93 
4.85 
4.89 
1.28 
1.52 
1.41 
3.16 
2.87 
3.00 
0.44 
0.56 
0.50 
1.07 
1.01 
1.04 
per liter 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
0.82a 
0.74 
0.77s 
0.17a 
0.26s 
0.25s 
0.74s 
0.66 
0 .71 s 
0.14s 
0.16s 
0.16s 
0.41 s 
0.36 
0.38s 
Trans-Diet 
4.85 
4.95 
4.90 
1.25 
1.48 
1.37 
3.14 
3.01 
3.07 
0.42 
0.51 
0.47 
1.00 
1.00 
1.00 
+ 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
0.65s 
0.78 
0.72s 
0.17s 
0.25s 
0.24s 
0.65s 
0.66s 
0.65s 
0 .11 s 
0.15s-0 
0.14 s ' * 
0.35 
0.31 
0.32 
Values are means ± SD. The 26 men and 30 women consumed each diet for 3 weeks each, in random 
order. To convert values for total, HDL, and LDL cholesterol to mg/dL, multiply by 38.67. To convert values 
for triglycerides to mg/dL, multiply by 88.54. 
a
 Significantly different from the Linoleate-diet, P<0.02. 
b
 Significantly different from the Stearate-diet, P<0.02. 
HDL cholesterol decreased by 0.06 mmol/L or 2.3 mg/dL (P< 0 .0001; 95% 
confidence interval, 0.03 to 0.10 mmol/L) on the Stearate-diet and by 0.10 mmol/L 
or 3.9 mg/dL (P<0 .0001 ; 95% confidence interval, 0.06 to 0.13 mmol/L) on the 
Trans-diet. Lower HDL cholesterol levels on the Trans-d\et than on the Linoleate-
diet were seen in 46 of the 56 subjects (Fig. 3). The difference of 0.034 mmol/L 
in HDL cholesterol between the Stearate-diet and the Trans-diet just failed to reach 
significance (/' = 0.0210; 95% confidence interval, - 0 . 0 0 to 0.07 mmol/L). 
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Fig 3. Individual changes in HDL cholesterol levels on diets high in trans fatty acids or 
stearic acid, relative to a diet high in linoleic acid. Bars indicate the level of each individual 
subject when on a particular diet minus his or her level when on the Linoleate-diet. 
The responses of HDL and LDL cholesterol to the different diets were 
correlated neither with their initial levels (day 1 ) nor with the differences in body 
weight between the dietary regimes. Out of the 12 correlation coefficients 
calculated the largest observed was - 0 . 2 4 (P=0.08) for the response in HDL 
cholesterol versus the difference in body weight between the Trans-d\et and the 
Stearate-diet. 
The HDL to LDL cholesterol ratio was 0.55 on the Linoleate-diet, 0.50 on the 
Stearate-diet, and 0.47 on the 7>aA7s-diet; all three values were significantly 
different from each other (P<0.0037 for each comparison). The level of serum 
triglycerides was 0.09 mmol/L or 8.0 mg/dL higher on the Stearate-diet than on the 
Linoleate-diet (P= 0.0074; 95% confidence interval, 0.01 to 0.17 mmol/L). 
Triglyceride values did not differ significantly between the 7raA7s-diet and the 
Stearate-diet (P = 0.22; 95% confidence interval, 0.04 to - 0 . 1 2 ) or between the 
Trans-û\e\ and the Linoleate-diet (P = 0.14; 95% confidence interval, - 0 . 0 3 to 
0.13 mmol/L). 
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Apolipoproteins 
Table 5 shows the mean apolipoprotein levels and their ratios at the end of 
each dietary period. Relative to levels on the Linoleate-diet, serum apolipoprotein 
B rose by 3.4 mg/dL on the Stearate-diet (95% confidence interval, 1.7 to 5.0 
mg/dL), and by 5.0 mg/dL (95% confidence interval, 3.4 to 6.6 mg/dL) on the 
7>aA?s-diet. All three values are significantly different from each other (P< 0.0184 
for each comparison). The apoB to LDL cholesterol ratio was essentially the same 
for each diet. Mean apoA-l level was 2.0 mg/dL higher on the Linoleate-diet than 
on the Trans-d\et (P= 0.0119; 95% confidence interval, 0.1 to 4.0 mg/dL). The 
difference in serum apoA-l between the Linoleate- and the Stearate-diet periods of 
1.3 mg/dL (P = 0.1044; 95% confidence interval, - 0 . 6 to 3.3 mg/dL), and 
between the Stéarate- and the Trans-diet period of 0.7 mg/dL {P=0.3586; 95% 
confidence interval, - 1.3 to 2.7 mg/dL) were not significant. The mean apoA-l to 
HDL cholesterol ratio (mg/mmol) increased from 856 on the Linoleate-diet to 887 
on the Stéarate-, and to 904 on the Trans-d\et (P<0.0081 for each comparison). 
Table 5. Serum apoA-l and apoB levels and their ratios at the end of the three dietary 
periods. 
Linoleate-Diet Stearate-Diet Trans-Diet 
Apolipoprotein A-l 
Men 
Women 
All 
Apolipoprotein B 
Men 
Women 
All 
Apolipoprotein A-l/B ratio 
Men 
Women 
All 
115.7 ± 7.8 
131.5 + 16.8 
124.1 ± 15.5 
69.5 ± 13.3 
68.8 ± 1 1 . 5 
69.1 ± 12.2 
1.73 ± 0.38 
1.95 ± 0.31 
1.85 ± 0.36 
mg/dL 
115.6 ± 8.5 
129.1 ± 13.9 
122.8 ± 13.5 
74.9 ± 14.4s 
70.4 ± 12.2 
72.5 ± 13.4a 
1.61 ± 0.37s 
1.88 ± 0.33s 
1.75 ± 0.37s 
114.9 ± 8.4 
128.4 ± 14.6 
122.1 ± 13.8s 
75.4 ± 12.7s 
73.1 ± 12.6 
74.1 12.6 a,b 
1.57 ± 0.32s 
1.80 ± 0 . 3 1 s ' * 
1.69 ± 0 .33 s ' è 
Values are means ± SD. The 26 men and 30 women consumed each diet for 3 weeks each, in random 
order. 
3
 Significantly different from the Linoleate-diet, P<0.02. 
b
 Significantly different from the Stearate-diet, P<0.02. 
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The ratio of apoA-l to apoB was 1.85 ± 0.36 on the Linoleate-diet, 1.75 ± 0.37 
on the Stearate-diet, and 1.69 ± 0.33 on the Trans-d\et. These values are also 
significantly different from each other (P<0.0012 for each comparison). 
Gender effects 
As compared with the Linoleate-diet, the mean response of the men on the 
Stearate-diet was significantly greater than that of the women for total cholesterol 
(difference in change, 0.22 mmol/L or 8.5 mg/dL; P= 0.0438) and for apoB 
(difference in change, 3.7 mg/dL; P = 0.0155). The statistical analyses did not 
reveal any other significant differences between the sexes in the responses of their 
lipid, lipoprotein, or apolipoprotein levels to the diets. 
DISCUSSION 
The three fatty acids under study all had 18 carbon atoms. Thus effects of the 
chain length of the fatty acids on serum lipid and lipoproteins can be excluded. 
Since the experimental diets did not materially differ in nutrients other than trans 
fatty acids, stearic acid, and linoleic acid, the changes observed between the diets 
must be due to differences in the number and/or geometry of the double bonds in 
these fatty acids. 
Trans fatty acids 
Effects on lipids and lipoproteins 
In a previous study conducted at our department it was found that 
monounsaturated trans fatty acids at a dose of 11 % of energy (on average 33 
g/day) increased LDL cholesterol by 14.3 mg/dL (0.37 mmol/L) and decreased HDL 
cholesterol by 6.6 mg/dL (0.17 mmol/L) as compared with their cis isomer oleic 
acid [10]. However, the dose of trans fatty acids consumed probably exceeded the 
range of intakes in free-living subjects. By contrast, the 7.7 energy % of total daily 
energy intake that was provided by the trans fatty acids in the present trial, 
although still higher than average consumption, may be reached by persons who 
eat large amounts of hardened vegetable fats and margarine and of products 
prepared with or fried in such fats [30,31]. Another difference with the previous 
trial was that we now studied the effects of trans fatty acids relative to linoleic 
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acid. If one assumes that linoleic acid and oleic acid differ little in their effects on 
serum lipids when consumed in moderate amounts [32-35], then the magnitude of 
changes observed here are compatible with a linear relation between the dose of 
trans monounsaturates consumed and the response of serum lipoprotein 
concentrations. Fig. 4 shows, side-by-side, the effects of monounsaturated trans-
C18:1 fatty acids as observed relative to linoleic acid in the present and relative to 
oleic acid in the previous study. Although more studies are needed to determine 
the true relationship between the dose of various types of trans fatty acids and 
their effects on serum lipoproteins, comparison of the results of the two studies 
mmol/L 
0.40 
0.20 
•0.20 
A LDL CHOLESTEROL 
\ 
Mensink & Kutan 
1990 
m g / d l 
9 10 11 12 
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A HDL CHOLESTEROL 
15 
10 
-10 
Fig. 4. Effects of trans fatty acids on LDL and HDL cholesterol in the present trial 
compared with those in a previous trial. Circles represent data from a comparison of trans-
C18:1 with oleic acid [10]. Squares are based on the present comparison between trans-
C18:1 and linoleic acid. Bars denote 95% confidence intervals. In addition to the two 
experiments, the origin provides a third point, because a zero change in intake will produce 
zero change in lipoprotein levels. 
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suggests that in our hands the effects of trans fatty acids on LDL and HDL 
cholesterol are proportional to the amounts consumed. 
The trans fatty acids supplied to our subjects consisted largely of C18:1n-9 
(elaidic acid), with traces of C18:1n-8 and C18:1n-10. These are also the 
predominant trans fatty acids produced by hydrogénation of vegetable oil in food 
manufacturing [2,3]. The spectrum of trans-^SA positional isomers consumed 
by the subjects in our previous trial was much broader [10,23]. Nevertheless, the 
observed effects in both trials were largely congruent if the differences in dose are 
taken into account. We therefore think that our findings will apply to most 
monounsaturated fraA7s-C18:1 fatty acid isomers as present in commercial fats and 
foods. 
Public-health implications 
Based on our two studies as summarized in Fig. 4, it can be speculated that 
one dietary energy % of trans fatty acids raises LDL cholesterol by about 1.2 
mg/dL (0.03 mmol/L) and lowers HDL cholesterol by about 0.6 mg/dL (0.015 
mmol/L) relative to oleic or linoleic acid. The current average trans intake of 3 to 
4 % of energy in the United States might thus cause an elevation of LDL cholesterol 
by about 4 mg/dL and a depression of HDL cholesterol by about 2 mg/dL relative 
to c/s-unsaturates. Although these figures appear modest, the predicted effect on 
HDL cholesterol is of the same magnitude as the difference in HDL cholesterol 
between physical active and sedentary people [36] or between individuals at the 
10th percentile of body mass index versus those at the 50th percentile [37]. For 
comparison, smoking 10 cigarettes per day will on average lower HDL cholesterol 
by about 2 to 4 mg/dL [38]. 
What would be the predicted effect on coronary heart disease risk if the 
average trans fatty acid consumption of 7 to 10 g/day in the United States 
population were to be completely replaced by oleic and linoleic acid? Both 
epidemiological data and results of controlled trials suggest that the predicted 
decrease of 4 mg/dL in LDL cholesterol should lead to a decrease in the average 
risk for coronary heart disease of 3%. The increase of 2 mg/dL in HDL cholesterol 
should add another 4 to 5% reduction in risk [39,40]. Total risk reduction should 
thus average 7 to 8%, provided that raising HDL indeed reduces risk, which is a 
plausible but still unproven assumption [39]. A reduction in risk of this magnitude 
does not appear to justify total elimination of partially hydrogenated oils from the 
United States food supply, especially since a sizeable part of current trans fatty 
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acid intake is supplied by dairy and beef fat. However, it is possible that selected 
individuals consume considerably higher amounts of trans fatty acids than the 
average of 3 to 4 percent [41], and for them the effects of trans fatty acids can 
be of clinical importance. Obviously, the trans fatty acid intake of various segments 
of the population needs to be assessed, and groups with high intake need to be 
identified. Even the intake in the United States is controversial, with quoted figures 
ranging from 8 to 15 g/day [31 ]. The estimate of 17 g/day for the Netherlands [42] 
is similarly based on incomplete data and a host of assumptions. Better intake data 
are thus urgently needed before any public-health measures at curbing trans intake 
can even be considered. 
Stearic acid 
Recent studies [32-35] suggest that the effects of linoleic acid and oleic acid 
on serum total and LDL cholesterol levels are more similar than previously observed 
[12,13]. Stearic acid has also repeatedly been reported to produce serum lipid 
levels similar to those seen on oleic acid [12-15]. Thus one would expect stearic 
acid and linoleic to be more or less equivalent with respect to their cholesterolemic 
effect. This was indeed observed for the women in our study, but nor for the men, 
who showed a small but significant rise in total and LDL cholesterol and 
triglycerides on the Stéarate- versus the Linoleate-diet. The increase of 10.4 mg/dL 
(0.27 mmol/L) in total cholesterol is in line with the equations of Keys, Anderson, 
and Grande [12] and Hegsted [13], which predict an increase of 9.7 to 11.6 mg/dL 
in men when 8 dietary energy % of linoleic acid is replaced by stearic or oleic acid. 
In the absence of an oleic acid diet period in the present trial it is impossible to tell 
whether the difference in cholesterol levels in males of 10.4 mg/dL between the 
Stéarate and Linoleate diet periods was due to stéarate being somewhat 
cholesterol-raising or linoleate being somewhat cholesterol-lowering relative to oleic 
acid. Whatever the relative effects of stéarate, oleate, and linoleate, they are much 
smaller than the 28.6 mg/dL (0.74 mmol/L) increase that can be predicted for a 
replacement of 8 dietary energy % of linoleic acid by a mixture of lauric (C12:0), 
myristic (C14:0), and palmitic (C16:0) acids [12]. Obviously, stearic acid raises 
total and LDL cholesterol less than other saturated fatty acids, and it will probably 
take a number of very large trials to tell whether the effects of stearic and oleic 
acid differ at all. 
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Our data do suggest that stearic acid might have some HDL cholesterol-
lowering potential relative to linoleic acid, 0.06 mmol/L or 2 mg/dL in the present 
study. In the study of Bonanome and Grundy [15] a diet enriched with 16 energy 
% from stearic acid resulted in HDL levels that were 3.9 mg/dL (0.10 mmol/L) 
lower than those on a diet enriched with oleic acid. This difference was not 
statistically significant, but at the very least the observations of Bonanome and 
Grundy [15] on stearic acid and HDL do not contradict ours. Becker et al. [43] 
compared the effects of saturated fat versus monounsaturated and polyunsaturated 
fat. Their saturated fat diet supplied 12 to 13 energy % from stearic acid as 
opposed to 1 energy % in the two other diets. The stearate-rich saturated fat diet 
decreased HDL cholesterol by 0.10 mmol/L compared with the monounsaturated 
and by 0.14 mmol/L compared with the polyunsaturated fat diet. As in the study 
of Bonanome and Grundy [15], these differences were not statistically significant. 
Nevertheless, data from both studies are in line with our present observation, and 
they suggest that stearic acid may be neutral as regards total but not as regards 
HDL cholesterol. The potential HDL cholesterol-depressing effect of stearic acid 
obviously needs more research. 
Effect of gender on responses of lipid and lipoproteins to diet 
Suitability of females for studies on diet and lipids 
Most trials on the effects of diet on serum lipid and lipoprotein levels have 
employed men only, partly because coronary heart disease was considered 
primarily a male disease, but partly also because women were considered less 
suitable because of confounding effects of the menstrual cycle. In fact, different 
studies on the influence of the natural menstrual cycle on serum lipids show 
different effects [44,45] or only minor if any effects [46], and a recent textbook 
concluded "the degree of variation observed is relatively small and results of 
separate studies have sometimes been inconsistent" [47]. However, oral 
contraceptives do influence the concentrations of total and HDL cholesterol in a 
cyclical manner [46]. At first sight one might think that this might confound our 
findings in the 13 women who used oral contraceptives. This, however, is not the 
case. Different women entered the study at different points in their cycle, and in 
addition, diets were fed in random sequence, so that the effects of the 
contraceptive cycle cancelled each other and averaged out. Thus, any woman who 
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had an unusually low HDL cholesterol during week 3 of the Linoleate diet because 
she was at the end of her cycle was counterbalanced on average by another 
woman whose HDL cholesterol was high when she was at week 3 of the Linoleate-
diet because she happened to be at the pill-free days of her cycle. 
Unlike the means, one would expect the standard deviations of the responses 
to be biased upwards because cyclic effects add a random positive or negative 
term to each lipid data point. The standard deviations of the responses to dietary 
changes of the women using oral contraceptives were indeed somewhat larger 
than those of the women not using contraceptives (on average 0.43 mmol/L vs. 
0.28 mmol/L for LDL cholesterol, and 0.15 mmol/L vs. 0.10 mmol/L for HDL 
cholesterol). However, standard deviations of the mean responses of all 30 women 
combined (13 users plus 17 non-users) were very similar to those of the 26 men 
(on average 0.38 vs. 0.34 mmol/L for LDL and 0.13 vs. 0.09 mmol/L for HDL 
cholesterol). This is in accord with our previous experience [19,33]. This would 
seem to validate the use of female volunteers as experimental subjects in studies 
of diet and lipids; at the very most, the number of females required to reach a 
certain statistical power should be adjusted upward when the majority is using oral 
contraceptives. 
Gender effects on response 
We found no differences between men and women in the response of serum 
lipoprotein or apolipoprotein levels to the trans fatty acid diet relative to linoleic 
acid (Tables 4 and 5). In a previous study the effects of replacing oleic acid by 
trans fatty acids were also similar in men and women [10]. It therefore appears 
that the lipoprotein levels of men and women respond similarly to dietary trans 
fatty acids. 
The increase in total and LDL cholesterol and triglycerides in men on the 
Stearate-diet was not observed for the women in our study (Table 4). Compared 
with the Linoleate-diet, the changes of the men's total cholesterol and apoB levels 
on the Stearate-diet were significantly larger than those of the women (Tables 4 
and 5). HDL cholesterol was decreased to a similar extent in men and women. The 
HDL/LDL ratio was significantly lowered on the Stearate-diet versus the Linoleate-
diet in both men and women, although the effect was very small in the women 
(Table 4). Whether stearic acid is cholesterol-raising in men but not in women 
could not be definitively addressed here. Obviously this point needs further 
investigation. 
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Consequences for the production of hardened fats 
Replacement of 8 dietary energy % of monounsaturated trans fatty acids by 
stearic acid resulted in only minor changes in serum lipid and lipoprotein values. 
Our data thus do not support the idea that increasing the stearic acid content of 
hardened fats at the expense of trans fatty acids is beneficial for the serum lipid 
profile; either mode of hydrogénation produced fatty acids that increased LDL and 
decreased HDL cholesterol relative to linoleic acid itself. 
However, trans fatty acids and stearic acid probably raise total and LDL 
cholesterol to a lesser extent than C12-16 saturated fatty acids. Even if the trans 
fatty acids were to be equated with C12-16 saturated acids because of their added 
unfavorable effect on HDL, the content of trans plus cholesterol-raising saturates 
in butter still far exceeds that in soft margarine. Butter is also very high in 
cholesterol. Therefore, replacement of butter by soft margarine remains of value 
in the dietary treatment of hypercholesterolemia. However, manufacturers should 
consider the option of producing soft margarine free of trans fatty acids. Diet 
margarine with zero trans fatty acids made from unmodified sunflower oil and a 
small amount of a stearate-rich hard stock [48] have been marketed successfully 
for many years in Europe and are also available in North America. 
Although data on the trans fatty acid content of brick margarine, vegetable 
shortenings, and solid vegetable frying fats are incomplete, it is probably much 
higher than in soft margarine, and the sum of trans fatty acids and cholesterol-
raising saturates in such fats may approach that in beef tallow or lard. If the 
unfavorable effects of trans fatty acids on serum lipoproteins are borne out by 
future studies, then the use of so-called "cholesterol-free" solid vegetable fats for 
cooking or (deep-fat) frying may offer few health benefits over beef tallow or lard, 
and at that time replacement of such fats by unmodified or very lightly 
hydrogenated oils should be considered. Use of b\gh-trans fats could then be 
limited to baked goods and other products where suitable replacements are much 
harder to find. 
However, any large-scale displacement of partially hydrogenated vegetable oils 
from the market should await the outcome of further experiments, which in 
addition to lipids should also attempt to gauge effects on fibrinogen and on platelet 
function and aggregation tendency. 
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CHAPTER 3 
Effects of stearic acid and trans fatty acids versus linoleic 
acid on blood pressure in normotensive women and men 
Zock PL, Blijlevens RAMT, de Vries JHM, Katan MB. 
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ABSTRACT 
Aim. The objective of this study was to compare the effect of linoleic acid (cis,cis-
C18:2) with that of its hydrogénation products stearic acid (C18:0) and elaidic acid 
(fra/?s-C18:1) on blood pressure levels in normotensive humans. 
Methods. We therefore measured the effects of these fatty acids on systolic and 
diastolic blood pressure in 30 women and 25 men. Three strictly controlled 
experimental diets were supplied to every subject for three weeks each, in different 
order (multiple cross-over). The composition of the three diets was constant, 
except for 8% of daily energy, which was provided by either linoleic acid, stearic 
acid, or monounsaturated trans fatty acids. The statistical power for detecting a 
true difference between two diets of 3 mmHg in systolic and diastolic blood 
pressure was over 90%. 
Results. Mean systolic/diastolic blood pressure at the end of the dietary periods 
was 114/69 mmHg on the linoleic-acid diet, 113/70 on the stearic-acid diet, and 
113/69 on the frans-fatty-acid diet. No significant differences were observed in 
blood pressure levels after 3 weeks on each diet. 
Conclusion. We conclude that a major increase in the intake of linoleic acid at the 
expense of stearic acid or trans fatty acids has no effect on blood pressure in 
normotensive young women and men. 
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INTRODUCTION 
A considerable part of saturated fat in Western diets is supplied by stearic acid 
(C18:0). Cocoa fat, beef fat, and other animal fats are natural sources of stearic 
acid, but it can also been formed when vegetable oils, rich in linoleic acid, are 
hydrogenated to produce fats with better texture and stability. In addition, partial 
hydrogénation of linoleic-acid-rich oils yields monounsaturated trans fatty acids 
with a length of 18 carbon atoms. Some studies suggested that diets high in 
linoleic acid may lower blood pressure [1-3], possibly through an effect on 
prostaglandin formation [2]. It has also been reported that an increase in saturated 
fat content of the diet can raise blood pressure at a nearly constant intake of 
linoleic acid [4,5]. Trans fatty acids are consumed in considerable amounts in 
Western societies [6], but little is known about their effect on blood pressure in 
humans. 
In this controlled trial we examined the effects of linoleic acid and its 
hydrogénation products stearic acid and trans fatty acids on systolic and diastolic 
blood pressure in normotensive subjects. Previously we have reported the effects 
of these diets on serum lipid and lipoprotein levels (Chapter 2). Linoleic acid in the 
diet was iso-energetically replaced by either stearic acid, or by monounsaturated 
trans fatty acids. The three experimental diets did not materially differ in other 
nutrients and minerals. 
METHODS 
Subjects 
Subjects were recruited through advertisements in local newspapers. Thirty-
one women and 28 men participated in the study, of which one purpose was to 
investigate the effects of trans fatty acids and stearic acid versus linoleic acid on 
serum lipids (Chapter 2). During the study 2 men withdrew, one because of 
personal reasons and one because of illness. One woman withdrew because of 
pregnancy and for one man the blood pressure measurements were discontinued 
halfway through the trial because he felt them to be too constraining. All analyses 
were therefore based on the 25 men and the 30 women in whom all blood 
pressure measurements were conducted successfully. The subjects were healthy, 
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as indicated by a medical questionnaire and by the absence of protein and glucose 
in the urine. None was hypertensive (systolic blood pressure > 1 5 0 mmHg, 
diastolic pressure > 9 0 mmHg) and none were taking blood-pressure-lowering 
medications. The men were between 19 and 48 years of age (mean, 26). They 
weighed 60 to 83 kg (mean, 73) and their body mass index ranged from 18.5 to 
26.0 kg/m2 (mean, 21.5). The women were between 19 and 49 years of age 
(mean, 24). They weighed 51 to 80 kg (mean, 63), and their body mass index 
ranged from 17.9 to 27.5 kg/m2 (mean, 21.5). Thirteen women used oral 
contraceptives, and 4 men and 4 women smoked. 
The protocol and aim of the study were fully explained, and subjects gave 
their written consent. Approval for the study had been obtained from the Ethics 
Committee of the Department. 
Design and diets 
The study was conducted using a multiple crossover design with each subject 
consuming the three experimental diets for three weeks each, in different order. 
In this way, any systematic bias due to the order in which the diets were supplied 
or to drift of variables over time were eliminated [7]. One diet was high in linoleic 
acid, another was high in stearic acid, and the third was high in monounsaturated 
trans fatty acids. Before the trial, the participants were stratified according to sex, 
and females also according to use of oral contraceptives. From each category 
about one sixth of the subjects were randomly allocated to one of the six possible 
treatment sequences. Table 1 shows the mean baseline characteristics of each 
treatment group. All subjects were studied simultaneously from January 29 until 
April 2, 1990. 
The study diets consisted of conventional solid foods, and menus were 
changed daily during each 3-week cycle. The planned composition of the three 
diets was similar, except for about 8% of daily energy, which was provided by 
either linoleic acid, stearic acid, or monounsaturated trans fatty acids (Table 2). For 
the linoleic acid group a commercially available margarine high in linoleic acid was 
used (Becel, Van den Bergh foods, Rotterdam, The Netherlands). Fats for the 
stearic-acid-rich diet were produced by interesterification of a mixture of 41 parts 
of fully hydrogenated high-linoleic-acid sunflower oil (Chempri, Raamsdonksveer, 
The Netherlands), 9 parts of unmodified high-linoleic-acid sunflower oil, and 50 
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Table 1. Baseline values (mean ± SD) of the age, body mass index, and systolic and 
diastolic blood pressure (BP) of male and female subjects per treatment sequence. 
Sequence 
L - S - T 3 
L - T - S 
S - L - T 
S - T - L 
T - L - S 
T - S - L 
Number of 
men/women 
5 men 
5 women (3) 
5 men 
5 women (3) 
4 men 
4 women (2) 
5 men 
5 women (1) 
4 men 
5 women (3) 
2 men 
6 women (1) 
Age 
(years) 
29 
24 
24 
22 
24 
21 
24 
28 
21 
28 
36 
21 . 
± 
± 
± 
± 
± 
± 
± 
± 
+ 
± 
± 
11 
2 
5 
2 
3 
1 
2 
11 
2 
13 
17 
± 1 
Body 
index 
21.7 
21.5 
19.7 
20.7 
20.6 
21.2 
23.2 
21.5 
21.1 
21.7 
24.3 
22.3 
mass 
(kg/m2) 
+ 
± 
± 
± 
± 
± 
+ 
± 
± 
± 
± 
+ 
1.3 
0.5 
0.6 
1.9 
2.3 
3.6 
1.4 
1.9 
1.1 
3.8 
2.4 
1.5 
Systolic BP 
(mmHg) 
123.6 
101.2 
128.0 
116.4 
124.7 
114.1 
121.3 
114.2 
127.4 
116.8 
112.6 
115.4 
± 
+ 
± 
± 
± 
+ 
± 
± 
+ 
± 
± 
± 
6.7 
6.6 
11.4 
11.7 
8.4 
10.0 
3.9 
8.2 
12.1 
12.2 
2.7 
12.7 
Diastolic BP 
(mmHg) 
76.4 
65.2 
77.7 
72.5 
72.1 
67.9 
69.6 
72.8 
67.4 
71.4 
76.4 
64.8 
± 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
± 
+ 
7.7 
4.5 
8.5 
10.1 
0.7 
5.4 
9.0 
7.9 
8.6 
8.5 
4.4 
10.0 
3
 L, linoleic acid diet; S, stearic acid diet; T, trans fatty acid diet. 
* Numbers in parentheses indicate the number of women using oral contraceptives in each treatment group. 
parts of high-oleic-acid sunflower oil (Trisun, SVO Enterprises, Wickliffe, OH). To 
produce margarine and shortening for the trans fatty acid diet, the same high-oleic-
acid sunflower oil (Trisun) was hydrogenated with a sulfurized nickel catalyst 
(Pricat 9908, Unichema, Emmerich, Germany) under conditions that favored 
formation of trans rather than saturated fatty acids. Seventy-five parts of this 
hydrogenated fat were mixed with 25 parts of the unaltered oleic-acid-rich oil. The 
special margarines and shortenings were developed and produced by the Unilever 
Research Laboratory, Vlaardingen, The Netherlands. 
Diets were formulated at 24 levels of energy intake ranging from 5.5 to 17.5 
M J per day. All foodstuffs were weighed out for each individual subject. In addition 
to the food supplied, subjects were allowed a limited number of items free from fat 
and cholesterol. The energy intake of these free-choice items was fixed for each 
level of energy intake and ranged from 7 to 13% of total energy intake. The 
subjects were urged to maintain their usual smoking habits, physical activity 
pattern, and use of oral contraceptives during the trial, and they were repeatedly 
asked not to change their selection of free-choice items between periods. Subjects 
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recorded in diaries their free-choice items, the amount and type of coffee used, and 
any deviations from the protocol. 
Duplicate portions of each study diet were collected on each of the 63 trial 
days for an imaginary participant with a daily energy intake of 11 MJ (2630 kcal), 
stored at - 2 0 °C, and pooled and analyzed after the study. 
Other details are described elsewhere (Chapter 2). 
Measurements 
Before the experiment, in October and November 1989, the subjects were 
asked to record their food intake on three separate days, including one weekend 
day. Foods were coded and the composition and the energy content of the habitual 
diets were calculated with use of the Netherlands Nutrient Data Base [8]. As it was 
known from previous experiments conducted at our department that such food 
records tend to underestimate actual energy needs by some 10 to 15%, levels of 
energy intake at the start of the study were set at 10% over stated habitual intake. 
Blood pressure was measured at the left arm with an automatic 
sphygmomanometer with recorder (Takeda Medical UA-751, Adquipment Medical 
BV, Rotterdam, The Netherlands) on one occasion before and once a week during 
the experiment. The cuff used was 14 cm wide and had a greatest length of 40 
cm. Systolic pressure was recorded at Korotkoff phase I and diastolic pressure at 
Korotkoff phase V. Subjects were asked not to perform any physical activity or to 
eat or smoke for 1 hour prior to the blood pressure measurements. Four 
measurements were made at each session with the subjects sitting upright. During 
the measurement the subject wore loosely fitting sleeves and they rested their left 
forearm on a table. One trained investigator (R.B.) performed all the measurements, 
using the same sphygmomanometer throughout the study. The first blood pressure 
measurement of each session was discarded and the three other measurements 
were averaged per subject. All measurements on a particular subject were generally 
made at the same time of the day to eliminate effects of diurnal variations in blood 
pressure. Subjects were never told their blood pressure readings while the study 
was still on. 
The duplicate portions of each dietary period were mixed thoroughly, and then 
freeze-dried. The ash content and the moisture levels [9] were determined and then 
the material was stored at - 2 0 °C. Aliquots were analyzed for protein [10], total 
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Table 2 . M e a n daily intake of energy and nutrients of the 5 5 subjects before the 
exper iment , and during the different dietary regimes. 
Diet 
Habitual3 Linoleic 
ac id* 
Stearic Trans fa t ty 
acid° acids 
Energy 
(MJ/d) 
(kcal/d) 
Protein (% of energy) 
Fat (% of energy) 
Saturated fatty acids 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated fatty acids 
Oleic acid (c/s-C18:1) 
7>ans-C18:1 
Polyunsaturated fatty acids 
Linoleic acid (c/s,c/s-C 18:2) 
Trans-C\ 8:2 
Carbohydrates (% of energy) 
Alcohol (% of energy) 
Cholesterol (mg/MJ) 
Dietary fibre (g/MJ) 
Sodium (mg/dc) 
Potassium (mg/dc) 
Calcium (mg/dc) 
Magnesium (mg/dc) 
10.3 
2464 
14.1 
36.2 
14.6 
12.7 
6.6 
5.6 
48.6 
1.4 
26.8 
3.3 
3117 
4052 
1387 
± 
± 
± 
± 
± 
± 
+ 
+ 
± 
± 
± 
± 
± 
± 
± 
2.7 
645 
2.4 
4.8 
2.4 
2.3 
1.8 
1.7 
5.7 
2.1 
11.0 
9.9 
967 
939 
416 
12.0 
2869 
12.3 
41.1 
11.0 
0.7 
0.9 
5.8 
2.8 
15.8 
14.7 
0.1 
12.5 
12.0 
0.0 
46.0 
0.9 
33.5 
3.6 
2918 
3893 
1283 
359 
11.9 
2845 
12.3 
43.5 
20.1 
0.5 
1.0 
5.7 
11.8 
16.6 
15.4 
0.3 
4.3 
3.9 
0.0 
43.5 
0.9 
32.6 
3.9 
3065 
4111 
1246 
378 
12.0 
2869 
12.8 
39.7 
10.3 
0.5 
1.0 
4.8 
3.0 
23.3 
14.6 
7.7 
4.2 
3.8 
0.0 
46.6 
1.0 
33.5 
4.0 
3311 
4149 
1384 
355 
3
 Estimated from three-day food records, which tend to underestimate energy needs (cf. Methods). No values 
for magnesium, cis and trans isomers, and specific saturated fatty acids are available in the food composition 
table used. 
b
 Determined by chemical analysis plus the calculated contribution of free-choice items (cf. Methods), each 
value represents the mean of three independent duplicates collected in three different periods during which 
each diet was consumed by one-third of the subjects. Variations between periods were negligible and standard 
deviations are therefore not given. 
0
 At an energy intake of 12 MJ (2869 kcal) per day. 
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fat [11], the proportion of individual fatty acids [12], dietary fibre [13] and 
cholesterol [14]. Available carbohydrate was calculated by difference. Sodium, 
potassium, calcium and magnesium were determined by atomic absorption 
spectrophotometry [15] after the sample had been wet-ashed and neutralized. The 
mean composition of the diets was calculated from the duplicate portion analysis 
plus the contribution of the free-choice items. 
In order to estimate dietary adherence, the fatty acid composition of serum 
cholesteryl esters of each subject was determined in blood samples obtained at the 
end of each dietary period. 
Body weights without shoes, jackets, and heavy clothing were recorded twice 
weekly. The level of energy intake was adjusted when necessary, as indicated by 
weight changes. Over the 63 days of the trial average body weight fell by 0.2 ± 
1.1 kg (range, - 2 . 5 to +2 .0 kg). The mean difference in body weight at the end 
of the dietary periods was 0.1 ± 0.7 kg between the linoleic acid diet and the 
stearic acid diet, 0.0 ± 0.8 kg between the linoleic and the trans fatty acid diet, 
and 0.1 ± 0.7 kg between the trans fatty acid and the stearic acid diet. 
Statistical methods 
The null hypothesis to be tested was that blood pressures measured at the 
end of each dietary period would not differ between diets. This hypothesis was 
tested by analysis of variance of the systolic and diastolic pressure values obtained 
in the third week of each dietary period, with use of the General Linear Model 
(GLM) procedure of the Statistical Analysis System [16]. The Tukey method was 
used for pairwise comparison of the diets and for calculation of 95% confidence 
limits for the differences between two diets. The statistical power for detecting a 
true difference of 3 mmHg between two diets in systolic and diastolic blood 
pressure was over 90%. Effects of gender, use of oral contraceptives by women, 
and the sequence of the diets were checked by entering these class variables as 
independent factors in the model. 
In secondary analyses, blood pressure values obtained in weeks 1 and 2 of 
the dietary periods were also tested. 
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RESULTS 
Diets and dietary adherence 
The habitual diets of the subjects, estimated from three-day food records, and 
the mean daily intakes of energy and nutrients of the three experimental diets as 
determined by chemical analyses of duplicate diets plus calculated contribution of 
free-choice items are given in Table 2. The estimate of habitual energy intake was 
14% lower than energy intake determined during the trial. This confirmed our 
previous experience that food records underestimate actual energy needs by some 
1 0 - 1 5 % (cf. Methods). The intakes of total energy, protein, carbohydrates, 
alcohol, cholesterol, dietary fibre, sodium potassium, calcium and magnesium were 
similar on all three experimental diets (Table 2). Total fat intake differed somewhat 
between the trans fatty acid diet and the stearic acid diet (3.8% of energy) due to 
small differences in the intake of oleic acid and C12-C16 saturates, and due to the 
fact that the difference in stearic acid turned out to be 8.8% of daily energy 
instead of the planned 8%. The percentage of total daily energy from linoleic acid 
decreased from 12.0% on the linoleic acid diet to 3.9% and 3.8% on the stearic 
acid and trans fatty acid diets, respectively. It was replaced by 9.0% stearic acid 
on the stearic acid diet and by 7.6% monounsaturated trans fatty acids on the 
trans fatty acid diet. 
Inspection of the subjects' diaries did not reveal any changes in smoking 
habits, physical activity pattern, use of oral contraceptives or other deviations from 
the protocol that might have affected the results. The proportion of linoleic acid in 
the serum cholesteryl esters was higher on the linoleic acid diet than on both other 
diets in 54 out of the 55 subjects. The average increase was 7.4 g linoleic acid per 
100 g of all fatty acids detected. This confirmed dietary adherence of the subjects. 
Blood pressure 
Mean systolic and diastolic blood pressure levels did not significantly change 
over the 9 weeks of the study. 
Blood pressure values averaged per dietary regime are shown in Fig. 1. In the 
third week on the linoleic acid diet, the mean systolic pressure was 114 ± 10.7 
mmHg and the mean diastolic pressure was 69 ± 8.7 mmHg. On the stearic acid 
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Fig. 1. Mean systolic and diastolic blood pressure during the experiment, averaged per diet. 
Thirty women and 25 men consumed the linoleic acid diet (D D), the stearic acid diet 
(O O), and the trans fatty acid diet (A A) for 3 weeks each, in random order. 
diet these values were 113 + 10.4 (95% CI for difference with linoleic acid diet, 
- 2 . 8 to 1.1 mmHg) and 70 ± 8.5 (95% CI, - 1 . 1 to 2.7 mmHg). Levels on the 
trans fatty acid diet were 113 ± 10.8 mmHg for systolic (95% CI for difference 
with linoleic-acid diet, - 2.9 to 1.0 mmHg) and 69 ± 7.5 mmHg for diastolic blood 
pressure (95% CI, - 2 . 5 to 1.3 mmHg). The analysis of variance showed no 
significant effect of the order in which diets were supplied on the differences in 
blood pressure between the diets. Gender and the use of oral contraceptives by 
women also did not affect the responses of blood pressure to the diets. 
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Table 3 shows the mean blood pressure levels in the third week of the three 
dietary regimes for all subjects and for men and women separately. No significant 
differences were found between the different diets. 
Table 3. Mean ( ± SD) systolic and diastolic blood pressure of the subjects after 3 weeks 
on the high-linoleic-acid diet, the high-stearic-acid diet, and the high-frans-fatty-acid diet. 
Systolic pressure (mmHg) 
Men 
Women 
All 
Diastolic pressure (mmHg) 
Men 
Women 
All 
Linoleic acid 
diet 
120 ± 8.4 
110 ± 10.5 
114 ± 10.7 
71 ± 8.7 
68 ± 8.5 
68 ± 8.7 
Stearic acid 
diet 
119 ± 7.7 
109 ± 9.9 
113 ± 10.4 
73 ± 8.6 
68 ± 7.7 
70 ± 8.5 
Trans fatty 
acid diet 
118 ± 9.6 
109 ± 10.1 
113 ± 10.8 
71 ± 8.0 
67 ± 6.7 
69 ± 7.5 
In the 28 subjects with the highest systolic blood pressure before the study, 
levels were 119 ± 9.6 mmHg on the linoleic acid diet, 119 ± 8.4 mmHg on the 
stearic acid diet, and 118 + 8.8 mmHg on the trans fatty acid diet. These values 
were not significantly different from each other. The mean diastolic pressure of the 
28 subjects with the highest diastolic blood pressure levels before the study was 
73 ± 9.2 mmHg on the linoleic acid diet, 73 ± 9.7 mmHg on the stearic acid diet, 
and 71 ± 8.6 mmHg on the trans fatty acid diet. Again, no significant differences 
were found between the three experimental diets. In a secondary statistical 
analysis, blood pressure measurements obtained in weeks 1 and 2 of each dietary 
period were added as dependent variables. The analysis of variance now showed 
a minor blood pressure-raising effect of stearic acid as compared with trans fatty 
acid; 1.4 mmHg (95% CI, 0.1 to 2.6 mmHg; P = 0.0167) for systolic, and 1.4 
mmHg (95% CI, 0.4 to 2.5; P = 0.0020) for diastolic pressure. There was also a 
small effect on diastolic blood pressure of stearic vs. linoleic acid (95% CI, 0.3 to 
2.4 mmHg, P = 0.0020). 
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DISCUSSION 
In humans, the essential fatty acid linoleic acid might lower blood pressure 
[1-3,17], while some studies reported that saturated fatty acids can raise blood 
pressure [4,5]. However, studies in normotensives have not produced consistent 
results. Two groups of investigators [2,18] did not observe an effect on blood 
pressure when the intake of saturated fat was decreased and replaced by 
carbohydrates. In other trials, the exchange of saturated fatty acids for linoleic acid 
at equal levels of total fat intake had no significant effects [19,20]. In the present 
study, no effects on blood pressure levels could be demonstrated after 3 weeks on 
a strictly controlled diet high in stearic acid, when compared with diets high in 
linoleic acid or in trans fatty acids; thus the null hypothesis had to be accepted. 
Blood pressures measured during the first two weeks were marginally higher 
on the stearic acid diet than on the other diets. However, these small differences 
were not seen after 3 weeks on the experimental diets. Also, these tests were 
performed after inspection of the data, and they are thus much less convincing 
than the test of the original null hypothesis. The statistical power in this 
experiment for detecting a true difference between two diets of 3 mmHg in systolic 
and diastolic blood pressure in the third week of the diets was over 90%. We 
therefore conclude that stearic acid has no important effect on blood pressure in 
young normotensive women and men. At the very most, stearic acid in a dose of 
8% of daily energy raises blood pressure by 1 - 2 mmHg, which is of little 
biological significance. 
Previous studies from our department showed that linoleic acid and oleic acid 
have similar effects on blood pressure [21 ] , and that trans fatty acids do not affect 
blood pressure relative to oleic acid or saturated fatty acids [22]. The present 
observation that trans fatty acids have the same effects on blood pressure as 
linoleic acid and stearic acid is in line with these findings. Our study confirms that 
monounsaturated trans fatty acids have no effects on blood pressure. 
It might be possible that the 3-week dietary periods in our trial were too short 
to induce a change in blood pressure. However, other studies suggested that blood 
pressure levels were already stabilized within 3 weeks after a dietary change 
[2,23]. 
We did not find a significant decrease in blood pressure during the 9 weeks 
of the trial due to a habituation effect [24]. Evidently the subjects had become 
habituated to the measurement procedures during the pre-experimental period. 
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Also, we did not observe an effect of the order in which the diets were supplied. 
Even if any of these effects would have been present, systematic bias in the 
comparison of the mean blood pressure levels between the different diet was 
eliminated by the balanced design of the study [7]. 
Puska and co-workers [25] found a larger decrease in systolic and diastolic 
blood pressure after dietary fat modification in subjects with mild hypertension 
than in normotensive subjects. The subjects in our study were normotensive, and 
it could be argued that their initial blood pressure values were too low to induce 
a change by diet. However, we think this is unlikely since blood pressure levels of 
subjects in two studies which did find effects of decreasing saturated fat intake 
[4,5] were even lower than those of our subjects. Moreover, we did not find 
differences in responses between subjects from the upper and the lower half of the 
blood pressure distribution. 
Body weights were kept constant during the trial. Also, the three experimental 
diets did not differ in their content of sodium, potassium, calcium, magnesium, 
alcohol, and dietary fibre. Thus, blood pressure could not have been affected by 
these factors. 
We conclude that a major increase in the intake of linoleic acid at the expense 
of stearic acid or monounsaturated trans fatty acids has no effect on blood 
pressure in normotensive young women and men. 
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ABSTRACT 
Aim. Serum lipoprotein(a) (Lp(a)) is a strong risk factor for coronary heart disease. 
We therefore examined the effect of dietary fatty-acid composition on serum Lp(a) 
levels in three strictly-controlled experiments with healthy normocholesterolemic 
men and women. 
Methods and Results. 
In the first experiment (Expt. I), 58 subjects consumed for 17 days a control 
diet high in saturated fatty acids. For the next 36 days 6.5% of total energy intake 
from saturated fatty acids was replaced by monounsaturates plus polyunsaturates 
(monounsaturated fatty acid diet; n = 29) or by polyunsaturates alone 
(polyunsaturated fatty acid diet; /7 = 29). Both diets caused a slight, nonsignificant, 
increase in median Lp(a) levels, with no difference between diets. 
In the second experiment (Expt. II), 10% of energy as the cholesterol-raising 
saturated fatty acids (lauric, myristic, and palmitic acid) was replaced by oleic acid 
or by frans-monounsaturated fatty acids. Each of the 59 participants received each 
diet for 3 weeks in random order. The median level of Lp(a) was 26 mg/L on the 
saturated fatty acid diet; it increased to 32 mg/L (P< 0.020) on the oleic acid diet 
and to 45 mg/L (P< 0.001) on the trans fatty acid diet. The difference in Lp(a) 
between the trans-fatty acid and the oleic acid diets was also highly significant 
(P<0.001). 
The third experiment (Expt. Ill) involved 56 subjects; all received 8% of 
energy from the stearic acid, from linoleic acid, or from rra/7s-monounsaturates, for 
3 weeks each. All other nutrients were equal. Median Lp(a) levels were 69 mg/L 
on both the stéarate diet and linoleate diet, and rose to 85 mg/L ( f < 0 . 0 1 ) on the 
trans diet. Changes in Lp(a) were positively related to initial levels. 
Samples from Expt. I had been stored for 43 months, those from Expt. II for 
31 months, and samples from Expt. Ill for 14 months at - 4 0 °C or lower. 
Comparison of nineteen paired samples suggested that storage may have caused 
an overall decrease of 5 - 1 2 % in Lp(a) levels, with no effect on the order of 
ranking of Lp(a) within studies. 
Conclusion. These short term experiments suggest that diets high in trans-
monounsaturated fatty acids may increase serum levels of Lp(a). 
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INTRODUCTION 
Lipoprotein(a) (Lp(a)) is a macromolecular complex, made up of apoprotein B, 
cholesterol, and other lipids, and a protein called apo(a). Apo(a) shows sequence 
homology to plasminogen [1 ]. The Lp(a) concentration in the blood is largely under 
genetic control and does not change much with age [2,3]. Most subjects have 
Lp(a) levels below 150 mg/L, but levels in some may well exceed 400 mg/L [2,3]. 
Such subjects have a markedly increased risk for coronary heart disease, a 
relationship that is not confounded by serum low-density or high-density lipoprotein 
(LDL or HDL) cholesterol levels [3,4]. 
In spite of the structural resemblance between Lp(a) and LDL [5], 
determinants of serum Lp(a) levels are distinctly different from those of LDL. 
Although niacin used with neomycin has been reported to decrease Lp(a) levels [6], 
attempts to modify Lp(a) by drug [7] or diet [8,9] have not been very successful. 
Recently, however, we have shown that dietary fatty acid composition may affect 
Lp(a): replacement of the habitual fat in the Dutch diet by palm oil resulted in a 
significant decrease in serum Lp(a) levels [10]. We therefore decided to analyze 
Lp(a) levels in serum samples from three controlled studies on diet and lipoproteins. 
Expt. I [11] involved replacement of saturated fatty acids by monounsaturated 
(oleic acid) or polyunsaturated fatty acids (linoleic acid). Expt. II [12] compared the 
cholesterol-raising saturated fatty acids with c/s-monounsaturated fatty acids (oleic 
acid) and with ?A3A7S-monounsaturated fatty acids, and Expt. Ill (Chapters 2 and 3) 
dealt with stearic acid, linoleic acid, and the trans fatty acid elaidic acid. 
METHODS 
Subjects and methods 
Most subjects were young, normolipidemic, nonobese students. They were 
all apparently healthy as indicated by a medical questionnaire, and by the absence 
of anaemia, glucosuria, and proteinuria. The experimental protocols, which had 
been approved by the Ethical Committee of the Department of Human Nutrition, 
Agricultural University, Wageningen, were fully explained to the subjects and their 
informed consent was obtained. No monetary inducement was offered, except for 
the food, which was free. 
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Diets consisted of conventional mixed solid foods. All foodstuffs were 
supplied individually according to each person's energy requirement. On weekdays 
at noon, hot meals were served at the Department of Human Nutrition in 
Wageningen. All other food was provided daily as a package. Food for the 
weekend and instructions for its preparation were provided on Fridays. In addition 
to the food supplied, each subject had to choose from a list food items that were 
free from fat and cholesterol. These items provided 9% of total daily energy intake. 
Body weight was recorded twice weekly and energy intake was adjusted when 
necessary to prevent changes in weight. 
Subjects were asked to maintain their usual pattern of activity and not to 
change their smoking habits or use of oral contraceptives. They recorded in diaries 
any sign of illness, medication used, the free-choice items selected, and any 
deviations from their diets. Inspection of the diaries did not reveal any deviations 
from the protocol which might have affected the results. 
Complete duplicate portions for one imaginary participant with a daily energy 
intake of 10 MJ or 11 MJ (2390 kcal or 2630 kcal) were collected daily for each 
diet. The duplicates were stored at - 2 0 °C, and were pooled and analyzed after 
the study. The free-choice items consumed were coded and their composition 
calculated using the Netherlands Nutrient Data Base [13]. The analyzed values of 
the duplicate diets were combined with the calculated values for the free-choice 
items. 
Fasting blood samples were collected between 7:15 AM and 10:00 AM. 
Blood was allowed to clot for 1 h and serum for lipid and lipoprotein measurements 
was obtained by low-speed centrifugation and stored at - 4 0 °C or lower until 
analysis. 
Lp(a) measurements 
Serum Lp(a) levels were analyzed by enzyme linked immunosorbent assay 
(ELISA) using a commercial kit (TintElize" Lp(a), Biopool, Umea, Sweden). The 
assay utilized polyclonal antibodies raised against purified Lp(a). It employs micro-
test wells coated with affinity purified goat anti-apo(a)-antibodies, which bind the 
Lp(a) particles present in the test sample. After incubation, anti-apo(a) antibodies 
conjugated to a peroxidase are added. These antibodies bind to the apo(a) of the 
immobilized Lp(a) from the test sample. Unbound conjugated antibodies are 
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washed off, and 1,2-phenylenediamine dihydrochloride is added. This is converted 
by peroxidase into a compound with a specific absorbance at 492 nm. A 
calibration curve is obtained from human standard plasma samples that are 
provided with the kit and represent eight different Lp(a) concentrations between 
0 and 600 mg/L, expressed in terms of particle mass. In all assays the correlation 
coefficient for the calibration curve was over 0.990. Addition of 3 to 1300 mg/L 
of human plasminogen to an Lp(a)-free medium or to a human plasma containing 
140 mg/L of Lp(a) did not change the assay response (Biopool Ltd, personal 
communication, 1991). A control serum pool was analyzed in each run. The 
average Lp(a) level for this pool was 245 mg/L and the inter-assay and intra-assay 
coefficient of variation were both 5.3%. However, due to a lack of international 
standardization, absolute levels of Lp(a) may not be directly comparable with those 
in other studies [14]. For each study, all samples of one subject were analyzed on 
the same plate. Samples had been stored at - 4 0 °C or lower for 1 4 - 4 3 months. 
In a separate run 29 pairs of serum and of citrated plasma, that had been 
stored for 1 - 3 weeks at - 8 0 °C, were analyzed. Lp(a) levels ranged between 6 
and 670 mg/L for the serum and from 6 to 637 mg/L for the plasma. Plasma 
samples were on average 11 mg/L lower than serum samples. The correlation 
coefficient was 0.99. These results suggest that the assay response is not 
materially changed when the clotting cascade has been activated, and that Lp(a) 
can be validly assayed in serum. 
Design and diets 
Expt. I was carried out from 4 October until 27 November 1987 [11]. Fifty-
eight healthy men and women first consumed for 17 days a control diet high in 
saturated fat. For the next 36 days, 14 of the men and 15 of the women received 
a diet enriched with olive oil and sunflower oil (monounsaturated fatty acid diet). 
The other 13 men and 16 women received a diet enriched with sunflower oil alone 
(polyunsaturated fatty acid diet). For the monounsaturated fatty acid group, 6.5% 
of total energy intake provided by saturated fatty acids on the control diet was 
replaced by a mixture of oleic acid (c/s-C18:1n-9) plus linoleic acid (cis,cis-
C18:2n-6) and for the polyunsaturated fatty acid group by linoleic acid alone. The 
intake of other nutrients was kept constant. 
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At the start of the study the mean ( ± SD) serum total cholesterol level of the 
subjects was 5.00 ± 0.79 mmol/L, and their mean body mass index 21.6 + 2.0 
kg/m2. During the study body weight increased by 0.2 ± 1.3 kg in the 
monounsaturated fatty acid group and by 0.2 ± 1.0 kg in the polyunsaturated 
fatty acid group. Three men and four women smoked. Nine women used oral 
contraceptive agents. 
Blood was sampled on days 14 and 17 (control period) and on days 50 and 
53 (test period). For Lp(a) analyses equal volumes were pooled per subject per diet 
period. The response to the monounsaturated fatty acid or the polyunsaturated 
fatty acid diet was calculated as the change from the end of the control period to 
the end of the test period. This design only allows comparison of differences 
between the effect of monounsaturated and polyunsaturated fatty acids; the 
absolute changes relative to the control diet high in saturated fatty acids may have 
been biased by unknown drifts with time. 
Expt. II was performed from 26 September until 28 November 1988 [12]. 
Twenty-five men and 34 women consumed three different diets for 3 weeks each, 
in random order. The composition of the diets was identical, except for 10% of 
daily energy intake which was provided by either a mixture of the cholesterol-
raising saturated fatty acids lauric, myristic, and palmitic acid, by oleic acid, or by 
trans isomers of oleic acid. The fat blend high in saturated fatty acids was 
composed of 55 parts of an interesterified mixture containing 4 0 % of palm oil and 
60% of palm kernel oil, 5 parts of an interesterified mixture containing equal 
volumes of fully hardened palm oil and palm kernel oil, and 40 parts of high oleic 
acid sunflower oil (TRISUN). The oleic acid group received olive oil and a margarine 
made with 85 parts of sunflower oil high in oleic acid and 15 parts of a mixture of 
equal volumes of interesterified fully hydrogenated palm oil and palm kernel oil. For 
the trans-fatty acid diet, the high oleic acid sunflower oil was hydrogenated under 
conditions promoting isomerization, and 78 parts were then mixed with 10 parts 
of the unaltered oleic acid-rich sunflower oil, 10 parts of regular sunflower oil and 
2 parts of low-erucic acid rapeseed oil. 
At the start of the study the mean ( ± SD) serum total cholesterol level was 
4.75 ± 0.64 mmol/L, and the mean body mass index 22.0 ± 2.3 kg/m2. Body 
weight increased by 0.1 ± 1.0 kg over the 63 days of the study. Two women, but 
none of the men, smoked. Eight women used oral contraceptive agents. 
Blood was sampled on the 18th and 21st day of each diet period and equal 
volumes of the two sera samples were pooled per subject. 
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Expt. Ill (Chapter 2) had the same design as experiment II. Between 29 
January and 2 April 1990, 26 men and 30 women participated. The difference 
between the three diets consisted of 8% of energy which was provided by either 
stearic acid, linoleic acid, or the fra/?s-monounsaturated fatty acid, elaidic acid. A 
fat high in stearic acid was made by interesterification of 41 parts of fully 
hydrogenated high linoleic acid sunflower oil, 50 parts of high oleic acid sunflower 
oil and 9 parts of regular high linoleic acid sunflower oil. For the fra^s-fatty acid 
diet, high oleic acid sunflower oil was hydrogenated so as to favor formation of 
trans fatty acids (Chapter 2). Seventy-five parts of this fat were mixed with 25 
parts of the unmodified oleic-acid rich sunflower oil. For the linoleate diet regular 
sunflower oil was the major source of linoleic acid. 
The mean initial serum total cholesterol level was 5.05 ± 0.79 mmol/L, and 
the mean body mass index 21.5 ± 2.1 kg/m2. During the 9 weeks of the study 
body weight decreased by 0.2 ± 1.1 kg. Four men and four women smoked, and 
thirteen women used oral contraceptives. 
Statistical analyses 
In all three studies the distribution of serum Lp(a) levels on the diets as well 
as that of the individual responses of Lp(a) to the diets was highly skewed. A 
square root-transformation rather than a log-transformation proved optimal for 
normalizing the distribution of Lp(a) levels and responses. In order to check the 
robustness of the statistical analyses we analyzed both the original and the 
normalized data. Absolute Lp(a) concentrations are presented as median levels and 
square root-transformed values as means. The untransformed individual changes 
were analyzed with nonparametric tests: the Mann-Whitney rank-sum test for Expt. 
I was used to examine the difference in change between the monounsaturated 
fatty acid and the polyunsaturated fatty acid diet, while the Friedman test for 
Expts. II and III was used to evaluate diet effects. Responses calculated from the 
square root-transformed Lp(a) levels were analyzed using an unpaired r-test for 
Expt. I and analysis of variance (ANOVA) for Expts. II and III. When a significant 
diet effect was observed (P<0.05) in Expts. II and III, the three diets were 
compared pairwise; to correct for multiple comparisons only P values of less than 
0.020 were then considered significant [15,16]. 
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RESULTS 
Effect of storage time on Lp(a) levels 
Nine subjects had participated in both Expt. I and Expt. II, and ten subjects 
in both Expt. II and Expt. III. To examine the effect of storage, Lp(a) levels of the 
nine subjects when they were eating the monounsaturated or polyunsaturated diet 
in Expt. I were compared with their values on the oleic acid diet in Expt. II. For the 
subjects who participated in both Expt. II and Expt. Ill, Lp(a) concentrations on the 
oleic acid diet in Expt. II were compared with levels on the linoleate diet in Expt. 
III. These diets were chosen, because they had similar effects on Lp(a) (see below). 
Samples from Expt. I had been stored for 43 months, those from Expt. II for 31 
months, and samples from Expt. Ill for 14 months. The nine samples of Expt. I 
were on average 5.4% lower than the corresponding samples of Expt. II. The ten 
samples of Expt. II were 12.2% lower than those of Expt. III. Thus, Lp(a) levels 
had decayed slightly with storage, but the order of ranking remained nearly 
unchanged (Fig. 1). For all 19 pairs combined the correlation coefficient was 0.96. 
Expt. I: Monounsaturates versus polyunsaturates 
Total fat intake of the participants was similar on all three diets (Table 1). The 
proportion of energy from the cholesterol raising saturated fatty acids (lauric acid, 
myristic acid and palmitic acid) decreased by 4 .3% on the monounsaturated fatty 
acid diet and by 5.3% on the polyunsaturated fatty acid diet. The intake of stearic 
acid decreased by slightly less than 1 % on both test diets. These decreases were 
compensated for by an increased intake of oleic acid (4.3%) and linoleic acid 
(3.6%) on the monounsaturated fatty acid diet and by linoleic acid alone (8.5%) 
on the polyunsaturated fatty acid diet. 
In the group that switched from the control diet high in saturated fatty acids 
to the monounsaturated fatty acid diet the median Lp(a) concentration increased 
by 7 mg/L, from 84 to 91 mg/L (range of individual changes: - 3 4 to 89 mg/L; 
Table 2). The median value of the polyunsaturated fatty acid group rose by 3 mg/L, 
from an initial 37 to 40 mg/L (range of changes: - 3 2 to 46 mg/L). The difference 
in response between the two diet groups was not significant (Mann-Whitney test: 
P = 0 . 8 5 2 , f-test: />=0.815). 
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Fig. 1. Effect of storage on Lp(a) levels. Nine subjects had participated in both Expt. I and 
Expt. II ( • ) and 10 subjects in both Expt. II and Expt. Ill ( • ) . To examine the effect of 
storage, Lp(a) levels of the 9 subjects when on the monounsaturated or polyunsaturated 
fatty acid diet in Expt. I (sample-1 ) were compared with their values on the oleic acid diet 
in Expt. II (sample-2). For the 10 subjects who participated in both Expt. II and Expt. Ill, 
Lp(a) concentrations on the oleic acid diet in Expt. II (sample-1 ) were compared with those 
on the linoleate diet in Expt. Ill (sample-2). Samples from Expt. I had been stored for 43 
months, those from Expt. II for 31 months, and samples from Expt. II for 14 months. 
Initial Lp(a) levels on the control diet high in saturated fatty acids were 
markedly though not significantly (Mann-Whitney test: P = 0.224, f-test: P = 0.219) 
higher in the monounsaturated-fatty acid than in the polyunsaturated-fatty acid 
group. As changes might occur only at relatively high levels, subjects were divided 
into two groups of 29 each, according to their Lp(a) concentration on the control 
diet high in saturated fatty acids. Of the 29 subjects with the highest initial Lp(a) 
levels, 17 were later to receive the monounsaturated fatty acid diet, and the other 
12 the polyunsaturated fatty acid diet. For the monounsaturated fatty acid group 
initial median Lp(a) levels on the control diet were 1 51 mg/L (range: 4 5 - 3 4 0 mg/L) 
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Table 1. Dietary fatty acids in experiment I. 
Total fat 
Saturated fa t ty acids 
Laurie acid (C12:0) 
Myrist ic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated fat ty acids 
Os-C18:1 
Polyunsaturated fat ty acids 
Linoleic acid (cis,cis-C18:2n-6) 
Control 
Diet 
36 .7 
19.3 
1.2 
3.2 
9.3 
4.1 
11.5 
10.2 
4 .6 
4.1 
Monounsaturated 
Fatty Acid Diet 
% of daily energy intake 
37 .4 
12.9 
0.7 
1.4 
6.8 
3.2 
15.1 
14.5 
7.9 
7.7 
Polyunsaturated 
Fatty Acid Diet 
37 .6 
12.6 
0.9 
1.3 
6.2 
3.4 
10.8 
10.2 
12.7 
12.6 
Values are based on chemical analyses of duplicate diets. All 58 subjects first consumed the control diet 
high in saturated fatty acids for 17 days; for the next 36 days 14 men and 15 women received the 
monounsaturated fatty acid diet, and 13 men and 16 women the polyunsaturated fatty acid diet. The intake 
of protein (13% of daily energy intake), carbohydrates (48 -49%) , alcohol (1 - 2 % ) , cholesterol ( 3 3 - 6 6 
mg/MJ), and other nutrients was virtually identical on all three diets. 
and decreased by 1 mg/L to 150 mg/L (range of changes: - 3 4 to 89 mg/L). 
In those who switched to the polyunsaturated fatty acid diet, Lp(a) declined by 8 
mg/L, from 199 mg/L (range: 47 - 235 mg/L) to 191 mg/L (range of changes: -32 
to 46 mg/L). Again, the difference in changes between the two groups did not 
reach statistical significance (Mann-Whitney test: P=0 .929 , r-test: P = 0.647). 
LDL cholesterol levels (Table 2) decreased by 0.59 mmol/L (23 mg/dL) on the 
monounsaturated and by 0.46 mmol/L (18 mg/dL) on the polyunsaturated fatty 
acid diet (P = 0.05 for difference between diets). Adherence to the diets was 
confirmed by changes in the fatty acid composition of serum cholesteryl esters. 
The proportion of oleic acid in serum cholesteryl esters decreased by 0.8% on the 
monounsaturated fatty acid group and by 4 .6% on the polyunsaturated fat acid 
diet (P<0.001) . The level of linoleic acid increased by 4 .2% and by 8.7%, 
respectively (P<0.001). 
Changes in Lp(a) levels, or the lack of them, were similar in man and women 
(Table 2), and in the five subjects who had suffered intercurrent illness [11] when 
compared with the other 54 subjects. 
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Table 2. Serum lipoprotein (a) and LDL-cholesterol levels in Experiment I. 
Group Control Diet Mono- or 
Polyunsaturated 
Fatty Acid Diet 
Lipoprotein(a)3 
Monounsaturated fatty acid group 
Men 
Women 
All 
Polyunsaturated fatty acid group 
Men 
Women 
All 
45 (0-77) 
142 (0-340) 
84 (0-340) 
37 (0-235) 
43 (0-220) 
37 (0-235) 
mg/liter 
52 (9-160) 
129 (0-336) 
91 (0-336) 
36 (0-240) 
44 (0.237) 
40 (0-240) 
\[ [Lipoprotein(a)] 
Monounsaturated fatty acid group 
Men 
Women 
All 
Polyunsaturated fatty acid group 
Men 
Women 
All 
6.6 ± 5.0 
10.9 ± 5.8 
8.8 ± 5.8 
6.6 ± 5.1 
7.3 ± 5.7 
7.0 ± 5.4 
6.7 ± 4.8 
11.3 ± 5.8 
8.9 + 5.7 
6.5 ± 5.4 
7.5 ± 5.7 
7.0 ± 5.5 
LDL-cholesterol 
Monounsaturated fatty acid group 
Men 
Women 
Allc 
Polyunsaturated fatty acid group 
Men 
Women 
Allc 
mmol/liter 
3.05 ± 0.79 
3.53 ± 0.65 
3.30 ± 0.75 
3.62 + 0.68 
3.09 ± 0.61 
3.33 ± 0.68 
2.52 ± 0.73 
2.89 ± 0.58 
2.71 ± 0.67 
3.06 ± 0.68 
2.73 ± 0.52 
2.87 ± 0.60 
Fifty eight subjects first received the control diet high in saturated fatty acids for 17 days; for the next 36 
days, 14 men and 1 5 women received a diet high in monounsaturated fatty acids, and 13 men and 16 women 
received a diet high in the polyunsaturated fatty acids. 
3
 Values are median levels (ranges). 
Values are square root-transformed means ± SD. 
0
 Denotes a significant difference in change between the two diet groups: P<0.05. 
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Expt. II: Saturates versus c/s-monounsaturates versus fra/75-monounsaturates 
The intake of the cholesterol-raising saturated fatty acids decreased by 8.5% 
of energy intake on the oleic acid diet and by 8.8% on the trans-fatty acid diet 
compared with the saturated fatty acid diet (Table 3). Stearic acid and total fat 
intake were similar on all three diets. 
Table 3. Dietary fatty acids in experiment II. 
Total fat 
Saturated fatty acids 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated fatty acids 
C/s-C18:1 
7>a/?s-C18:1 
Polyunsaturated fatty acids 
Linoleic acid (cis,cis-C18:2n 
Saturated 
Fatty Acid Diet 
38.8 
19.4 
3.4 
2.7 
8.1 
3.5 
14.7 
12.8 
1.8 
3.4 
-6) 2.9 
Oleic 
Acid Diet 
% of daily energy intake 
39.6 
9.5 
0.5 
0.5 
4.7 
3.0 
24.1 
23.0 
0.0 
4.6 
4.0 
7>a/7s-Fatty 
Acid Diet 
40.2 
10.0 
0.4 
0.7 
4.3 
3.6 
24.2 
12.6 
10.9 
4.6 
4.2 
Values are based on chemical analyses of duplicate diets. Fifty-nine subjects received each diet for three 
weeks each in random order. The intake of protein ( 1 3 - 1 4 % of daily energy intake), carbohydrates (46%), 
alcohol (1%), cholesterol ( 3 2 - 3 5 mg/MJ), and other nutrients was virtually identical on all three diets. 
Table 4 shows that the median serum Lp(a) level was 26 mg/L on the 
saturated fatty acid diet and rose to 32 mg/L on the oleic acid diet (range of 
individual changes: - 7 7 to + 1 1 0 mg/L; Friedman test: P = 0.020 / ANOVA: 
P = 0.0024) and to 45 mg/L on the trans-fatty acid diet (range of changes: - 5 8 
to + 2 5 4 mg/L; Friedman test and ANOVA: P< 0.001 ). The difference between the 
median Lp(a) levels on the trans-fatty acid and the oleic acid diet was also highly 
significant (range of changes: - 3 2 to 144 mg/L; Friedman and ANOVA: 
P<0 .001) . The effects were observed to a similar extent in men and women. 
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Table 4. Serum lipoprotein(a) and LDL-cholesterol levels in Experiment II. 
Group 
Lipoprotein(a)3 
Men 
Women 
All 
\/[lipoprotein(a)r 
Men 
Women 
All 
LDL-cholesterol 
Men 
Women 
All 
Saturated 
Fatty Acid Diet 
22 (0-220) 
31 (0-447) 
26 (0-447) 
5.6 ± 4.6 
5.5 ± 5.9 
6.5 ± 5.4 
3.05 ± 0.66 
3.20 ± 0.50 
3.14 ± 0.57 
Oleic Acid 
Diet 
mg/liter 
27 (0-200) 
34 (0-484)c 
32 (0-484)c 
5.9 ± 4.6 
7.8 ± 5.9C 
7.0 ± 5.4C 
mmol/liter 
2.59 ± 0.61 c 
2.73 ± 0.48c 
2.67 ± 0.54c 
Trans-Fatty 
Acid Diet 
44 (0-297) c-d 
48 (0-510) c'd 
45 (0-510) c'd 
6.8 ± 4.9 c'd 
8.6 ± 6.4 c'd 
7.8 ± 5.8 c'd 
2.93 ± 0.65 c'd 
3.12 ± 0.58 d 
3.04 ± 0.61 c'd 
Twenty five men and 34 women received each diet for 3 weeks each in random order. 
a
 Values are median levels (ranges). 
Values are square root-transformed means ± SD. 
c
 Significantly different from levels on the diet high in saturated fatty acids: P<0.020. 
d
 Significantly different from levels on the diet high in oleic acid: P< 0.020. 
To examine the effect of intrinsic serum Lp(a) levels subjects were ranked 
according to their levels on the saturated fatty acid diet. Fig. 2 shows that subjects 
with the highest innate Lp(a) levels had the greatest changes on both the oleic acid 
and the trans-fatty acid diet. Higher Lp(a) levels on the trans-fatty acid diet than 
on the saturated fatty acid diet were seen in 47 of the 59 subjects, while 40 
subjects had higher Lp(a) levels on the oleic acid diet than on the saturated fatty-
acid diet. Four subjects had no detectable amounts of Lp(a) on any diet. 
Serum LDL cholesterol decreased by 0.47 mmol/L ( 18 mg/dL) on the oleic-acid 
diet (P< 0.001) and by 0.10 mmol/L (4 mg/dL) on the trans-fatty acid diet 
(P<0.001) as compared with the saturated fatty acid diet (Table 4). 
Relative to levels on the oleic acid diet, the proportion of oleic acid in serum 
cholesteryl esters decreased by 3.9% on the saturated fatty acid diet (P<0.02) , 
and by 7 . 1 % on the fra/is-fatty-acid diet (P<0.02). The percentage of trans-
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monounsaturated fatty acids in serum cholesteryl esters was 0 . 1 3 % on the oleic 
acid diet, 0 . 2 1 % on the saturated fatty acid diet ( P < 0 . 0 2 0 ) , and 1 .34% on the 
trans-iatty acid diet (P< 0 . 020 ) . 
Serum Lp[a 
(mg/L) 
400 
200 
Levels of Lp[a] on the saturated-fatty-acid diet (Expt II) - 1 
200 
100 H 
0 
Change in Lp[a] on the oleic-acid diet (Expt II) 
;_j^-M|a-i-t± 
200 
100 
0 
Change in Lp[a] on the frans-fatty-acid diet (Expt II) 
B _ • _• I _• • • • !*.• _._• - _ _ J_ll 11«
 B • IJJ11B 
Fig. 2. Individual levels of serum Lp(a) in Expt. II (n = 59) on the diet high in the cholesterol-
raising saturated fatty acids, and responses to the diet when 10% of energy from the 
cholesterol-raising saturated fatty acids was replaced by either oleic acid or trans-
monounsaturated fatty acids. 
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Expt. Ill: Stearic acid versus linoleic acid versus fra/is-monounsaturates 
Intake of the cholesterol-raising saturated fatty acids and of oleic acid differed 
by less than 1 % between the three diets (Table 5). Nine percent of energy from 
stearic acid was replaced by 8 . 1 % of linoleic acid on the linoleate diet and by 
7.4% of fraAjs-monounsaturated fatty acids on the trans-d\et. 
Table 5. Dietary fatty acids in experiment III. 
Total fat 
Saturated fatty acids 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated fatty acids 
C/s-C18:1 
7re/7S-C18:1 
Polyunsaturated fatty acids 
Linoleic acid (cis,cis-C18:2n-6) 
Stéarate 
Diet 
43.5 
20.1 
0.5 
1.0 
5.7 
11.8 
16.6 
15.4 
0.3 
4.3 
3.9 
Linoleate 
Diet 
% of daily energy intake 
41.1 
11.0 
0.7 
0.9 
5.8 
2.8 
15.8 
14.7 
0.1 
12.5 
12.0 
Trans-Fatty 
Acid Diet 
39.7 
10.3 
0.5 
1.0 
4.8 
3.0 
23.3 
14.6 
7.7 
4.2 
3.8 
Values are based on chemical analyses of duplicate diets. Fifty-six subjects received each diet for 3 weeks 
each in random order. The intake of protein ( 1 2 - 1 3 % of daily energy intake), carbohydrates ( 4 4 - 4 7 % ) , 
alcohol (1 %), cholesterol ( 3 3 - 3 4 mg/MJ), and other nutrients was virtually identical on all three diets. 
In this set of subjects the median Lp(a) level was 69 mg/L on both the stéarate 
and the linoleate diets (Table 6). It rose to 85 mg/L on the trans-fatty acid diet 
(range of individual changes relative to stearic acid diet: - 9 9 to 230 mg/L; 
Friedman test: P = 0.006, ANOVA: P = 0.018). The difference between the trans-
fatty acid diet and the linoleate diet was also highly significant (Friedman test: 
P<0.00'\, ANOVA: P = 0.0'\8). Gender did not affect the changes observed. 
As shown in Fig. 3, changes in Lp(a) on the fra^s-diet relative to the stéarate 
diet were related to initial levels. Lp(a) increased on fre^s-fatty acids in 34 out of 
the 56 subjects, it decreased in 17 subjects, and 5 subjects showed no change. 
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The mean LDL cholesterol level was 3.00 mmol/L (116 mg/dL) on the stéarate 
diet, 2.83 mmol/L (109 mg/dL) on the linoleate diet (P< 0.001), and 3.07 mmol/L 
(119 mg/dL) on the trans-fatty acid diet (Table 6). 
Table 6. Serum lipoprotein(a) and LDL-cholesterol levels in Experiment III. 
Group 
Lipoprotein(a)a 
Men 
Women 
All 
Vtlipoprotein(a)]6 
Men 
Women 
All 
LDL-cholesterol 
Men 
Women 
All 
Stéarate 
Diet 
78 (0-298) 
63 (0-749) 
69 (0-749) 
8.8 ± 5.5 
10.9 ± 7.8 
9.9 ± 6.9 
3.16 ± 0.74 
2.87 ± 0.66 
3.00 ± 0.71 
Linoleate 
Diet 
mg/liter 
84 (1-310) 
63 (0-782) 
69 (0-782) 
8.8 ± 5.5 
11.0 ± 8.0 
9.9 ± 7.0 
mmol/liter 
2.90 ± 0.71 c 
2.78 ± 0.55 
2.83 ± 0.63c 
Trans-Fatty 
Acid Diet 
103 (0-351) d 
69 (0-891) 
85 (0-891) c'd 
9.4 ± 5.9 c'd 
11.2 ± 8.2 
10.3 ± 7.2 c'd 
3.14 ± 0.65 d 
3.01 + 0.66 d 
3.07 ± 0.65 d 
Twenty six men and 30 women received each diet for 3 weeks each in random order. 
3
 Values are median levels (ranges). 
b
 Values are square root-transformed means ± SD. 
c
 Significantly different from levels on the stéarate diet: P<0.020. 
d
 Significantly different from levels on the linoleate diet: P< 0.020. 
The proportion of linoleate in serum cholesteryl esters increased by 6.6% on 
the linoleate diet (P<0.020), but decreased by 1.6% on the trans-fatty acid diet 
(P< 0.020) compared with the stéarate diet. The proportion of trans-
monounsaturated fatty acids in serum cholesteryl esters was 0.12% on the 
stéarate diet, 0.13% on the linoleate diet, and 0.94% on the frans-fatty acid diet 
(P<0.020) . 
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Fig. 3. Individual levels of serum Lp(a) in Expt. Ill (n = 56) on the diet high in the saturated 
fatty acid stearic acid, and responses to the diet when 8% of energy from stearic acid was 
replaced by either linoleic or frans-monounsaturated fatty acids. 
Summary of results 
These three studies together strongly suggest that fra/7s-monounsaturated 
fatty acids elevate serum Lp(a) levels as compared with oleic acid, linoleic acid or 
stearic acid (Expts. II and III). Oleic acid and linoleic acid had similar effects on 
serum Lp(a) (Expt. I). The cholesterol-raising saturated fatty acids caused 
marginally lower Lp(a) levels than oleic acid in Expt. II. Changes were related to 
initial levels, and were similar for men and women. 
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DISCUSSION 
The level of Lp(a) is largely under genetic control, and initial studies suggested 
that, unlike LDL, Lp(a) levels are singularly insensitive to diet. Although this 
suggestion appears to be correct as far as dietary cholesterol is concerned [9,17], 
dietary fat composition did affect Lp(a) concentrations in some [10,18], but not all 
[19,20], studies. Our results suggest that frarts-monounsaturated fatty acids 
(trans-C\8:1) increase Lp(a) levels relative to three other fatty acids with 18 
carbon atoms: stearic acid (C18:0), oleic acid (c/s-C18:1 ), and linoleic acid (cis,cis-
C18:2). Compliance with the diets was very good, as indicated by changes in 
cholesteryl ester fatty acid composition. 
We have shown recently in a 2 x 6 week double-blind cross-over trial that 
replacement of the habitual fat by palm oil lowered Lp(a) in healthy normolipidemic 
men [10]. We suggested that the effect observed was due either to a component 
in palm oil or to displacement of a component present in the habitual dietary fat. 
Our present findings are in agreement with the latter suggestion, as replacement 
of the habitual fat by palm oil decreased the intake of trans fatty acids by more 
than 50% [10]. Thus, the apparent Lp(a)-lowering effect of palm oil may have been 
due to displacement of trans fatty acids. 
In Expt. II, Lp(a) levels were slightly, though significantly, lower on the diet 
high in the cholesterol-raising saturated fatty acids than on the oleic acid diet. In 
Expt. I, however, there was a only nonsignificant increase in median Lp(a) when 
subjects were switched from saturated fatty acids to oleic or linoleic acid. Apart 
from not being statistically significant, this slight change could also have been 
caused by an nonspecific drift with time, as a parallel design was used in Expt. I. 
Recently, Brown et al. [17] also reported similar Lp(a) levels on a saturated fatty 
acid diet and a diet high in polyunsaturated fatty acids. Although the level of the 
cholesterol-raising saturated fatty acids differed by less than 3% of total energy 
intake between the two diets [17] - t h e major exchange being between 
monounsaturated and polyunsaturated fatty acids, which, according to our results 
(Expt. I), have similar effects on Lp(a) - these findings do not support the evidence 
for an Lp(a)-lowering effect of saturated fatty acids. 
Other studies have suggested that serum Lp(a) levels are not related to serum 
LDL cholesterol or apolipoprotein B levels [3,17]. This is confirmed by our present 
findings: depending on the type of fatty acid studied, diet-induced changes in Lp(a) 
and in LDL cholesterol or apolipoprotein B levels could be either in the opposite 
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direction, as in Expt. II where oleic acid lowered LDL cholesterol but raised Lp(a) 
relative to saturates, or in the same direction, as in Expt. Ill where trans fatty acids 
raised both LDL cholesterol and Lp(a) relative to linoleic acid. These observations 
make it less likely that dietary effects on LDL cholesterol and Lp(a) levels are 
mediated by the same pathway. 
Changes were positively related to intrinsic Lp(a) levels as has also been 
observed by others [6,10]. 
It has been reported that storage of serum samples at - 2 0 °C for 6 months 
[21] or even for up to seven years does not affect serum Lp(a) levels [22], when 
ELISA-kits were used from the same manufacturer as ours. Our results, however, 
do suggest that Lp(a) levels decay slightly with storage. However, in each 
experiment each subject was sampled on two (Expt. I) or three (Expts. II and III) 
different diets, and only changes in Lp(a) between diets within one experiment 
were compared. Thus, a slight overall decay in Lp(a) might underestimate slightly 
the extent of response of Lp(a) to diet, but is highly unlikely to affect the direction 
of this response. Also, the significance of responses was similar when tested by 
two different statistical approaches - t h e conventional f-test and ANOVA versus 
nonparametric t e s t s - which supports the robustness and consistency of the 
effects observed. 
The experimental diets were consumed for 3 - 5 weeks. Although 3 weeks is 
long enough for serum total or LDL lipoprotein cholesterol levels to stabilize [11], 
we cannot exclude the possibility that the observed changes in Lp(a) by us are 
transient or, alternatively, underestimated and not yet at their maximum level. Our 
results do suggest that the observed effects are proportional to the amounts of 
fatty acids consumed. The intake of frans-monounsaturated fatty acids in Expt III 
was about 4 % of daily energy intake lower than in Expt. II, while the changes in 
Lp(a) were also less pronounced (Tables 4 and 6). 
In conclusion, these short-term dietary experiments suggest that diets high in 
fra/7S-monounsaturated fatty acids may increase serum levels of Lp(a). 
Additional note 
Recently, Nestel et al. [23] reported that a diet rich in the trans fatty acid 
elaidic acid elevated the levels of Lp(a) in mildly hypercholesterolemia men. Our 
findings our in good agreement with this observation. 
87 
Chapter 4 
REFERENCES 
1. McLean JW, Tomlinson JE, Kuang W-J, et al. cDNA sequence of human apolipoprotein(a) is 
homologous to plasminogen. Nature 1987; 300: 132-137. 
2. Dahlén GH. Incidence of Lp(a) among populations. In: Scanu AM, ed. Lipoprotein(a). San 
Diego: Academic Press Inc., 1990:151-173. 
3. Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein(a) is an independent risk 
factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23. 
4. Seed M, Hoppichler F, Reaveley D, et al. Relationship of serum lipoprotein(a) concentration and 
apolipoprotein(a) phenotype to coronary heart disease in patients with familial 
hypercholesterolemia. N Engl J Med \ 990; 322: 1494-1499. 
5. Fless GM, ZumMallen ME, Scanu AM. Physicochemical properties of apolipoprotein(a) and 
lipoprotein(a-) derived from dissociation of human plasma lipoprotein(a). J Biol Chem 1986; 
261: 8712-8718. 
6. Guraker AJ, Hoeg M, Kostner G, Papadopoulos M, Brewer HB. Levels of lipoprotein Lp(a) 
decline with neomycin and niacin treatment. Atherosclerosis 1985; 57: 293-301. 
7. Vessby B, Kostner G, Lithell H, Thomis J. Diverging effects of cholestryamine in 
hypercholesterolaemia. Atherosclerosis 1982; 44: 61-71. 
8. Masarei JRL, Rouse IL, Lynch WJ, Robertson K, Vandongen R, Beilin LJ. Effects of lacto-ovo 
vegetarian diet on serum concentrations of cholesterol, triglyceride, HDL-C, HDL2-C, HDL3-C, 
and Lp(a). Am J Clin Nutr 1984; 40: 468-479. 
9. Katan MB, Beynen AC. Characteristics of human hypo- and hyperresponders to dietary 
cholesterol. Am J Epidemiol 1987; 125: 387-399. 
10. Hornstra G, van Houwelingen AC, Kester ADM, Sundram K. A palm oil-enriched diet lowers 
serum lipoprotein(a) in normocholesterolemic volunteers. Atherosclerosis 1991; 90: 91-93. 
11. Mensink RP, Katan MB. Effect of a diet enriched with monounsaturated or polyunsaturated 
fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women 
and men. NEnglJMed 1989; 321: 436-441. 
12. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density 
lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990; 323: 439-445. 
13. Kommissie UCV. UCV tabel: uitgebreide voedingsmiddelentabel 1985. The Hague, The 
Netherlands: Voorlichtingsbureau voor de Voeding, 1985: 1-77. 
14. Albers JJ, Marcovina SM, Lodge MS. The unique lipoprotein(a): properties and 
immunochemical measurement. Clin Chem 1990; 36: 2019-2026. 
15. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, Iowa: The Iowa State 
University Press, 1980: 1-507. 
16. Conover WJ. Practical Nonparametric Statistics. 2nd ed. New York: John Wiley and Sons, 
1980. 
17. Brown SA, Morrisett J, Patsch JR, Reeves R, Gotto AM,Jr., Patsch W. Influence of short term 
dietary cholesterol and fat on human plasma Lp(a) and LDL levels. J Lipid Res 1991; 32: 
1281-1289. 
18. Beil FU, Terres W, Orgass M, Greten H. Dietary fish oil lowers lipoprotein(a) in primary 
hypertriglyceridemia. Atherosclerosis 1991; 90: 95-97. 
19. Mehabrian M, Peter JB, Barnard RJ, Lusis AJ. Dietary regulation of fibrinolytic factors. 
Atherosclerosis 1990; 84: 25-32. 
20. Malle E, Sattler W, Prener E, et al. Effect of dietary fish oil supplementation on platelet 
aggregability and platelet membrane fluidity in normolipemic subjects with amd without high 
plasma Lp(a) concentrations. Atherosclerosis 1991; 88: 193-201. 
88 
Trans fatty acids and lipoprotein (a) 
21 . Craig WY, Ledue TB. The effects of long term storage on serum Lp(a) levels. Atherosclerosis 
1992; 93: 261. 
22. Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein (a) and coronary heart disease risk: 
a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 
59-67. 
23. Nestel P, Noakes M, Belling B, et al. Plasma lipoprotein lipid and Lp(a) changes with 
substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029-1036. 
89 
CHAPTER 5 
Impact of myristic versus palmitic acid on serum lipid 
and lipoprotein levels in healthy women and men 
IOHIEZLDUE 
iPMiDlMUfflR 
^ ^ M 3 
Zock PL, de Vries JHM, Katan MB. 
Arteriosclerosis and Thrombosis 1994; 14: 567-575. 
91 
Chapter S 
ABSTRACT 
Aim. The cholesterol-raising effect of dietary saturated fatty acids is largely 
accounted for by lauric, myristic, and palmitic acid. Dairy fat is a major source of 
myristic acid, while palm oil is especially rich in palmitic acid. Myristic acid is 
suspected of being much more cholesterolemic than palmitic acid, but direct 
comparisons were lacking. 
Methods. We therefore fed 36 women and 23 men three diets which differed from 
each other in palmitic, oleic and myristic acid content by about 10% of total 
energy. We used palm oil, high-oleic acid sunflower oil, and a specially produced 
high-myristic acid fat to achieve these differences. Each diet was supplied for 3 
weeks, in random order. 
Results. Mean serum cholesterol was 4.53 mmol/L on the high oleic acid diet, 4.96 
mmol/L on the palmitic acid diet, and 5.19 mmol/L on the myristic acid diet 
(P<0.0001 for all comparisons). Myristic acid raised low-density (LDL) cholesterol 
level by 0.11 mmol/L, high-density (HDL) cholesterol by 0.12 mmol/L, and 
apolipoprotein (apo) A-l by 7.2 mg/dL relative to palmitic acid; increases relative 
to oleic acid were 0.50 mmol/L for LDL, 0.15 mmol/L for HDL cholesterol, 6.0 
mg/dL for apoB, and 8.9 mg/dl for apoA-l (P<0.01 for all comparisons). The HDL 
cholesterol and apoA-l levels on the palmitic and the oleic acid diets were the 
same. None of the responses differed significantly between women and men. 
Conclusion. Myristic and palmitic acid both caused high LDL cholesterol and apoB 
levels and low HDL to LDL ratios. Thus, diets for the treatment of 
hypercholesterolemia should be low in myristic and palmitic acids. 
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INTRODUCTION 
Reducing saturated fat (and cholesterol) intake is the therapy of choice in the 
treatment of moderate hypercholesterolemia, and an important adjunct to drug 
therapy in the treatment of severe hypercholesterolemia [1]. Restriction of 
saturated fatty acids in the diet is more effective than limiting total fat 
consumption [2]. However, saturates with different chain lengths may differ in 
their cholesterol-raising effect. Laurie acid (C12:0), myristic acid (C14:0) and 
palmitic acid (C16:0) are thought to increase cholesterol levels, while stearic acid 
(C18:0) has little or no effect [3-7]. In experimental animals, saturated fatty acids 
raise plasma cholesterol through down-regulation of LDL receptor activity, and 
subsequent accumulation of LDL cholesterol in plasma and increased LDL 
production from its precursor VLDL [8,9]. These effect are seen with lauric, 
myristic, and palmitic acid, but not with medium-chain saturates (C6:0, C8:0, and 
C10:0) or stearic acid [10]. In humans lauric acid has been found to be less potent 
than palmitic acid in raising total and LDL cholesterol [4,11,12]. Myristic and 
palmitic acid together make up about 2 5 - 3 0 % of the fat in Western diets (D. 
Kromhout, unpublished data, 1988), but their relative cholesterol-raising potencies 
have not been clearly defined in man. Meta-analyses of dietary trials that employed 
commercially available fats indicated that myristic acid might be four to six times 
more cholesterolemic than palmitic acid [4,13]. Some recent studies also suggest 
that palmitic acid lowers cholesterol relative to a mixture of lauric and myristic acid 
[14-16]. However, others have found that palmitic acid strongly increases 
cholesterol levels [5,7,12,17]. A problem in studies with natural fats [4,13-16] is 
that the amount of myristic acid is linked with either the amount of lauric acid, 
such as in coconut oil, or with that of palmitic acid, such as in dairy fat. The 
effects of different saturates are therefore hard to examine. An early study with 
specially synthesized fats by McGandy et al. [11] did not resolve the issue. 
Synthetic fats are expensive, and the effort has not been repeated until now. 
Myristic acid is the third common saturate in the diet. Average intake levels 
are about 1 g/d in Japan, 6 g/d in the United States, 8 g/d in the Netherlands, and 
14 g/d in eastern Finland (Kromhoutetal. , unpublished data, 1988). Major sources 
are butter fat, which is also rich in palmitic acid, and two vegetable oils, coconut 
oil and palm kernel oil; the latter two also contain large amounts of lauric acid. 
Palm oil, another vegetable oil that is high in saturated fatty acids, is low in 
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myristic acid and high in palmitic acid. Palm oil is the number one edible oil 
worldwide, and its consumption is rising. If much of the cholesterol-raising effect 
of saturated fatty acids is indeed specifically due to myristic acid, then palm oil 
would be a suitable substitute for animal fats and hydrogenated vegetable oils [ 18] 
in a wide range of products for cholesterol-lowering diets. Also, modern 
biotechnology could be applied to replace myristic with palmitic acid in other fats. 
To investigate the relative potencies of myristic and palmitic acids, we 
produced a fat high in myristic acid and compared its effects with those of palmitic 
and oleic acids on lipoprotein levels in humans. Serum lipids have an important role 
in the atherosclerotic process in both women and men [19], but data on the 
differences in dietary effects on serum lipids between women and men are scarce 
[20]. To determine whether women and men have similar lipoprotein responses to 
dietary saturated fat, we included enough female volunteers to allow detection of 
gender-specific responses. 
SUBJECTS AND METHODS 
Hypotheses, design, and statistical analysis 
The objective of the trial was to estimate the effects of myristic and palmitic 
acids relative to each other and to oleic acid on serum lipids and lipoproteins in 
healthy women and men. The study was designed to detect a significant (P = 0.05) 
effect of myristic acid versus palmitic acid on total and LDL cholesterol with a 
power of 80% if the real population effect exceeded 0.13 mmol/L. The a priori 
power was also 80% for detecting a difference in response of total and LDL 
cholesterol of 0.30 mmol/L between women and men. 
The trial consisted of three consecutive 3-week periods, during which each 
participant consumed each of the three diets. Our experience agrees with that of 
earlier workers [3,21] in that serum lipid and lipoprotein levels stabilize within 2 
weeks after a dietary change [22,23]. One diet was high in palmitic acid, another 
high in myristic acid, and the third high in oleic acid. Thus, there were six possible 
treatment sequences. Each of the six diet sequence groups had the same ratio of 
men to women and of women using and not using oral contraceptives. In this way, 
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bias due to the order in which the diets were consumed or to drift of variables over 
time was eliminated [24]. All subjects participated simultaneously, from January 
27 until March 30, 1992. 
The data were analyzed with the General Linear Models (GLM) procedure of 
the SAS Program [25]. When the ANOVA indicated a significant effect of diet 
(P<0.05) , the Tukey correction was used for pairwise comparisons of the diets 
and for calculation of 95% confidence limits for the differences between two diets. 
Subjects 
Seventy-nine persons responded to calls via local newspapers and posters in 
university buildings. Five women and 2 men withdrew before or during the 
screening procedure. Of the remaining 42 women and 30 men, 2 men were 
excluded because they consumed over 10% of daily energy intake as alcohol, 3 
men and 3 women because their serum cholesterol levels exceeded 7.1 mmol/l or 
their blood pressure was over 140/90 mmHg, and 2 women for medical reasons 
as judged by an independent physician. One man and 1 woman withdrew after the 
screening because their partner was excluded for one of the reasons mentioned 
above, and one man for unstated reasons. The 36 women and 23 men who 
entered the study were all apparently healthy, as indicated by a medical 
questionnaire. None had anemia, glycosuria, proteinuria, and none were taking 
medications known to affect blood lipids. Eleven women used oral contraceptives, 
and 6 women and 2 men smoked cigarettes. Pre-experimental fasting serum 
cholesterol levels ranged from 3.67 to 7.10 mmol/L (mean, 5.06 mmol/L). The 
women were between 18 and 55 years old (mean, 29 years) and weighed between 
53 and 83 kg (mean, 65 kg); their body mass index ranged from 19.0 to 26.8 
kg/m2 (mean, 22.4 kg/m2). The men's ages ranged from 18 to 62 years (mean, 28 
years), they weighed between 59 and 97 kg (mean, 76 kg), and their body mass 
index was 17.9 to 32.4 kg/m2 (mean, 22.3 kg/m2). 
Approval for the study had been obtained from the Ethics Committee of the 
department, and the protocol and aims of the study were fully explained to the 
subjects, who gave their written informed consent. No reward was given, except 
for the food, which was free. 
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Diets 
The diets consisted of conventional solid foods, and 21 different menus were 
provided over the course of each 3-week cycle. The nutrient composition of each 
diet was similar, except that approximately 10% of total energy intake was 
provided by either myristic acid, palmitic acid, or oleic acid. These differences were 
achieved by the use of special margarines (Table 1). To prepare a fat high in 
myristic acid, 46 parts of myristic acid were mixed with 10.8 parts of glycerol, 
10.8 parts of stearic acid, 29 parts of oleic acid, and 3.5 parts of linoleic acid. This 
mixture was then heated under reduced pressure with 0 .2% by weight tetrabutyl 
titanate as a catalyst until the reaction was complete, cooled, refined with diluted 
sodium hydroxide, dried, and filtered. The resulting product was free of titanium 
(detection limit, 5 mg/kg). Subsequently the triglycerides were dissolved at 45 °C 
in acetone, cooled and partly crystallized in a surface-scraped heat exchanger. 
After filtering off a fraction consisting mainly of trimyristate, the second 
crystallization yielded the desired fraction. The final fat had a myristic acid content 
Table 1. Fatty acid composition of margarines used in the three study diets. 
Fatty Acid 
Saturated 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated 
Oleic acid (c/s-C18:1) 
Elaidic acid + isomers (fA3fls-C18:1) 
Polyunsaturated 
Linoleic acid (c/s,c/s-C18:2) 
Trans isomers of C18:2 
Others 
Myristic 
Acid Rich 
65.5 
0.3 
50.7 
1.0 
13.4 
28.4 
25.4 
3.0 
4.6 
3.8 
0.7 
1.5 
Margarine, g/100 g Fatty 
Palmitic 
Acid Rich 
58.5 
0.1 
1.1 
45.6 
11.2 
30.2 
29.6 
0.3 
11.2 
10.9 
0.2 
0.1 
Acid 
Oleic 
Acid Rich 
19.2 
0.0 
0.1 
6.5 
12.0 
71.4 
69.8 
0.5 
9.4 
9.3 
0.0 
0.1 
The special margarine supplied 53% of the total fat in the myristic acid, 66% in the palmitic acid, and 54% 
in the oleic acid diets. 
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of 50.7 g/110 g fatty acids, with 10.2% of the triglycerides being trimyristate. A 
high-palmitic acid margarine was produced by blending 80.5 parts of fractionated 
palm oil, 12.5 parts cotton seed oil, and 7 parts fully hydrogenated sunflower oil 
free of trans fatty acids. It contained 45.6 g palmitic acid/100 g fatty acids, and 
5.0% of all triglycerides was tripalmitate. Fat for the oleic acid diet was 
manufactured from a blend of 77 parts of high-oleic acid sunflower oil (Trisun, SVO 
Enterprises), 3.5 parts fully hydrogenated sunflower oil, 3.5 parts unmodified 
high-linoleic acid sunflower oil, 3 parts fractionated palm oil, and 13 parts of an 
interesterified mixture of sunflower oils (47% high-oleic, 15% unmodified 
high-linoleic, and 38% fully hydrogenated sunflower oil). The fats were developed 
by the Unilever Research Laboratory, Vlaardingen, The Netherlands, and 
manufactured in collaboration with Unichema Chemie, Gouda, The Netherlands, 
and the Unilever Research Laboratory, Colworth, England. The respective 
margarines were developed by the Unilever Research Laboratory, Vlaardingen. 
These margarines were used as spreads with the bread meals, in sauces and 
gravies, and for the preparation of a special bread containing 7% fat. Cookies 
prepared with palmitic acid-rich margarine and small amounts of olive oil and 
sunflower oil were used to fine-tune the fatty acid composition of the experimental 
diets. 
Before the trial, participants recorded their usual diet for 1 weekend day and 
2 working days as described (Chapter 2). The study diets were formulated at 30 
levels of energy intake, ranging from 5.5 to 20 MJ per day, so that each subject 
received a diet that met his or her energy needs. Body weights were recorded 
twice weekly, and energy intake was adjusted when necessary as to maintain a 
stable weight. Over the 63 days of the trial average body weight fell by 0.4 ± 1.2 
kg (range, - 2 . 2 to 2.3 kg). The mean difference in body weight at the end of the 
dietary treatments ranged from - 0.1 ± 0.7 kg (individual range, - 2.2 to 1.6 kg) 
between the palmitic acid and the oleic acid diets to 0.0 ± 0.7 kg (range, - 1.6 
to 1.5 kg) between the myristic acid and the palmitic acid diets. 
Each study diet was assigned a color code that was used for labeling all 
packages and foods supplied during the trial. In this way, the subjects were blinded 
as to the nature and the sequence of the diets. All foodstuffs were weighed out 
for each subject. On week days at noon, hot meals were served and eaten at the 
department. All other food was supplied daily as a package. Food for the weekend 
and guidelines for its preparation were provided on Fridays. In addition to the food 
supplied, subjects were allowed a limited number of items free from fat and 
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cholesterol. The energy intake from these free-choice items was fixed for each 
level of daily energy intake and ranged from 6% to 10% of total energy. Subjects 
were urged not to change their selection of free-choice items throughout the study. 
They were also repeatedly asked to maintain their usual pattern of physical activity 
and not to change their smoking habits, consumption of coffee, or use of oral 
contraceptives. The participants kept diaries in which they recorded any sign of 
illness, medication used, the consumption of free-choice items, and any deviations 
from their diets. At the end of the trial the subjects were asked to complete an 
anonymous questionnaire regarding the blinding of the diets, problems, and 
non-compliance during the study. 
Duplicate portions of each study diet were collected on each of the 63 trial 
days for an imaginary participant with a daily energy intake of 11 MJ (2630 kcal), 
stored at - 2 0 °C, and pooled and analyzed after the study. Records of the 
free-choice items were coded, and their energy and nutrient content [26] were 
combined with the analyzed values of the food supplied (Table 2). 
Blood sampling and analysis 
All participants were assigned a random number that was used for labeling 
blood and serum tubes. In this way the laboratory technicians were unaware of the 
subjects' diet sequence. Blood samples were taken after a 12-hour fast on days 1, 
17, and 21 (period 1), days 38 and 42 (period 2), and days 59 and 63 (period 3). 
All venipunctures were performed by the same technician, in the same location, 
and at the same time of the same days of the week. Serum was obtained by low 
speed centrifugation within 1 hour of venipuncture, stored at - 8 0 °C, and 
analyzed enzymatically for total cholesterol, HDL cholesterol, and triglycerides 
[27-29]. All samples from a particular subject were analyzed within one run. The 
coefficient of variation within runs was 1 .1% for total cholesterol, 1.3% for HDL 
cholesterol, and 1.9% for triglycerides. Mean bias with regard to the target values 
of serum pools provided by the Centers for Disease Control and Prevention, 
Atlanta, G A, was - 0 . 1 0 mmol/L for total cholesterol, 0.0 mmol/L for HDL 
cholesterol, and 0.07 mmol/L for triglycerides. LDL cholesterol was calculated 
using the Friedewald equation [30]. 
Apolipoproteins were measured by Dr. A. von Eckardstein at the 'Institut für 
Klinische Chemie und Laboratoriumsmedizin', Münster, Germany, by using a 
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Table 2. Mean daily intake of energy and nutrients of the subjects while on the three study 
diets. 
Energy/Nutrient 
Energy 
MJ/d 
kcal/d 
Protein, % of energy 
Fat, % of energy 
Saturated fatty acids 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated fatty acids 
Oleic acid ( c / s d 8:1) 
Elaidic acid (trans-C\Q-A) 
Carbohydrates, % of energy 
Alcohol, % of energy 
Cholesterol 
mg/d 
mg/MJ 
Dietary fiber 
g/d 
g/MJ 
Myristic Acid 
11.9 ± 2.6 
2841 ± 627 
13.2 
39.2 
21.3 
0.4 
11.3 
4.7 
4.3 
11.9 
10.9 
0.7 
46.9 
0.7 
344.9 
29.0 
42.0 
3.5 
Diet 
Palmitic Acid 
11.7 ± 2.6 
2807 ± 624 
12.6 
39.6 
21.0 
0.3 
1.1 
14.9 
4.1 
12.1 
11.6 
0.2 
47.2 
0.6 
358.9 
30.6 
43.0 
3.7 
Oleic Acid 
11.7 ± 2.7 
2806 ± 634 
12.4 
38.5 
10.8 
0.3 
0.8 
5.0 
3.8 
21.6 
20.9 
0.3 
48.3 
0.8 
351.8 
30.0 
39.9 
3.4 
Each subject consumed each diet for 3 weeks in random order. Values are based on chemical analyses of 
duplicate diets plus the calculated contribution of free-choice items (see Methods). Each value represents the 
mean of three independent duplicates collected in three different periods during which each diet was 
consumed by one third of the subjects. Variations between periods were negligible. 
turbidimetric method on microtiter plates as described [31]. Lipoprotein and 
apolipoprotein values obtained at the two sampling days at the end of each dietary 
period were averaged for data analyses. 
The fatty acid composition of serum cholesteryl esters was determined in 
samples obtained at the end of each dietary period (days 2 1 , 42, and 63) as 
described [32](Chapter 2). Results are expressed as proportion by weight of all 
fatty acids detected. 
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RESULTS 
Diets and dietary adherence 
The analyzed composition of the diets agreed with our objectives: about 10% 
of daily energy from oleic acid was replaced by palmitic acid or myristic acid, and 
other dietary constituents, notably lauric acid and trans fatty acids, were virtually 
unchanged (Table 2). Fifty-seven of the 59 subjects returned the anonymous 
questionnaire that was handed out at the end of the trial. The blinding was 
successful with respect to the myristic and palmitic acid diets, but most subjects 
had recognized the oleic acid diet. Neither the questionnaires nor the diaries 
revealed any deviations from the protocol that might have affected the results. The 
largest deviation reported in the questionnaire was the consumption by one subject 
of two herrings over the full 9-week study period. Adherence to the study diets 
was confirmed by the fatty acid composition of the serum cholesteryl esters, which 
uniformly followed the dietary composition (Table 3). In all 59 subjects the 
proportion of myristic acid in the cholesteryl esters was higher on the myristic acid 
diet than on either the palmitic or the oleic acid diet. The proportion of palmitic acid 
was increased on the palmitic acid diet in 58 out of 59 subjects relative to the 
myristic or the oleic acid diet, and all 59 subjects showed the highest proportion 
Table 3. Fatty acid composition of serum cholesteryl esters on the three study diets. 
Fatty Acid 
C14:0 
C16:0 
C16:1n-7 
C18:0 
C18:1n-9 
C18:2n-6 
C20:4n-6 
Other 
Myristic Acid 
2.83 ± 0.62a ' * 
9.25 ± 0.64 b 
2.67 ± 0.57 a 
0.95 ± 0.15 a ' 6 
16.76 ± 1.11 a 
54.56 ± 2.95a 'b 
6.53 ± 1.203 '* 
6.63 ± 0.83 
Diet, g/100 g Fatty Acid 
Palmitic Acid 
0.65 ± 0.17 
10.87 ± 0.54a 
2.71 ± 0.56a 
0.91 ± 0.16a 
16.89 ± 1.01a 
56.12 ± 2.77a 
6.03 ± 1.07a 
5.83 ± 0.76 
Oleic Acid 
0.66 ± 0.16 
9.18 ± 0.65 
2.24 ± 0.86 
0.83 ± 0.12 
23.15 ± 1.83 
51.34 ± 3.14 
6.64 ± 1.20 
5.96 ± 1.00 
Values are mean ± SD. The 59 subjects consumed each diet for 3 weeks in random order. 
a
 Significantly different from the oleic acid diet, P<0.02. 
6
 Significantly different from the palmitic acid diet, P<0.02. 
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of oleic acid in their cholesteryl esters when on the oleic acid diet. All these 
differences are highly significant (P<0.0001). 
Serum lipids and lipoproteins 
The mean levels of serum total and lipoprotein cholesterol and triglycerides 
on the three diets are shown in Table 4. 
Table 4. Serum lipid and lipoprotein cholesterol levels on the three study diets. 
Fatty Acid 
Total cholesterol 
All 
Women 
Men 
HDL cholesterol 
All 
Women 
Men 
LDL cholesterol 
All 
Women 
Men 
HDL to LDL ratio 
All 
Women 
Men 
Triglycerides 
All 
Women 
Men 
Myristic Acid 
5.19 
5.27 
5.08 
1.65 
1.76 
1.46 
3.09 
3.07 
3.14 
0.56 
0.61 
0.49 
0.99 
0.96 
1.05 
± 0.90 s ' 6 
± 0.79 a-b 
± 1.04 s ' * 
± 0.37 a'b 
± 0.31 a'b 
± 0.38 a'b 
± 0.78 a-b 
± 0.75 a 
± 0.83 a 
± 0.17a 'b 
± 0.17 a 
± 0.15 a 
± 0.52 
± 0.42 
± 0.65 
Diet 
Palm 
4.96 
5.03 
4.85 
1.52 
1.63 
1.34 
2.98 
2.96 
3.01 
0.54 
0.58 
0.47 
1.00 
0.95 
1.10 
tic Acid 
+ 
+ 
± 
+ 
± 
± 
+ 
± 
± 
± 
± 
± 
+ 
+ 
± 
0.853 
0.78a 
0.96a 
0.33 
0.29 
0.32 
0.72 s 
0 . 7 1 s 
0.75s 
0.17 s 
0.16 s 
0.15s 
0.55 
0.39 
0.72 
Oleic Acid 
4.53 
4.67 
4.32 
1.50 
1.62 
1.32 
2.60 
2.63 
2.55 
0.62 
0.66 
0.56 
0.95 
0.93 
1.00 
± 0.81 
± 0.75 
± 0.87 
± 0.30 
+ 0.25 
± 0.28 
± 0.71 
± 0.71 
± 0.73 
± 0.20 
± 0.19 
± 0.20 
± 0.43 
± 0.36 
± 0.54 
Values are mean ± SD. The 23 men and 36 women consumed each diet for 3 weeks in random order. To 
convert values for total, HDL, and LDL cholesterol to milligrams per deciliter, multiply by 38.67. To convert 
values for triglycerides to milligrams per deciliter, multiply by 88.54. 
a
 Significantly different from the oleic acid diet, P<0.02. 
b
 Significantly different from the palmitic acid diet, P<0.02. 
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Fig. 1 depicts the changes in serum cholesterol levels on myristic acid and 
palmitic acid diets relative to the oleic acid diet. Compared with the level on the 
oleic acid diet, total cholesterol increased by 0.66 mmol/L (P<0.0001; 95% CI, 
0.54 to 0.79 mmol/L) on the myristic acid diet and by 0.43 mmol/L (P<0 .0001 ; 
95% CI, 0.30 to 0.56 mmol/L) on the palmitic acid diet. The difference in total 
cholesterol between the myristic and the palmitic acid diet was 0.23 mmol/L 
(P<0 .0001 ; 95% CI, 0.11 to 0.36 mmol/L). LDL cholesterol rose by 0.50 mmol/L 
(95% CI, 0.40 to 0.60 mmol/L) on the myristic acid diet, and by 0.38 mmol/L 
(95% CI, 0.28 to 0.48 mmol/L) on the palmitic acid diet compared with the level 
on the oleic acid diet (P<0.0001 for both comparisons). The difference in LDL 
cholesterol of 0.11 mmol/L between the two saturated fat diets was also 
statistically significant (P = 0.0086; 95% CI, 0.01 to 0.22 mmol/L). The mean HDL 
cholesterol level on the myristic acid diet was higher than on the two other diets 
mmol/L mg/dL 
Total cholesterol HDL cholesterol LDL cholesterol 
Myristic acid (ZU Palmitic acid I Oleic acid 
Fig. 1. Bar graph showing mean responses of total, HDL, and LDL cholesterol to myristic 
and palmitic acid diets relative to the level on the oleic acid diet. Differences between the 
myristic and palmitic acid diets were all statistically significant (P<0.01). 
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(Table 4 and Fig. 1), increasing by 0.12 mmol/L (95% CI, 0.05 to 0.18 mmol/L) 
compared with the palmitic acid diet and by 0.15 mmol/L (95% CI, 0.10 to 0.19 
mmol/L) compared with the oleic acid diet (P<0.0001 for both comparisons). The 
HDL cholesterol- raising effect of myristic acid was evident in 51 of the 59 subject. 
Mean HDL cholesterol levels on the palmitic and the oleic acid diets were the same. 
The HDL to LDL cholesterol ratio on the myristic acid diet was significantly lower 
than that on oleic acid (P< 0.0001) but slightly higher than that on the palmitic 
acid diet (P = 0.0133). Serum triglyceride levels did not differ significantly between 
any of the diets (Table 4). 
The rise of apolipoprotein A-l (Table 5) paralleled the change observed in HDL 
cholesterol (Table 4), although not to the same extent; the mean ratio of apoA-l to 
HDL cholesterol was 994 mg/mmol on both the palmitic acid and oleic acid diets, 
but it decreased significantly to 966 mg/mmol on the myristic acid diet 
( /3<0.0006). ApoB levels on the myristic acid and palmitic acid diets were both 
higher than on the oleic acid diet (P<0.0001), but unlike LDL cholesterol, apoB 
levels did not differ between the two saturated fat diets (Table 5). 
The responses of lipid, lipoprotein, or apolipoprotein levels to the diets did not 
differ significantly between men and women, or between women using and not 
using oral contraceptives. 
Table 5. Serum apoA-l and apoB levels on the three study diets. 
Fatty Acid 
ApoA-l, mg/dL 
All 
Women 
Men 
ApoB, mg/dL 
All 
Women 
Men 
Myristic Acid 
154.6 ± 21.Qa-b 
160.8 ± 19.7a-b 
145.0 ± 19.7a-b 
74.6 ± 16.6s 
73.6 ± 15.6s 
76.1 ± 18.3s 
Diet 
Palmitic Acid 
147.4 ± 21.1 
154.9 ± 20.6 
135.7 ± 16.1 
74.3 ± 15.9s 
74.0 ± 15.5s 
74.7 ± 16.7s 
Oleic Acid 
145.8 ± 18.9 
153.0 ± 17.8 
134.5 ± 14.8 
68.6 ± 16.6 
68.5 ± 16.3 
68.6 ± 17.6 
Apo indicates apolipoprotein. Values are mean ± SD. The 23 men and 36 women consumed each diet for 
3 weeks in random order. 
3
 Significantly different from the oleic acid diet, P<0.02. 
* Significantly different from the palmitic acid diet, P<0.02 
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DISCUSSION 
Myristic acid versus palmitic acid 
The relative cholesterol-raising potential of the various saturated fatty acids 
has been controversial for many years. Several reports [4,11-16,33] indicate that 
the cholesterol-raising saturated fatty acids (lauric, myristic, and palmitic acids) 
differ in their effects on cholesterol levels. No study has directly examined myristic 
acid except that of McGandy et al. [11], who conclude that both myristic and 
palmitic acid raise total cholesterol. However, a consistent difference between the 
two could not be detected, in part because the number of subjects was small. In 
the present trial a large group of healthy volunteers consumed three strictly 
controlled diets in which either myristic acid or palmitic acid was exclusively 
substituted for oleic acid. Our data show that myristic acid is about 1.5 times as 
cholesterol-raising as palmitic acid, which is much less than the factor of 4 to 6 
suggested by meta-analytical studies [4,13]. The high values found in meta-
analyses [4,13] could be a statistical artifact, because in experiments that use 
natural fats the intake of myristic acid is strongly correlated with that of either 
lauric or palmitic acid. Such "collinearity" [34] may produce unreliable outcomes 
of multiple regression analyses. Other investigators reported that palm oil, rich in 
palmitic acid, causes remarkably lower cholesterol levels than coconut oil, which 
is rich in lauric and myristic acid [14-16,33]. Ng et al. [16] therefore suggested 
that myristic acid is the major contributor to the cholesterol-raising effect of 
saturated fatty acids and that palmitic acid may be neutral, just like stearic and 
oleic acid. This, however, is not confirmed by the present study. Hayes and Khosla 
[35,36] proposed that palmitic acid might have a conditional effect on serum 
cholesterol, with palmitic acid being cholesterol-raising in hypercholesterolemic 
subjects ( > 5 . 8 mmol/L or 225 mg/dL), but not in normocholesterolemic subjects. 
Our findings do not support this: the increase of total cholesterol on the palmitic 
acid diet relative to the oleic acid diet of subjects in the lowest tertile of initial 
cholesterol level (initial level, 3.78 mmol/L; increase 0.37 mmol/L) was similar to 
that of subjects in the highest tertile (initial level, 5.97 mmol/L; increase, 0.42 
mmol/L). Myristic acid did raise cholesterol more than palmitic acid, but about one 
half of the effect was due to HDL cholesterol. Both myristic and palmitic acids 
104 
Specific saturates and lipoprotein levels 
markedly raised LDL cholesterol and apoB levels compared with oleic acid. This 
accords with other well-controlled studies in which palmitic acid was shown to 
raise LDL cholesterol relative to that produced by oleic acid [5,7,12]. 
It must be noted that we investigated a synthetic myristic acid-rich fat in 
which myristic acid is randomly attached to glycerol molecules. In contrast, the 
triglycerides in natural coconut oil or dairy fat have a specific fatty acid distribution 
that might modulate the effect of myristic acid on cholesterol metabolism [37]. 
However, in our experience two dietary fats with equal total fatty acid composition 
but contrasting positional distribution of saturated fatty acids resulted in highly 
similar serum lipid and lipoprotein levels in volunteers (Chapter 6). It is therefore 
unlikely that myristic acid in synthetic fats would have a totally different effect on 
serum lipoproteins than in coconut oil or in dairy fat. 
Changes in HDL cholesterol 
Myristic acid increased HDL cholesterol by about 9% as compared with 
palmitic acid and oleic acid. The apoA-l to HDL cholesterol ratio was lower on the 
myristic acid diet than on both other diets which indicates an increase in the less 
dense HDL particles and suggests that the change in HDL cholesterol occurred 
mainly in HDL2. A specific HDL cholesterol-raising effect of myristic acid has not 
been reported before, but myristic acid-rich coconut oil diets, apart from increasing 
total and LDL cholesterol, generally produce higher HDL cholesterol levels than 
other saturated fat diets [14-16,33,38]. A large cross-cultural study [39] showed 
that men in Finland, who consume large amounts of myristic acid from dairy fat 
[40], not only have high total cholesterol but also very high HDL cholesterol 
concentrations. Although these epidemiological data provide no direct evidence, 
they are in line with the present observation that myristic acid raises HDL 
cholesterol. In spite of their high HDL levels, the Finnish men still had very high 
rates of coronary heart disease. Thus, the beneficial effect (if any [41]) of raising 
HDL cholesterol through diet is evidently more than undone by the unfavorable 
effect on LDL cholesterol, a lipoprotein that is well-known to be atherogenic. 
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Gender-specific effects 
It is often believed that women are less suitable subjects for studying dietary 
effects on serum lipids because of confounding effects of the menstrual cycle 
[42,43] or the use of oral contraceptives [44]. With a proper study design, 
however, this is not the case. In our study different women entered the trial at 
different points of their cycle; moreover, the diets were fed in random sequence. 
In this way effects of menstrual cycle canceled each other and averaged out and 
thus could not have systematically biased the comparisons of the diets. Unlike the 
means, one would expect the SDs of the responses to be enlarged because cyclic 
effects add a random positive or negative term to each lipid data point of an 
individual woman. However, we found that the SDs of the mean responses of the 
36 women to the diets did not differ significantly from those of the 23 men or 
were even smaller (on average, 0.42 mmol/L vs. 0.41 mmol/L for total cholesterol; 
0.16 vs. 0.14 mmol/L for HDL cholesterol; and 0.23 vs. 0.28 mmol/L for 
triglycerides!. Moreover, the SDs of the mean serum lipid changes of the women 
using oral contraceptives (0.45 mmol/L for total cholesterol, 0.16 mmol/L for HDL 
cholesterol, and 0.22 mmol/L for triglycerides) were similar to those of the men. 
The present observation that women show no substantially larger within-subject 
variation in their serum lipid levels than men is in accord with our previous studies 
and again shows that female volunteers are as suitable subjects as men for studies 
on diet and lipoproteins (Chapter 2). 
The mean responses of total and LDL cholesterol to the two saturated fat 
diets tended to be nonsignificantly higher for men than for women, whereas the 
HDL levels of men and women responded similarly. We have earlier reported 
gender-specific effects of dietary fats on HDL cholesterol levels [23,45]. It is 
possible that we missed small gender-specific effects in the present study. 
However, in other trials both sexes were also found equally responsive to changes 
in dietary fat saturation [15,16,18,20,46]. At the very least, lipoprotein levels of 
both sexes respond in the same direction and with the same order of magnitude. 
It therefore appears that diets low in saturated fat can be recommended for both 
male and female patients. Furthermore, mean effects of diet on lipoproteins in the 
11 women using and the 25 women not using oral contraceptives were identical. 
Oral contraceptives may influence absolute serum lipid levels [44], but apparently 
they do not affect responsiveness of lipoproteins to diet. This is in line with our 
previous experience (Chapter 2). 
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Dosage 
The differences in intake of myristic and palmitic acid between the diets 
amounted to about 10% of total daily energy. For palmitic acid this is a realistic 
amount; it is similar to the difference between an affluent high-saturated fat diet 
and the American Heart Association Step I diet [47]. The difference in myristic 
acid, however, was much higher than is achievable with natural fat sources. Thus, 
when extrapolating our findings for myristic acid to lower levels of intake one must 
assume that the amount of myristic acid in the diet and its effects on serum lipids 
and lipoproteins are related in a linear way. Such a linear relation has in fact been 
observed for saturated fatty acids in general [3,4,13]. 
Comparison with other dietary fatty acids 
Fig. 2 puts our findings into the context of other studies which directly 
compared effects of individual fatty acids in humans. It must be noted that Fig. 2 
merely summarizes data currently available from a few well-controlled trials; it is 
not meant to quantify the exact differences in cholesterolemic effect between the 
various fatty acids. Nevertheless, the estimates suggest that myristic and palmitic 
acids are the most important cholesterol-raising saturated fatty acids. Palmitic acid 
appears to be more potent than lauric acid [12] but less potent than myristic acid. 
Trans fatty acids [17,18] (Chapter 2) raise total cholesterol less than lauric, myristic 
and palmitic acids, but they simultaneously raise LDL cholesterol and lower HDL 
cholesterol, which also results in an unfavorable lipoprotein risk profile. Stearic acid 
[7](Chapter 2) produces lower cholesterol levels than the other saturates and nearly 
equals oleic acid, i.e. it is approximately neutral in its effects on serum total and 
lipoprotein cholesterol. 
The effects of different fatty acids on LDL levels in humans summarized in 
Fig. 2 correspond well with the effects of dietary fatty acids on LDL metabolism 
in the model developed by Spady and coworkers [8] In this model LDL cholesterol 
levels are affected through changes in the activity of the hepatic LDL receptor. The 
liver enzyme acyl coenzyme A:cholesterol acyl transferase, which converts free 
cholesterol into cholesteryl esters, has a much lower activity towards saturated 
than towards unsaturated fatty acids. As a consequence, feeding saturated fatty 
acids to hamsters decreases hepatic cholesteryl ester content [48,49]. It is 
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m m o l/L mg/dL 
0.06 
0.04 
S Total cholesterol [ZI LDL cholesterol H HDL cholesterol 
Fig. 2. Overview of the effects of individual dietary fatty acids on serum total, HDL, and 
LOL cholesterol in recent trials, expressed as the changes that occur when 1 % of dietary 
energy as carbohydrates is replaced by a specific fatty acid. The values for lauric acid 
(12:0) were obtained in a direct comparison with oleic acid [12]; values for myristic acid 
(14:0) are those of the current study (Table 4). The estimates for palmitic acid (16:0) are 
averages of results from the present plus three other strictly controlled trials in which 
palmitic acid was isoenergetically exchanged for oleic acid [5,7,12]. The values for 
monounsaturated trans fatty acids (f/a/7s-18:1) are averages from reference [18] and 
Chapter 2. Values for stearic acid (18:0) are also derived from two direct comparisons with 
oleic acid [7] and linoleic acid (Chapter 2). Reported plasma levels were multiplied by 1.03 
to convert them to serum values, and the amount of fatty acids in total dietary fat was set 
at 0.96 g/g. Data for oleic acid (c/s-18:1) and linoleic acid (18:2) are based on regression 
coefficients derived from a meta-analysis of 27 trials [13]. These regression coefficients 
were also used to recalculate the effects of all fatty acids relative to carbohydrates. 
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assumed that at the same time the amount of free cholesterol increases in certain 
hepatocyte compartments, including the putative pool that controls the expression 
of the LDL receptor, presumably via the LDL receptor mRNA level in the cell. This 
leads to down-regulation of the receptor activity and the accumulation of LDL in 
plasma and increased formation of LDL from its precursor VLDL [50,51]. In this 
way, saturated fatty acids raise LDL cholesterol levels relative to unsaturated oleic 
and linoleic acid [48,49]. Oleic acid (c/s-C18:1) loses its ability to increase receptor 
activity when it is converted to its trans isomer, elaidic acid (rra/7s-C18:1n-9), 
which might explain why trans fatty acids result in higher LDL cholesterol levels 
than oleic acid [8]. The exact mechanisms involved in regulating plasma lipoprotein 
cholesterol levels in humans, however, require additional investigation. 
Limitations of the data presented in Fig. 2 need to be stressed. First, 
estimates are based on a limited number of studies and for lauric and myristic acids 
on only one trial each. The precise differences in cholesterolemic effects among the 
various saturated fatty acids still need to be established. Second, we assumed a 
linear dose-response relationship between the amount of fatty acids in the diet and 
their effects on serum total and lipoprotein cholesterol. Previous studies do support 
this assumption [3,4,13]. Third, the values for lauric, myristic, and stearic acids are 
based on studies in which the fatty acids were supplied as synthetic or 
interesterified fats. These triacylglycerols contain one third of the saturated fatty 
acids at each of the three positions of the glycerol molecule. In contrast, the 
estimates for palmitic acid in Fig. 2 are derived from studies which used natural 
palm oil, in which palmitic acid is predominantly esterified at the C1 or C3 position 
of glycerol [37,52]. However, in our experience the intramolecular position of 
palmitic acid in dietary triglycerides had no effect on fasting lipid and lipoprotein 
concentrations in volunteers (Chapter 6). 
In conclusion, both myristic and palmitic acids are dietary constituents that 
powerfully raise serum total and LDL cholesterol levels. Myristic acid as well as 
palmitic acid should be reduced in diets for the treatment of hypercholesterolemia. 
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ABSTRACT 
Aim. We examined the effect of the positional distribution of fatty acids within 
dietary triglycerides on serum lipoproteins. 
Methods. Sixty subjects consumed two diets of equal fatty acid compositions for 
three weeks each. In the palm oil diet 82% of palmitic acid was attached to the 
outer two carbon atoms of glycerol, and 18% to the middle carbon. In the diet rich 
in enzymatically modified palm oil these figure were 35% and 65%, respectively. 
Results. On the modified fat, average lipoprotein levels showed nonsignificant 
(P> 0.13) rises of 0.06 mmol/L for total, 0.03 mmol/L for HDL, and 0.04 mmol/L 
for LDL cholesterol compared with palm oil. The small increases in total and LDL 
cholesterol reached statistical significance in the men (n = 23) but not in the 
women (n = 37). The HDL to LDL cholesterol ratio and serum triglyceride levels 
were unchanged. 
Conclusion. Thus, a large difference in dietary fatty acid configuration had little 
effect on lipoprotein levels in humans. 
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INTRODUCTION 
Dietary fatty acids may differ from each other in four aspects: number of 
double bonds, chain length, configuration of the double bonds, and position of the 
fatty acid on the glycerol molecule (Fig. 1). The number of double bonds modulates 
the effects of fatty acids on cholesterol levels; more specifically, saturated fatty 
acids (with zero double bonds) raise serum cholesterol [1,2]. The cholesterol-raising 
effect of saturated fatty acids depends on their chain length [2-5] (Chapter 5). 
H-1C-0-FAA 
H-3C-0-FAC 
Fig. 1. Structure of a triglyceride molecule showing the stereospecific numbering (sn) of 
the carbon atoms of glycerol. If the fatty acid of the middle carbon (sn-2-FAB) is drawn to 
the left (above the plane of the paper), then the top carbon is numbered 1 and the bottom 
carbon 3 (behind the plane of the page). Different fatty acids on the 1 and 3 positions 
make carbon atom 2 asymmetric, and then 2 optical isomers are possible; 1 -FAA,2-FAB,3-
FAc-glycerol and 1-FAC,2-FAB,3-FAA-glycerol. 
The geometry of the double bonds of unsaturated fatty acids, in particular the trans 
versus the c/s-configuration, also influences lipoprotein cholesterol levels 
[6-8](Chapter 5). However, little is known about the influence of the position of 
fatty acids within dietary triglycerides on lipoprotein levels and cholesterol 
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metabolism. More than 20 years ago, Hegsted and coworkers [9] found that stearic 
acid (C18:0) in synthetic fats, in which this saturate is randomly distributed over 
each of the 3 positions of glycerol, raised cholesterol levels [9]. In contrast, the 
cholesterol-raising effect of stearic acid is less when fed as cocoa fat [1,3] , in 
which it is predominantly esterified to the 1 and 3 position. In laboratory animals 
randomization of fats with specific fatty acid distributions, such as peanut oil, can 
alter their atherogenicity and cholesterolemic effect [10-12]. This has raised 
interest in the influences of the fatty acid configuration of triglycerides on the 
biologic effects of dietary fat [12-15], but at present few data on this topic are 
available. 
By itself it is not implausible that the positional distribution of dietary fatty 
acids could affect lipoprotein levels. Triglycerides are absorbed in the intestine after 
hydrolysis to SA7-2-monoglycerides and fatty acids [16], and are then resynthesized 
into triacylglycerols and secreted in chylomicrons. The chylomicron triglycerides 
largely retain the original fatty acid in the 2 position [16,17]. Fatty acids attached 
to the s/7-2 position might then be preferentially transported to the liver instead of 
to the extra-hepatic organs because lipoprotein lipase, like pancreatic lipase, 
primarily attacks the 1 and 3 positions of triglycerides [18]. Since the hepatocyte 
is the major site of action of fatty acids on LDL metabolism, saturated fatty acids 
in the sn-2 position of dietary triglycerides might elevate LDL levels more than the 
same fatty acid in the snA or 3 position [14]. 
Common dietary fats show large differences in the positional distribution of 
their constituent fatty acids [13]. In palm oil and other vegetable fats, palmitic acid 
(C16:0) is predominantly esterified at the 1 and 3 positions, while pork fat contains 
palmitic acid mainly on the 2 position [19]. The fatty acid configuration of dietary 
triglycerides can also be altered to produce confectionary and other fats with better 
texture or certain desired physical properties. Palmitic acid is the most abundant 
saturate in the diet, and it is thus important to know whether its position in the 
triglyceride molecule modulates its effects on total and LDL cholesterol levels. In 
newborn piglets a synthesized fat with palmitic acid mainly in the 2 position raised 
fasting total and HDL cholesterol levels as compared with palm oil [20]. However, 
direct comparisons of the effects of palmitic acid in different triglyceride positions 
in humans are lacking. We therefore compared the effects of two dietary fats wi th 
equal amounts of individual fatty acids but different positional distribution on serum 
lipid and lipoprotein levels in healthy male and female volunteers. 
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METHODS 
Subjects 
In response to announcements via local newspapers and posters in University 
and community buildings, 47 women and 28 men applied for enrollment in the 
study. They were invited to participate in a medical and dietary screening. Three 
women withdrew during the screening phase. Two men and one woman were 
excluded because their cholesterol levels exceeded 7.1 mmol/L (275 mg/dL) or 
their blood pressure was over 140/90 mmHg, one woman because she had a low 
hemoglobin level, and three women and one man because their food records 
revealed irregular dietary habits or an alcohol intake over 10% of daily energy. Two 
men withdrew after the screening procedure because their spouses had been 
excluded for one of the reasons mentioned above. We accepted all 23 remaining 
men. Of the 39 eligible women, two were excluded by lot because only 60 
subjects could be admitted to the trial. All 23 men and 37 women completed the 
study. None suffered from anemia, glycosuria, or proteinuria, and they were 
apparently healthy, as indicated by a medical questionnaire. Pre-experimental 
fasting total cholesterol ranged from 2.80 to 6.98 mmol/L (mean, 4.62 mmol/L), 
HDL cholesterol from 0.76 to 2.42 mmol/L (mean, 1.52 mmol/L), and triglycerides 
from 0.41 to 2.24 mmol/L (mean, 0.92 mmol/L). The men were aged from 19 to 
67 years (mean, 29 years), they weighed between 63 and 108 kg (mean, 79 kg), 
and their body mass indexes ranged from 18.5 to 30.9 kg/m2 (mean, 22.9 kg/m2). 
The women were between 20 and 67 years old (mean, 32 years), they weighed 
between 54 and 84 kg (mean, 66 kg); their body mass indexes ranged from 18.1 
to 29.7 kg/m2 (mean, 22.4 kg/m2). The habitual diet of the subjects as measured 
by self-recorded food intake on 2 working and 1 weekend day supplied on average 
10.7 MJ/day (2560 kcal), of which 37% was fat, 13% was protein, 4 8 % was 
carbohydrates, and 2% was alcohol. They consumed on average 280 mg 
cholesterol and 35 grams of dietary fiber per day. Nine women used oral 
contraceptives and 5 were post-menopausal. Nine women and 4 men smoked. A 
majority of the subjects were university students, and most of the others had 
college degrees. They lived in or around Wageningen, a small university town in the 
center of the Netherlands. The protocol and goals of the study were fully explained 
to the subjects, who gave their written consent. Before the study, they were 
thoroughly instructed about the daily routines during the trial and the necessity of 
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full compliance, and they were strongly advised not to take part if not highly 
motivated or if they anticipated any problems in adhering to the protocol. No 
payment was given except for the study diets, which were free. The study had 
been approved by the Ethics Committee of the Department of Human Nutrition. 
Design 
The objective of the study was to investigate the effects of the positional 
distribution of fatty acids in the dietary triglyceride molecules on serum lipid and 
lipoprotein levels. The trial was designed to detect a significant (P<0.05) effect 
of modified fat versus palm oil on total cholesterol with a power of 8 0 % if the real 
population effect exceeded 0.13 mmol/L. This power calculation was based on the 
within subject variation (SD) in cholesterol response to diet of 0.35 mmol/L 
observed in previous studies [6](Chapters 2 and 5). 
All subjects participated simultaneously from February 15 to March 29, 1993. 
The trial consisted of two consecutive 3-week periods, during which each 
participant followed both diets, in different order (cross-over). One diet was high 
in palm oil, with palmitic acid predominantly esterified at the SAÎ-1 and sn-3 
position, and the other diet was high in an enzymatically modified palm oil (Betapol, 
Loders-Croklaan, Wormerveer, The Netherlands) which contains palmitic acid 
mainly in the sn-2 position. Before the study began, subjects were categorized 
according to sex, and women also according to the use of oral contraceptives. 
Subjects within each subcategory were then randomly allocated to one of the two 
diet sequences, except members of a couple living together, who were assigned 
to the same sequence group. Both sequence groups had a nearly equal number of 
each category, and they were well-balanced for age, baseline total and HDL 
cholesterol level, and body mass index. Use of this cross-over design eliminated 
possible bias due to the order in which the diets are consumed or to drift of 
variables over time [21 ]. As described earlier (Chapters 2 and 5), this experimental 
design also eliminates bias due to lipid variation during the hormonal cycle. This 
enables the measurement of the influence of diet on serum lipids in women, 
without confounding effects of menstrual cycle or use of oral contraceptives 
(Chapters 2 and 5). Foodstuffs and packages were color-coded so as to keep 
subjects unaware of the nature of their diets. 
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Diets 
The diets consisted of conventional solid foods, and menus were changed 
daily during each 3-week dietary period. The amount and type of foodstuffs were 
the same for the two diets. The differences in the positional distribution of the 
fatty acids were achieved by the use of special margarines and oils with highly 
distinct fatty acid configurations (Table 1). A fat rich in s/7-1,3-palmitate was 
obtained by solvent fractionation of natural, unprocessed palm oil. Subsequently 
87.5 parts of this fraction were blended with 11 parts of high-oleic acid sunflower 
oil and 1.5 parts of high-linoleic acid sunflower oil. This yielded an oil blend with 
palmitic acid predominantly in the 1 and 3 position. An oil with palmitic acid mainly 
in the 2 position was derived by s/?-1,3-enzymatic interesterification of a palm oil 
fraction with sunflower fatty acids using immobilized Rhizomucor miehei lipase 
(Novo Industries, Copenhagen, Denmark), followed by solvent fractionation. The 
palm oil-based fat had a slightly higher melting point than the enzymatically 
modified fat, but both were liquid at 37 °C. 
Table 1. Total, sn-2, and sn-1,3 fatty acid composition of the special oils and margarines. 
Fatty Acid 
Saturated 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated 
Oleic acid (c/s-C18:1) 
Polyunsaturated 
Linoleic acid (C18:2) 
Unknown 
Total 
Total 
39.9 
0.4 
1.0 
28.8 
9.1 
47.8 
47.2 
12.0 
11.8 
0.3 
100 
Palm Oil Rich 
Sn-2a 
13.7 
0.3 
0.5 
6.4 
6.5 
63.5 
63.4 
22.4 
22.1 
0.4 
100 
S/7-1,3a 
Modified Fat Rich 
Total 
g/100 g of fatty acids 
53.0 
0.4 
1.3 
40.0 
10.4 
39.9 
39.1 
6.8 
6.6 
0.3 
100 
38.2 
0.6 
1.2 
28.9 
7.1 
49.5 
48.0 
10.5 
10.1 
1.8 
100 
Sn-2a 
78.1 
0.7 
1.9 
66.9 
8.4 
18.5 
18.1 
3.3 
3.2 
0.1 
100 
Sn-1,33 
18.2 
0.5 
0.9 
9.9 
6.5 
65.0 
62.9 
14.1 
13.5 
2.7 
100 
The margarine provided 64% and oil 6% of all dietary triglycerides; together they provided 28% of total 
energy intake. 
3
 Out of every 100 g of total fatty acids 33.3 g is in the sn-2 and 66.7 g is the s/7-1 or sn-3 position. 
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Margarines were made from a blend of 93 parts of these special oils with 7 
parts of fully hydrogenated sunflower oil high in stearic acid. These margarines had 
similar textures and were easy to spread. They contained equal total amounts of 
individual fatty acids, but differed substantially in the positional distribution of the 
fatty acids over the triglyceride molecules. Table 1 shows that the palm oil-rich fats 
contained mainly oleic and linoleic acid in the 2 position of the triglycerides, while 
the 2 position in the modified fat product was predominantly occupied by palmitic 
acid. These margarines were used as spreads with the bread meals, in sauces and 
gravies, and for baking cookies and special bread containing on average 8% fat. 
The oils from which the margarines had been made were also used to prepare salad 
dressings. The margarines and oils provided 70% of all triglycerides in the study 
diets. 
The diets were formulated at 30 levels of energy intake, ranging from 5.5 to 
20 MJ/day, so that each subject received a diet that met his or her energy needs. 
The energy requirements of each participant were estimated from 3-day food 
records kept by the subjects before the trial. As such food records underestimate 
actual energy requirements [22], we provided the subjects with an initial amount 
of energy 10% higher than his or her reported intake. Body weights were recorded 
twice weekly, and the energy level was adjusted when necessary, so as to 
maintain a stable weight. Over the 42 days of the trial, average body weight fell 
by 0.3 ± 1.1 kg (range, - 2 . 6 to 1.6 kg). Mean body weight at the end of the 
dietary treatments was 0.1 ± 0.8 kg (range, - 1 . 5 to 1.9 kg) higher on the 
modified fat diet than on the palm oil diet. 
All foodstuffs were weighed out for each individual subject. On weekdays at 
noon, hot meals were served and eaten at the department. All other foods were 
supplied daily as a package. Foods for the weekends and guidelines for its 
preparation were provided on Fridays. In addition to the food supplied, the subjects 
chose each day a limited number of food items free from fat and cholesterol, which 
provided 8 - 9 % of total daily energy. Subjects were urged not to change their 
selection of free-choice items between the dietary periods. They were also 
instructed to maintain their habitual pattern of physical activity and not to change 
their smoking habits, consumption of coffee, or use of oral contraceptives. The 
participants kept diaries in which they recorded their selection and amount of free-
choice items, any sign of illness, all medications used, and any deviation from their 
diets. At the end of the trial, subjects completed an anonymous questionnaire 
relating to the blinding of the diets and problems and noncompliance during the study. 
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Food composition 
Duplicate portions of both study diets were collected on each of the 42 days 
for an imaginary participant with a daily energy intake of 11 MJ/day, stored at 
- 2 0 °C, and pooled and analyzed after the study for protein [23], total fat [24], 
total fatty acid composition [25], dietary fiber [26], and cholesterol [27]. Available 
carbohydrate was calculated by difference. Sn-2 fatty acid composition was 
determined enzymatically [28]. After partial hydrolysis of triglycerides by sn-"\ ,3 
specific porcine pancreatic lipase (Type II, EC 3.1.1.3, Sigma, St. Louis, MO), sn-2-
monoglycerides were isolated on aminopropyl columns (Bond Elut, Varian, Harbor 
City, CA) [29] and hydrolyzed, and the fatty acids were methylated and then 
separated by gas liquid chromatography. This yielded the fatty acid composition 
of one third of all dietary fatty acids, namely those esterified to the sn-2 position 
(Table 1 and Table 2, columns 2 and 5). The composition of thes/7-1,3 fatty acids, 
which made up the other two thirds of dietary fatty acids (Tables 1 and 2, columns 
3 and 6), was calculated from the total and the sn-2 fatty acid compositions. The 
following example illustrates this calculation: 
sn-1,3 oleic acid= [3 x (total oleic acid) - (sn-2 oleic acid)] / 2. 
We also calculated percentages "horizontally". For instance, the amount of palmitic 
acid present on the 2 position as a percentage of all dietary palmitic acid was 
calculated from the data in Tables 1 and 2 as: 
[sn-2 palmitic acid / (3 x total palmitic acid)] x 100%, 
and the percentage present on the 1 or 3 position as: 
[100% - percentage on the 2 position]. 
The energy and nutrient content of the free choice-items, which contained 
negligible amounts of fat, was calculated [30] and combined with the analyzed 
values of the foods supplied (Table 3). 
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Table 2. Total, sn-2, and sn-1,3 fatty acid composition all triglycerides in the two diets. 
Fatty Acid 
Saturated 
Laurie acid (C12:0) 
Myrist ic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated 
Oleic acid (c/s-C18:1) 
Polyunsaturated 
Linoleic acid (C18:2) 
Unknown 
Total 
Total 
42 .1 
1.0 
2.5 
27.7 
9.2 
42 .8 
41 .3 
13.2 
12.2 
1.9 
100 
Palm Oil Diet 
Sn-2a 
26.5 
1.1 
3.5 
14.6 
6.2 
52 .0 
51.0 
20.6 
19.6 
0.9 
100 
Sn-1 ,3 a 
g/100 g 
49.9 
0.9 
2.0 
34.2 
10.8 
38.1 
36 .4 
9.6 
8.5 
2.4 
100 
Modif ied Fat Diet 
Total 
of fatty acids 
40 .6 
1.0 
2.7 
27 .4 
8.1 
4 4 . 4 
42 .1 
12.3 
11.2 
2.7 
100 
Sn-2a 
67.8 
1.4 
4 .3 
53.5 
6.9 
22 .3 
20 .9 
8.4 
7.2 
1.5 
100 
S A ? - 1 , 3 3 
26.9 
0.8 
1.9 
14.3 
8.6 
55.5 
52.7 
14.2 
13.1 
3.3 
100 
Special oils and margarines supplied 70% of total fat. The remaining 30% came from conventional 
foodstuffs, largely dairy products and meat. 
3
 Out of every 100 g of total fatty acids 33.3 g is in the sn-2 and 66.7 g is the s/7-1 or sn-3 position. 
Blood sampling and analysis 
Subjects were assigned a random number that was used for labeling blood and 
serum tubes. In this way, technicians were blinded as to the subjects' diets. Blood 
was sampled after a 12-hour fast on days 1,17, and 21 (period 1), and days 38 
and 42 (period 2). All venipunctures of a particular subject were performed by the 
same technician, in the same location, and at the same time of the same days of 
the week for the two dietary periods. Serum was obtained by low-speed 
centrifugation within one hour of venipuncture, stored at - 8 0 °C, and analyzed 
enzymatically for total and HDL cholesterol and triglycerides [31-33]. All samples 
from a particular subject were analyzed within one run. The coefficient of variation 
within runs was 1.4% for total, 0.7% for HDL, and 1.3% for triglycerides. Mean 
bias with regard to the target values of serum pools provided by the Centers for 
Disease Control (Atlanta, GA) was - 0 . 0 4 mmol/L for total cholesterol, 0.01 
mmol/L for HDL cholesterol, and 0.12 mmol/L for triglycerides. LDL cholesterol was 
calculated using the Friedewald equation [34]. 
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Statistical analysis 
The two lipid and lipoprotein values obtained for each subject at the end of 
each dietary period were averaged for statistical analyses. The data were analyzed 
with the General Linear Models (GLM) procedure of the Statistical Analysis System 
[35], using a 2-way ANOVA with subject and diet as class variables. This way of 
testing is equivalent to the paired f-test [21]. Carry-over effects of previous diet 
were checked by introducing a diet-by-period interaction term in the model. 
Differences in responses between men and women or between women using or 
not using oral contraceptives were compared with unpaired r-tests [35]. 
RESULTS 
Diets and dietary adherence 
Table 2 shows that the two diets contained equal amounts of each specific 
fatty acid (columns 1 and 4), but markedly differed in their positional fatty acid 
distribution. In the modified-fat diet, 65% of the palmitic acid was on the 2 
position, and the remaining 35% on the 1 and 3 position. In contrast, 82% of the 
palmitic acid in the palm-oil diet was on the 1 and 3 position and only 18% was 
found on the 2 position. Sixty-eight percent of the sn-2 fatty acids in the modified 
fat diet was saturated, mainly palmitic acid, whereas 73% of the sn-2 fatty acids 
in the palm oil diet were unsaturated, the majority being oleic acid (Table 2, 
columns 2 and 5). Table 3 shows that the intake of energy and all other relevant 
food components was similar for both diets. 
Inspection of the diaries and the anonymous questionnaires that were handed 
in at the end of the trial revealed only minute deviations from the study protocol. 
The diaries showed that consumption of foods outside the dietary regime provided 
at most 0.2 g of fat per day. The magnitude and the frequency of deviations 
reported in the anonymous questionnaires were in line with those reported in the 
diaries. This indicated that compliance was high, and that deviations probably did 
not materially affect the results. A two-choice question about the color-coding of 
the diets yielded 30 correct and 25 false answers (P = 0.25). Thus, blinding was 
successful. 
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Table 3. Mean daily intake of energy and nutrients of the 60 subjects on the two diets. 
Energy/Nutrient Palm Oil Diet Modified Fat 
Diet 
12.3 ± 3.0 
2941 ± 725 
13.4 
40.1 
15.6 
0.4 
1.0 
10.5 
3.1 
17.1 
16.2 
4.8 
4.3 
45.4 
1.0 
367 
29.8 
43.0 
3.5 
Values are based on chemical analyses of complete duplicate diets plus the calculated contribution of free-
choice items. Each value represents the mean of two independent duplicates collected and pooled in the two 
different periods during which each diet was consumed by one half of the subjects. Variations between periods 
were negligible. 
Serum lipids and lipoproteins 
The diets had little effect on serum lipoprotein cholesterol levels (Fig. 2 ) . 
Thirty-six participants showed higher total cholesterol values on the modified fat 
diet than on the palm oil diet, one showed no change, and 23 participants had 
lower values on modified fat (Fig. 3) . The changes in total cholesterol were not 
related to initial cholesterol level (Pearson correlation coefficient (r) = 0 . 1 3 , 
P = 0 .34 ) , age (r = 0 . 0 7 , P = 0 .61 ) , or body mass index ( r = - 0 . 1 1 , P = 0 . 4 0 ) . 
1 2 4 
Energy 
MJ/d 
kcal/d 
Protein (% of energy) 
Total fat (% of energy) 
Saturated fatty acids 
Laurie acid (C12:0) 
Myristic acid (C14:0) 
Palmitic acid (C12:0) 
Stearic acid (C18:0) 
Monounsaturated fatty acids 
Oleic acid (c/s-C18:1) 
Polyunsaturated fatty acids 
Linoleic acid (c/s,c/s-C18:2) 
Carbohydrates (% of energy) 
Alcohol (% of energy) 
Cholesterol 
mg/d 
mg/MJ 
Dietary fiber 
g/d 
g/MJ 
12.4 ± 3.1 
2958 ± 740 
13.0 
40.8 
16.5 
0.4 
1.0 
10.8 
3.6 
16.7 
16.2 
5.3 
4.8 
44.9 
1.1 
368 
29.8 
44.6 
3.6 
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0 
start 
2 4 
cross-over 
6 weeks 
end 
period 1 period 2 
Fig. 2. Mean concentration of serum total, LDL, and HDL cholesterol and of serum 
triglycerides throughout the experiment. During the first 3 weeks, thirty subjects 
consumed a diet rich in sn-2-saturated triglycerides (modified fat, • ) and in the 
subsequent period a diet rich in sn-2-unsaturated triglycerides (palm oil, O) . Thirty other 
subjects consumed these diets in reverse order (palm oil, D ; modified fat, • ) . The two 
diets had the same total fatty acid composition (see Table 3). 
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The average rise in total cholesterol of 0.06 ± 0.32 mmol/L or 2.3 ± 12.4 
mg/dL on modified fat relative to palm oil was not significantly different from zero 
(P = 0.15). The mean changes in HDL (0.03 mmol/L or 1.2 mg/dL, P=0 .13) , non-
HDL (VLDL + LDL) cholesterol (0.03 mmol/L or 1.2 mg/dL, P = 0.39), and LDL 
cholesterol (0.04 mmol/L or 1.5 mg/dL, P = 0.23) were also not statistically 
significant (Table 4). In addition, The HDL to LDL cholesterol ratio (P = 0.89) and 
the triglyceride levels did not differ (P = 0.35) between the diets. The absence of 
significant diet-by-period interactions regarding the lipid and lipoprotein levels 
indicated that there were no important carry-over effects from previous diet. 
Confidence intervals for changes in lipoprotein levels (Table 4) were narrow, and 
left little room for major effects. 
mmol/L mg/dL 
0.9 
0.6 
0.3 
0.0 
-0.3 
-0.6 
-0.9 
imnn— 
..„mill 
• - 3 0 
1-20 
1-10 
0 
- -10 
-20 
- -30 
Fig 3. Individual differences in serum total cholesterol level between the end of the 
modified fat diet and the end of the palm oil diet, sorted by magnitude. The average 
change was 0.06 mmol/L ± 0.32 mmol/L {/>= 0.15). The 60 subjects consumed both diets 
for 3 weeks each. 
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Table 4. Serum lipid and lipoprotein cholesterol levels in 60 subjects on diets high in palm 
oil or in an enzymatically modified palm oil analogue in which palmitic acid is attached 
mainly to the middle isn-2) instead of the outer two carbon atoms (sn-1,3) of glycerol. 
Total cholesterol 
All 
Women 
Men 
HDL cholesterol 
All 
Women 
Men 
Non-HDL cholesterol 
All 
Women 
Men 
LDL cholesterol 
All 
Women 
Men 
HDL to LDL ratio 
All 
Women 
Men 
Triglycerides 
All 
Women 
Men 
Palm Oil Diet 
4.66 ± 
4.89 ± 
4.31 ± 
1.60 ± 
1.77 ± 
1.33 ± 
3.07 ± 
3.12 ± 
2.98 ± 
2.62 ± 
2.69 ± 
2.51 ± 
0.67 ± 
0.70 ± 
0.62 ± 
0.97 + 
0.92 ± 
1.04 ± 
0.90 
0.84 
0.89 
0.33 
0.24 
0.26 
0.85 
0.78 
0.94 
0.78 
0.76 
0.81 
0.29 
0.20 
0.39 
0.42 
0.33 
0.54 
Modified Fat Diet 
4.72 
4.92 
4.41 
1.63 
1.79 
1.37 
3.09 
3.13 
3.04 
2.66 
2.71 
2.59 
0.67 
0.70 
0.63 
0.94 
0.91 
0.99 
± 
± 
± 
+ 
+ 
± 
± 
± 
± 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
mmol per 
0.94 
0.88 
0.96 
0.37 
0.31 
0.29 
0.86 
0.79 
0.97 
0.80 
0.76 
0.86 
0.30 
0.19 
0.41 
0.40 
0.38 
0.44 
Change 
liter 
0.06 
0.03 
0.103 
0.03 
0.03 
0.04 
0.03 
0.01 
0.06 
0.04 
0.01 
0.083 
0.00 
0.00 
0.00 
-0 .03 
-0 .02 
- 0 . 0 4 
(95% CI) 
( -0 .02 to 0.14) 
( -0 .09 to 0.16) 
(0.02 to 0.18) 
( -0 .01 to 0.07) 
( -0 .04 to 0.09) 
( -0 .00 to 0.08) 
( -0 .04 to 0.09) 
( -0 .08 to 0.10) 
( -0 .02 to 0.13) 
( -0 .03 to 0.10) 
( -0 .08 to 0.11) 
(0.00 to 0.15) 
( -0 .02 to 0.03) 
( -0 .04 to 0.04) 
( -0 .02 to 0.03) 
( -0 .08 to 0.03) 
( -0 .08 to 0.05) 
( -0 .16 to 0.07) 
Values are mean ± SD. The twenty-three men and thirty-seven women consumed both diets for 3 weeks 
each, in different order. To convert values for total, HDL, non-HDL (VLDL + LDL), and LDL cholesterol to 
milligrams per deciliter, multiply by 38.67. To convert values for triglycerides to milligrams per deciliter, 
multiply by 88.54. 
a
 Significantly different from zero, P<0.05. 
The small increases in total (0.10 mmol/L) and LDL cholesterol (0.08 mmol/L) 
on the modified-fat diet reached statistical significance in the men (Table 4). 
However, the men's non-HDL (or VLDL + LDL) cholesterol was not significantly 
different (P = 0.39) between the two diets. None of the responses in lipid and 
127 
Chapter 6 
lipoprotein levels was significantly different between men and women (P>0.30) . 
Also, no significant differences were detected between responses of women using 
or not using oral contraceptives. 
Before the sera were analyzed, we had identified 5 women who experienced 
events that probably influenced their lipoprotein levels: one received estrogen 
therapy during part of the trial, one had a sinus infection and was treated with 
antibiotics, one reported frequent deviations from the study diets, one suffered a 
knee injury and stopped daily vigorous exercise, and one lost more than 3 kg of 
body weight during the trial. Statistical analysis without the data of these 5 
women (A7 = 5 5 men and women) did not yield substantially different results. The 
mean effect of modified fat relative to palm oil for the remaining 32 women was 
somewhat, but not significantly, larger for total cholesterol (0.08 mmol/L; 95% CI, 
- 0 . 0 4 to 0.21 mmol/L) and for HDL cholesterol (0.06 mmol/L; 95% CI, 0.01 to 
0.12 mmol/L) than for the 37 women in the initial analysis (Table 4). Again, the 
responses in women and men were not significantly different. The mean effects 
of the modified-fat diet versus the palm oil diet in the 55 subjects who experienced 
no health problems or material changes in body weight were 0.09 mmol/L or 3.5 
mg/dL (95% CI, 0.01 to 0.17 mmol/L) for total cholesterol, 0.05 mmol/L or 1.9 
mg/dL (95% CI, 0.02 to 0.09 mmol/L) for HDL, and 0.05 mmol/L or 1.9 mg/dL 
(95% CI, - 0 . 0 2 to 0.12 mmol/L) for LDL cholesterol. As in the analysis with all 
60 subjects, the HDL to LDL ratio was identical on both diets. 
DISCUSSION 
Fasting serum lipids and lipoproteins 
We found that two dietary fats with an extreme contrast in the type of fatty 
acid on the 2 position, specifically palmitic versus oleic acid, resulted in minimal 
differences in serum total or lipoprotein cholesterol levels. The only statistically 
significant effects were observed in the men, who showed small rises in LDL and 
total cholesterol on the diet with palmitic acid on the sn-2 position. In view of the 
more modest differences in positional distribution that can be achieved in everyday 
diets, the influence on serum cholesterol levels in free-living people should be much 
smaller than the 0.1 mmol/L for men observed here. The design and the size of the 
trial provided a high statistical power to detect real population differences. It is 
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therefore unlikely that we failed to pick up any major effect through chance 
fluctuations. Also, most of the effect of dietary lipids on serum lipoproteins is 
established within one or two weeks [3,36-38]; therefore, 3 weeks should have 
been amply sufficient to observe an important effect if there had been one. We 
used solvent fractionation of palm oil to increase the proportion of triglycerides 
with unsaturated fatty acids in the sn-2 position, which is typical for vegetable oils. 
Solvent fractionation is a physical process that does not produce changes in 
molecular structures. Our results therefore suggest that fat with palmitic acid 
mainly on the sn-1,3 position does not confer any major advantage in terms of 
effects on serum lipoproteins over other fats with the same fatty acid composition 
but a different positional distribution of fatty acids. 
Innis and coworkers [20] fed formulas containing palm oil or enzymatically 
modified fat to newborn piglets. At 18 days of age the modified fat formula high 
in SA7-2-palmitate triglycerides resulted in higher plasma total and HDL cholesterol 
levels than the palm-oil formula high in sn-2-oleate glycerides [20]. These changes 
were in the same direction, but much larger than observed in the present study. 
However, the effects of dietary fat on lipid metabolism of newborn piglets are 
difficult to compare with those of adult humans, not only because of species 
differences, but also because in newborn animals and humans the absorption of 
palmitic acid in the 2 position might be more efficient than that of palmitic acid in 
the 1 and 3 positions [39-41]. 
Other potential effects of positional fatty acid distribution 
Although dietary fatty acid configuration had no substantial effect on fasting 
lipoprotein levels, it might still influence postprandial lipoprotein concentrations. 
Indeed, Mortimer and Redgrave [42,43] injected chylomicrons or lipid emulsions 
into rats and found that hydrolysis of triglycerides by lipoprotein lipase and liver 
uptake of remnant particles were slower when the fatty acid in the 2 position was 
saturated than when it was unsaturated. If these findings can be extrapolated to 
humans, then eating sn-2-saturated triglycerides, such as lard, might result in 
elevated plasma remnant concentrations. Myher and coworkers [44] found that in 
human volunteers fed a lard-rich breakfast the chylomicron triglycerides contained 
considerably more palmitic acid in the 2 position than those in subjects who 
consumed a control breakfast. This shows that in humans the sn-2 position of 
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palmitic acid in lard is at least partly retained after hydrolysis by pancreatic lipase 
in the gut. Myher et al. [44], however, did not report effects of lard on chylomicron 
concentrations. Recently, Zampelas and coworkers [45] examined the effects of 
positional distribution of dietary palmitic acid on postprandial plasma lipids. Sixteen 
healthy men consumed the same dietary fats as studied in our trial, and plasma 
total and chylomicron triglyceride levels were monitored over 6 hours after the 
liquid test meals. No differences between the palm oil and the modified-fat meal 
were detected. The authors concluded that the positional distribution of fatty acids 
in dietary triglycerides is not an important determinant of postprandial lipemia [45]. 
Kritchevsky et al. [10-12] found that randomization of fats with a specific 
fatty acid distribution such as peanut oil reduces their atherogenicity in laboratory 
animals. Peanut oil contains 4 - 7 % of saturated C20:0, C22:0 en C24:0, almost 
all of it in the sn-3 position [46]. Although these very long chain saturates can 
slow down chylomicron metabolism in rats [43], this cannot explain why 
randomized peanut oil, in which these fatty acids are present in the 2 position as 
well as in the 1 and 3 position, should be less atherogenic than native peanut oil. 
The atherogenesis in animals fed native peanut oil does not seem to be mediated 
by elevated plasma cholesterol levels [10,11]. It has been suggested that the 
presence of C20-24 saturates in the 3 position of peanut oil might render linoleic 
acid in the 2 position relatively unavailable, which could promote the atherogenicity 
of the oil [46]. 
Conclusion 
The fatty acid configuration of food fats can be altered to produce 
confectionary and other fats with better texture or certain desired physical 
properties. Our study provides no evidence that changing the position of palmitic 
acid in this "structuring" process has important health consequences. However, 
future studies should also investigate the positional effects of other fatty acids. 
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Partial conservation of the sn-2 position of dietary 
triglycerides in fasting plasma in humans 
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ABSTRACT 
Aim. We investigated the effect of the position of fatty acids within dietary 
triglycerides on the composition of plasma triglycerides and cholesteryl esters. 
Methods. Sixty volunteers consumed two diets of equal fatty acid compositions 
for three weeks each. In the palm oil diet 82% of palmitic acid (C16:0) was 
attached to the sn-1 and sn-3, and 18% to the sn-2 position of glycerol. In the 
diet rich in a palm oil analogue, Betapol, these figures were 35% and 65%, 
respectively. 
Results. Consumption of Betapol increased palmitic plus palmitoleic acid {cis-
C16:1 ) in the plasma cholesteryl esters by about 1 g/100 g fatty acids (P< 0.0001 ) 
at the expense of oleic and linoleic acid. The proportion of palmitic acid in the 2-
position of fasting plasma triglycerides was 10.2 g/100 g on palm oil and 12.3 
(P<0.0001) on Betapol; that of oleic acid (c/s-C18:1) was 46.9 versus 43.6 
(P<0.0001 ). Overall oleic acid content of triglycerides was 1.4 g/100 g fatty acids 
lower on Betapol than on palm oil (P = 0.002), while palmitoleic and 
polyunsaturated fatty acids showed small increases. 
Conclusion. The fatty acid configuration of dietary fat is partially reflected in 
fasting plasma triglycerides. Dietary palmitic acid is incorporated more efficiently 
into plasma cholesteryl esters when attached to the middle then when attached to 
the outer positions of dietary triglycerides. The positional distribution of fatty acids 
in dietary fat has effects on lipid metabolism that persist beyond fat absorption and 
chylomicron clearance. 
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INTRODUCTION 
Every triglyceride (triacylglycerol) molecule contains three distinct and non-
equivalent attachment sites for fatty acids. These are numbered sn-1, sn-2, and sn-
3, where sn stands for stereospecific numbering. Natural fats and oils in the human 
diet differ in the positional distribution of their constituent fatty acids (Table 1). 
The influence of the stereospecific distribution of fatty acids within dietary 
triglycerides on lipid metabolism is largely unknown, especially for the in vivo 
situation in humans. 
Table 1. Approximate total and sn-2 fatty acid composition (g/100 g) and the percentage 
of each type of fatty acid at the 2 position {%sn2)a in triglycerides of major dietary fats. 
Fat 
Beef (tallow) 
Dairy fat6 
Pork (lard) 
Palm kernel oil 
Soybean oil 
Cocoa butter 
Total 
54 
68 
36 
49 
13 
60 
Saturates 
Sn-2 
29 
73 
71 
13 
0 
10 
%sn2 
18 
36 
65 
9 
0 
5 
Monounsaturates 
Total 
44 
28 
50 
40 
27 
36 
Sn-2 
64 
26 
22 
70 
42 
88 
%sn2 
49 
31 
16 
59 
53 
81 
Polyunsaturates 
Total 
3 
3 
14 
11 
60 
4 
Sn-2 
7 
1 
7 
17 
58 
2 
%sn2 
88 
11 
17 
52 
33 
15 
Values are derived from references [1-3]. 
3
 Calculated as ( sn-2 fatty acids / 3 x total fatty acids ). When fatty acid distribution would be random this 
figure would equal 33%. 
b
 Short chain fatty acids (C4-C10) and stearic acid (CI 8:0) in milk are mainly at the sn-1 and sn-3 positions, 
and the C12-C16 saturates predominantly at the sn-2 position [1]. 
The major pathways of lipid metabolism as currently envisaged (Fig. 1) do not 
allow for effects of dietary triglyceride configuration on plasma lipid composition 
beyond the postprandial phase. After partial hydrolysis by pancreatic lipase in the 
intestine, dietary triglycerides are absorbed as 2-monoglycerides and free fatty 
acids [4,5]. Reacylation of the monoglycerides in the mucosal cells results in 
chylomicron triglycerides which largely retain the original fatty acid in the middle 
or sn-2 position [6] (route B in f ig. 1). When these triglycerides are hydrolyzed in 
the capillary bed, free fatty acids, glycerol, and 2-monoglycerides are formed 
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Fig.1 (left page). Potential metabolic routes of fatty acids attached to the sn-2 position of 
dietary triglycerides. The phosphatidic acid pathway of triglyceride synthesis in the mucosa 
and the liver, and the exchange of cholesteryl esters and triglycerides between HDL, LDL, 
and VLDL are not shown. The majority of the fasting plasma lipids do not contain (sn-2) 
fatty acids which originate from the 2 position of dietary triglycerides; these lipids have 
been left out for reasons of clarity. A: formation of chylomicron cholesteryl esters by 
intestinal ACAT [7], B: reacylation of absorbed 2-mono-acylglycerols to chylomicron 
triglycerides [6], C: reacylation of 2-mono-acylglycerols to chylomicron phosphatidylcholine 
[8], D: peripheral hydrolysis of fatty acids on the sn-1 and sn-3 position of chylomicron 
triglycerides by LPL [9], E: tissue uptake of lipolytic products generated by LPL [10], F: 
transport to the liver of 2-mono-acylglycerols formed by LPL [11], G: hydrolysis of 2-mono-
acylglycerols reaching the liver [11,12], H: transfer of chylomicron triglycerides to other 
lipoproteins by LTP [13], J: hepatic triglyceride synthesis from 2-mono-acylglycerols 
transported to the liver (speculative), K: hepatic phospholipid synthesis from 2-mono-
acylglycerols transported to the liver (speculative), L: formation of plasma cholesteryl 
esters by hepatic ACAT [7], M: formation of plasma cholesteryl esters by transfer of the 
sn-2 fatty acid from phosphatidylcholine to free cholesterol by LCAT [14], N: plasma 
phospholipid synthesis by intestinal reacylation of absorbed lysolecithin [15,16], O: de 
novo phospholipid synthesis in the intestine [17], P: de novo phospholipid synthesis in the 
liver [18]. ACAT, acyhCoA acyltransferase; LCAT, lecithinxholesterol acyltransferase; 
LPL, lipoprotein lipase; LTP, lipid transfer protein. 
=fatty acid, triglyceride, = monoglyceride, 
/ V \ A / =fatty acid originating from the sn-2 position of dietary triglyceride, 
— =glycerol, 
Ke> 
= phospholipid, — =lysolecithin, C H O L ='••«• 
KE) 
cholesterol, (CE) =cholesteryl ester, ^> =speculative pathw ay. 
because lipoprotein lipase, like pancreatic lipase, primarily attacks the 1 and 3 
position [9] (route D). The fate of the monoglycerides is not exactly known, but it 
is believed that they are removed quickly from the circulation after further 
139 
Chapter 7 
hydrolysis by lipoprotein lipase [10] or monoglyceride hydrolase [19] (route E). 
Alternatively, the monoglycerides may be transported to the liver attached to 
albumin or in the core of the chylomicron remnants [11] (route F). Upon uptake in 
the liver they are probably further degraded [11,12] (route 6) . Thus, according to 
these pathways, any memory of the original sn-2 position of the dietary 
triglycerides should be erased by the time chylomicron clearance has been 
completed. 
Plasma cholesteryl esters are mainly formed by the lecithin:cholesterol 
acyltransferase (LCAT) reaction on HDL, which transfers the sn-2 acyl chain from 
phosphatidylcholine to cholesterol [14] (route M in f ig. 1 ). Phosphatidylcholine in 
plasma is synthesized de novo in the liver [18] (route P) and the intestine (route 0) , 
or by mucosal reacylation of lysolecithin absorbed from the intestinal lumen 
[15,16] (route A/). Cholesteryl esters are also formed from cholesterol and fatty 
acids by the AcyhCoA acyltransferase (ACAT) reaction in hepatic (route L) and 
intestinal mucosa cells (routed) and excreted into plasma in VLDL and chylomicron 
particles [7]. None of these routes predicts an effect of dietary triglyceride 
configuration on the fatty acid composition of cholesteryl esters. 
Therefore, neither endogenous VLDL triglycerides in fasting blood nor plasma 
cholesteryl esters are expected to reflect changes in the position of fatty acids in 
dietary triglycerides as long as the overall mix of dietary fatty acids remains 
constant. However, current knowledge about the pathways by which dietary fat 
influences lipid metabolism is largely based on animal and in vitro experiments (Fig 
1 ). We now compared the effect of the positional distribution of dietary fatty acids 
on the fatty acid composition of fasting plasma lipids in a large group of human 
subjects. 
METHODS 
Design and statistical analyses 
The aim of the study was to investigate the effects of the positional 
distribution of fatty acids in the dietary triglyceride molecules on fasting blood 
lipids and lipid metabolism in humans. The effects on serum total and lipoprotein 
cholesterol levels have been reported elsewhere (Chapter 6). 
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The trial consisted of two consecutive periods, during which each participant 
consumed both diets, in random order (cross-over). The diets were high in either 
palm oil, with palmitic acid predominantly in the snA and sn-3 positions, or in 
Betapol, which contains palmitic acid mainly in the sn-2 position. The two 
sequences contained a nearly equal number of male and female subjects, and of 
women using and not using oral contraceptives. In this way, bias due to treatment 
order, drift of variables over time, or effects of hormonal cycle was eliminated [20]. 
The subjects were masked as to the nature of their diets. 
Effects of diet were analyzed statistically by comparison of each subject's 
data on the two diets using paired t-tests [21]. 
Subjects 
All 23 men and 37 women who were admitted completed the trial 
successfully (Chapter 6). None suffered from anemia, glycosuria, or proteinuria, 
and they were apparently healthy, as indicated by a medical questionnaire. At the 
beginning of the study fasting serum total cholesterol ranged from 2.80 to 6.98 
mmol/L (mean, 4.62 mmol/L), HDL cholesterol from 0.76 to 2.42 mmol/L (mean, 
1.52 mmol/L), and triglycerides from 0.41 to 2.24 mmol/L (mean, 0.92 mmol/L). 
The subjects were between 19 and 67 years old (mean, 31 years), and weighed 
between 54.4 and 108.4 kg (mean, 71.3 kg); their body mass index (mean ± SD) 
was 22.6 ± 2.8 kg/m2. Approval for the study had been obtained from the Ethics 
Committee of the department. The protocol and aims of the study were thoroughly 
explained to the subjects, who gave their written consent. No financial reward was 
given, except for the study diets, which were free. 
Diets 
The diets were composed of conventional solid foodstuffs, and menus were 
changed daily during each 3-week dietary period. On week days at noon hot meals 
were served and eaten at the department, and other foods were supplied daily as 
a package. All foods were weighed out individually, according to each person's 
energy requirement. Body weights were essentially constant during the 6 weeks 
of the study (Chapter 6). 
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Both diets supplied on average 12.4 MJ (2950 kcal) per day, of which 41 % 
as fat, 4 5 % as carbohydrates, 13% as protein, and 1 % as alcohol. Cholesterol 
content was 30 mg per MJ (368 mg/day). The differences in the positional 
distribution of fatty acids were achieved by the use of special margarines and oils, 
developed by the Unilever Research Laboratory, Vlaardingen, the Netherlands. 
Table 2 shows that the fat in the two diets contained equal amounts of each 
specific fatty acid (columns 1 and 4), but differed widely in the positional fatty acid 
distribution. In the Betapol diet, 65% of the palmitic acid was attached to the 2 
position, and the remaining 35% to the 1 and 3 position. In contrast, 8 2 % of the 
palmitic acid in the palm-oil diet was on the 1 and 3 position, while only 18% was 
found on the 2 position. Sixty-eight percent of the sn-2 fatty acids in the Betapol 
diet was saturated, mainly palmitic acid, whereas 73% of the sn-2 fatty acids in 
the palm-oil diet were unsaturated, the majority being oleic acid (Table 2, columns 
2 and 5). 
Table 2. Total, sn-2, and sn-1,3a fatty acid composition of the triglycerides in the 
experimental diets. 
Fatty acid 
Saturated 
Laurie acid (C12:0) 
Myrist ic acid (C14:0) 
Palmitic acid (C16:0) 
Stearic acid (C18:0) 
Monounsaturated 
Oleic acid (c/s-C18:1) 
Polyunsaturated 
Linoleic acid (C18:2) 
Unknown 
Total 
Total 
42 .1 
1.0 
2.5 
27.7 
9.2 
42 .8 
41 .3 
13.2 
12.2 
1.9 
100 
Palm oil diet 
Sn-2 
26.5 
1.1 
3.5 
14.6 
6.2 
52.0 
51.0 
20.6 
19.6 
0.9 
100 
SAJ-1,3 Total 
g/100 g of dietary fatty acids 
49.9 
0.9 
2.0 
34.2 
10.8 
38.1 
36 .4 
9.6 
8.5 
2.4 
100 
40 .6 
1.0 
2.7 
27 .4 
8.1 
44 .4 
42.1 
12.3 
11.2 
2.7 
100 
Betapol diet 
Sn-2 
67.8 
1.4 
4 .3 
53.5 
6.9 
22 .3 
20 .9 
8.4 
7.2 
1.5 
100 
Sn-1,3 
26 .9 
0.8 
1.9 
14.3 
8.6 
55.5 
52.7 
14.3 
13.1 
3.3 
100 
The special oils supplied 70% of the total fat in the study diets, of which 64% as margarine. The remaining 
30% came from conventional foodstuffs, largely dairy products and meat. 
3
 Calculated from the total and sn-2 fatty acid composition. 
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Blood was sampled after a 12 h fast on days 17 and 21 of each dietary 
period. Serum was obtained by low speed centrifugation within one hour of 
venipuncture and used for enzymatic analysis of total and HDL cholesterol and of 
total triglyceride levels [22-24]. On day 21 of each period blood was also drawn 
into tubes with EDTA as anticoagulant. These tubes were immediately centrifuged 
at low speed and 4 °C to separate plasma from the red blood cells. The cells were 
washed twice with ice-cold isotonic saline, transferred into glass tubes, and 
hemolyzed at - 8 0 °C. Samples were stored at - 8 0 °C until analysis. 
For the isolation of cholesteryl esters and triglycerides, 3 mL of isopropanol 
and 1 mL of distilled water were added to 0.65 mL plasma, the sample was mixed 
for 30 s, 3 mL of /7-octane were added and this mixture was shaken for 15 min. 
After centrifugation for 3 min. at 1580 x g the (upper) octane layer was removed 
and evaporated to dryness in a stream of nitrogen. The lipids were redissolved in 
2 mL 2.5 vo l% diethyl ether in hexane, applied to a silica column (Varian, 
Analytichem Bond Elut) and eluted twice with 2 mL of the same solvent to obtain 
the cholesteryl ester fraction. Subsequently, the triglycerides were eluted with 2 
mL of 15 vo l% diethyl ether in hexane. Thin-layer chromatography [25] of the 
fractions showed that separation was essentially complete. 
1.5 mL of the eluate that contained the triglycerides was dried down under N2. 
If the amount of triglycerides was less then 0.3 mg, then more plasma lipids was 
extracted until sufficient material was obtained. The triglycerides were dissolved 
in 0.05 ml of hexane and incubated with 2.53 mL of buffered porcine pancreatic 
lipase emulsion (EC 3.1.1.3, Sigma), plus 0.125 mL sodium cholate solution and 
0.05 mL calcium chloride solution to hydrolyse the sn-1 and SA7-3 fatty acids. The 
reaction was stopped after 3 min. by adding 1 mL of hydrochloric acid, 6 mol/L. 
The lipids were extracted with diethyl ether, dried, dissolved in chloroform and 
applied to an aminopropyl column (Varian, Analytichem Bond Elut). Diglycerides 
plus triglycerides were eluted with 4 mL of 1 5 vo l% ethyl acetate in hexane and 
the 2-monoglycerides with 4 mL of chloroform/2-propanol, 2/1 (vol/vol). The 2-
monoglyceride fraction and an aliquot of the original triglyceride fraction were 
saponified and methylated for gas chromatographic analysis [26]. 
Fatty acid compositions of monoglyceride fractions obtained at different lipase 
concentrations were highly similar, but absolute amounts recoverd differed. We 
reduced the concentration of lipase from 10 mg per mL [27] to 2.5 mg/mL in order 
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to optimize the proportion of total fatty acids recovered in the monoglyceride 
fraction. The sn-2 fatty acid compositions of Betapol and palm oil as determined 
by the official method [27] were similar to the compositions as determined by our 
method; differences were less than 1.4 g/100 g for every sn-2 fatty acid. A serum 
pool with a triglyceride concentration of 1 mmol/L and a solution of 0.3 mg Betapol 
in 0.65 mL hexane were used as internal controls and for calculation of the 
reproducibility. The analytical coefficient of variation within runs of the main fatty 
acids (C16:0, C18:1 , C18:2, and C20:4) was on average 1.3% for total fatty acids 
and 4 .8% for sn-2 fatty acids in triglycerides. All samples of a particular subject 
were analyzed within one run. 
Erythrocyte lipids were extracted from hemolyzed cells into isopropanol/hexane 
3/4 (vol/vol); the hexane contained 50 mg 2,6-di-tert-butyl-p-cresol (BHT; BDH 
Biochemicals, Poole, UK) per L as an anti-oxidant. The lipids from erythrocytes 
were transmethylated for 18h at 60 °C and the cholesteryl esters from plasma for 
1 h at 90 °C, both with 40 mL H2S04/L methanol [26]. The coefficients of variation 
within runs for the major fatty acids was 0.7% for cholesteryl esters and 1.9% for 
erythrocyte phospholipids. 
RESULTS 
Fasting serum triglyceride levels were similar (P = 0.35) on the palm oil diet 
(0.97 ± 0.42 mmol/L) and the Betapol diet (0.94 ± 0.40 mmol/L). Lipoprotein 
cholesterol concentrations were also highly similar (Chapter 6). Table 3 shows the 
total and sn-2 fatty acids compositions of the plasma triglycerides. On the Betapol 
diet, in which oleic acid was attached to the outer positions of the dietary 
triglycerides, the proportion oleic acid of total fatty acids in triglycerides was 1.4 
g/100 g fatty acids lower (P = 0.002; 95% confidence interval, - 2 . 3 to - 0 . 5 
g/100 g) than on the palm oil diet. There were small increases in the proportions 
of palmitoleic and polyunsaturated fatty acids (Table 3, column 3). Changes were 
largely located in the sn-2 position: column 6 of Table 3 shows that the Betapol 
diet raised the proportion of palmitic acid on the sn-2 position of plasma 
triglycerides by 2.1 g/100 g sn-2 fatty acid (P<0.0001; 95% confidence interval, 
1.4 to 2.9 g/100 g) and lowered oleic acid by 3.3 g/100 g sn-2 fatty acids 
(P<0 .0001 ; 95% confidence interval, - 4 . 5 t o - 2 . 0 g/100 g). Fig. 2 depicts the 
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individual differences in sn-2 fatty acids between the two diets. Out of all 60 
subjects, 45 had a higher proportion of palmitic acid and 46 had a lower proportion 
of oleic acid on the sn-2 position of plasma triglycerides on the Betapol diet relative 
to the palm oil diet. 
g/100 g sn-2 fatty acids of plasma triglycerides 
• Change in sn-2-C16:0 D Change in sn-2-C18:1 
Fig. 2. Individual differences in the proportions of palmitic (C16:0) and oleic acid (C18:1) 
on the sn-2 position of fasting plasma triglycerides between the Betapol and the palm oil 
diet. 
Table 4 shows the fatty acid compositions of the plasma cholesteryl esters. 
Betapol increased the proportion of palmitic acid by 0.7 (P< 0.0001) and 
palmitoleic acid by 0.3 (P< 0.0001) g/100 g cholesterol ester fatty acids, and 
decreased oleic by 0.4 (P=0.014), linoleic by 0.6 (P=0.029), and arachidonic acid 
by 0.2 (=0.004) g/100 g cholesteryl ester fatty acids. 
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Table 4. Fatty acid composition (mean ± SD) of the plasma cholesteryl esters in the 60 
subjects at the end of the two dietary periods. 
C14:0 
C16:0 
C16:1 
C18:0 
C18:1n 
C18:1n 
C/S-C18 
C18:2n 
C18:3n 
•9 
7 
:1 
6 
3 
C20:4n-6 
Palm 
0.43 
10.09 
2.34 
0.78 
18.61 
0.99 
19.60 
55.16 
0.45 
6.01 
oil diet 
± 
± 
± 
± 
+ 
± 
+ 
± 
+ 
± 
0.10 
0.64 
0.96 
0.15 
1.52 
0.13 
1.53 
3.68 
0.10 
1.08 
Betapol diet Difference 
g/100 g of cholesteryl esters fatty acids 
0.45 
10.76 
2.63 
0.72 
18.18 
1.05 
19.23 
54.52 
0.49 
5.83 
± 
+ 
± 
+ 
± 
± 
± 
± 
± 
± 
0.11 
0.64 
0.88 
0.15 
1.46 
0.17 
1.51 
3.44 
0.10 
1.01 
0.02 
0.67 
0.29 
-0 .06 
-0 .43 
0.06 
-0 .37 
- 0 . 6 4 
0.04 
-0 .18 
± 0.08s 
± 0.57* 
± 0.486 
± 0.120 
± 1.206 
± 0.15s 
± 1.20s 
± 2.19s 
± 0.09* 
± 0.506 
(95% CI) 
(0.00 to 0.04) 
(0.53 to 0.81) 
(0.16 to 0.41) 
(-0.09 to -0.03) 
(-0.72 to-0.14) 
(0.02 to 0.10) 
(-0.66 to -0.08) 
(-1.20 to -0.07) 
(0.01 to 0.06) 
(-0.30 ± -0.06) 
3
 Significantly different from zero, P<0.05. 
b
 Significantly different from zero, P<0 .01 . 
Fig. 3 shows that 55 out of 60 subjects had a higher proportion of palmitic and 43 
had a lower proportion of oleic acid in their cholesteryl esters on the Betapol diet 
than on the palm oil diet. 
Fatty acid compositions of the erythrocyte membranes are given in Table 5. 
On Betapol the proportion of palmitic acid increased by 0.2 g/100 g fatty acids 
(P-0.038), while the proportions of polyunsaturated fatty acids were somewhat, 
although not significantly, lower than on the palm oil diet. 
Five women experienced events during the trial that could have influenced 
their lipid metabolism, e.g. estrogen therapy during part of the trial, treatment with 
antibiotics, and weight loss (Chapter 6). However, statistical analyses without the 
data of these 5 women produced essentially similar results. 
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g/100 g cholesteryl ester fatty acids 
H Change in C16:0 D Change in C18:1 
Fig. 3. Individual differences in the proportions of palmitic (C16:0) and oleic acid (C18:1) 
in fasting cholesteryl esters between the Betapol and the Palm oil diet. 
DISCUSSION 
Plasma triglyceride configuration 
Our findings show that the positional distribution of dietary fatty acids 
significantly influences the fatty acid configuration and composition of fasting 
plasma lipids. Although the differences in plasma triglyceride configuration between 
the diets were much smaller than the differences in the dietary triglycerides, the 
changes in sn-2 fatty acids in plasma triglycerides clearly reflected changes in the 
sn-2 fatty acids in dietary fat. Myher et al. [28] found an increase in palmitic acid 
at the sn-2 position of plasma triglycerides 4 hours after subjects consumed a large 
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Table 5. Fatty acid composition (mean ± SD) of the erythrocyte membranes in the 60 
subjects at the end of the two dietary periods. 
C14:0 
C16:0 
C16:1 
C18:0 
C18:1n-9 
C18:1n-7 
c/s-C18:1 
C18:2n-6 
C18:3n-3 
C20:3n-6 
C20:4n-6 
C22:0 
C22:4n-6 
C22:5n-3 
C24:0 
C22:6n-3 
C24:1 
Palm oil diet 
0.35 ± 
20.83 ± 
0.36 ± 
14.10 ± 
11.59 ± 
1.25 ± 
12.85 ± 
9.89 ± 
0.29 ± 
1.42 ± 
12.82 ± 
1.81 ± 
3.02 ± 
2.04 ± 
4.83 ± 
3.84 ± 
4.37 ± 
0.08 
0.60 
0.11 
0.62 
0.73 
0.18 
0.73 
1.10 
0.43 
0.37 
0.85 
0.43 
0.46 
0.38 
0.40 
0.80 
0.48 
Betapol diet 
g/100 g 
0.36 
21.00 
0.39 
13.99 
11.59 
1.31 
12.91 
9.92 
0.34 
1.43 
12.74 
1.86 
3.01 
2.04 
4.76 
3.86 
4.32 
Difference (95% CI) 
of erythrocyte membrane fatty acids 
± 0.07 
± 0.62 
± 0.10 
± 0.72 
± 0.62 
± 0.16 
± 0.62 
± 1.14 
± 0.42 
± 0.40 
± 0.92 
± 0.30 
± 0.45 
± 0.36 
± 0.45 
± 0.81 
± 0.39 
0.01 
0.17 
0.03 
-0 .11 
-0 .00 
0.06 
0.06 
0.04 
0.05 
0.01 
-0 .08 
0.05 
-0 .01 
- 0 . 0 0 
-0 .07 
0.01 
- 0 . 0 4 
± 
± 
+ 
+ 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
+ 
+ 
0.09 
0.64 a 
0.11 a 
0.66 
0.46 
0.11 b 
0.45 
0.53 
0.41 
0.28 
0.50 
0.49 
0.15 
0.25 
0.23 a 
0.41 
0.28 
(-0.01 to 0.03) 
(0.01 to 0.34) 
(0.00 to 0.06) 
(-0.06 to -0.28) 
(-0.09 to 0.09) 
(0.04 to 0.08) 
(-0.04 to-0.16) 
(-0.10 to 0.17) 
(-0.06 to 0.15) 
(-0.06 to 0.08) 
(-0.20 to -0.05) 
(-0.07 to 0.17) 
(-0.04 to 0.03) 
(-0.06 to 0.05) 
(-0.13 to-0.00) 
(-0.09 to -0.11) 
(-0.11 to 0.02) 
a
 Significantly different from zero, P<0.05. 
* Significantly different from zero, / 3 < 0 . 0 1 . 
single dose of lard, which, like Betapol, contains palmitic acid mainly at the sn-2 
position. This effect was somewhat larger than observed here but still modest. A 
change of this kind was to be expected because Myher measured postprandial 
triglycerides. Our observation that fasting plasma triglycerides partly reflect the 
dietary fatty acid configuration is new and suggests an effect beyond chylomicron 
clearance. 
The positional distribution of dietary fatty acids was also reflected in the total 
fatty acid composition of plasma lipids; when a fatty acid was mainly on the sn-2 
position of the dietary fat, its proportion in both total triglycerides and cholesteryl 
esters was increased. Changes in the pattern of the fatty acids in erythrocyte 
membranes —mainly phospholipids- were in the same direction as seen in the 
triglycerides and cholesteryl esters. Although these effects were smaller than those 
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seen when the overall pattern of dietary fatty acids is changed [29](Chapter 5), 
they were highly consistent. 
Innis and co-workers [30] found that in newborn piglets Betapol increased 
palmitic and decreased linoleic acid in the plasma triglycerides, while the proportion 
of oleic acid was unaltered. We found that Betapol did not affect total palmitic acid 
in the plasma triglycerides, and decreased the oleic acid content. Innis et al. [30] 
reported an increase in palmitic acid and decreases in unsaturated fatty acids in 
cholesteryl esters on the Betapol diet. This agrees with our findings, although the 
differences seen in piglets were larger. However, the effects of dietary fat on lipid 
metabolism of newborn piglets are difficult to compare with those of adult humans, 
not only because of species differences, but also because in neonates the 
absorption of palmitic acid in the sn-2 position is much more efficient than that of 
palmitic acid in the sn-1 and sn-2 position [31,32]. 
It is unlikely that the differences in the configuration of triglycerides in plasma 
were due to residual chylomicrons. Blood samples were taken 11.5 to 14.0 hours 
after the last meal. Compliance of the subjects with instructions for fasting was 
high (Chapter 6), and the fasting state was confirmed by low triglyceride levels. 
The observed differences in sn-2 fatty acids must thus be due to triglycerides in 
lipoproteins other than chylomicrons. A plausible explanation is that chylomicron 
triglycerides absorbed after a meal escape lipolysis through transfer to VLDL, LDL, 
or HDL by lipid transfer proteins [13] (route H in f ig. 1). VLDL particles are 
converted to LDL [33] and LDL triglycerides cannot be hydrolyzed by lipoprotein 
lipase because LDL lacks apolipoprotein CIL Furthermore, catabolism of VLDL, LDL 
and HDL is much slower than that of chylomicron (remnant) particles [33]. 
Observations that substantial amounts of retinyl ester are transferred from 
chylomicrons to VLDL [34,35] supports this explanation. 
An alternative explanation is that newly synthesized hepatic triglycerides 
reflect the positional distribution of dietary triglycerides (route J in f ig. 1). 
Theoretically, 2-monoglycerides resulting from peripheral lipoprotein lipase action 
on exogenous triglycerides (route D) could be transported to the liver by 
chylomicron remnants or albumin [11] (route F) and then be used for synthesis of 
VLDL triglycerides in the microsomes (route J). However, this presumes that 2-
monoglycerides are not hydrolyzed by hepatic lipases (route G) and that the 2-
monoacylglycerol pathway of triglyceride synthesis (route J) is active in the adult 
human liver. Significant activity of microsomal monoacylglycerol acyltransferase, 
the enzyme which defines this pathway, has been observed in neonatal but not in 
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adult rat liver [36]. It is possible that the high proportion of energy obtained from 
dietary fat by humans induces this pathway, but this mechanism remains 
speculative [37], and lipid transfer from chylomicrons to other lipoproteins seems 
the most plausible explanation for our findings. 
Fatty acid composition of cholesteryl esters 
The majority of cholesteryl esters in plasma are generated by LCAT, which 
transfers a fatty acid from phosphatidylcholine to free cholesterol (route M in f ig. 
1). LCAT has a preference for the unsaturated sn-2 fatty acids of 
phosphatidylcholine. Most phospholipids circulating in plasma are synthesized in 
the liver (route P), but intestinal mucosal cells also produce phosphatidylcholine, 
either by reacylation of absorbed lysolecithin [16] (route A/), or by de novo 
synthesis [38] (route O). An early study [17] with isolated microsomes from rat 
intestinal cells suggested that mucosal phosphatidylcholine is synthesized only via 
the phosphatidic acid pathway (route O), but it was recently shown that rat and 
hamster mucosal cells can also utilize 2-monoacylglycerols for phospholipid 
production in vitro [8] (route C). We are not aware of any human data on this 
subject. If route C operates in vivo in man, then dietary sn-2 fatty acids might end 
up in the sn-2 position of chylomicron phosphatidylcholine and be subsequently 
transferred to cholesteryl esters by LCAT in plasma (route M). This explanation is 
supported by the fatty acid composition of erythrocyte phospholipids, which 
showed a small but significant enrichment of palmitic acid on the Betapol diet. 
Our data do not support formation of chylomicron phospholipids through 
reacylation of the 2-position of absorbed lysolecithin (s/?-1-acylglyceryl-
phosphorylcholine) in mucosal cells in man in vivo (route N in f ig. 1). During 
digestion and absorption of fat, dietary sn-2 fatty acids remain esterified to glycerol 
- a t least pa r t l y - and are thus less available for reacylation of the 2 position of 
lysolecithin than are sn-'\ or sn-3 fatty acids, and by inference they would also be 
less available for cholesteryl ester formation by LCAT (route M). However, we 
observed enrichment of dietary sn-2 fatty acids in cholesteryl esters; therefore 
selective reacylation of lysolecithin in the human gut does not explain our findings. 
The same reasoning suggests that intestinal ACAT is not a major route towards 
formation of plasma cholesteryl esters (route A): sn-1 and sn-3 fatty acids from 
dietary triglycerides are more available for mucosal ACAT than the sn-2 fatty acids, 
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but we observed an enrichment rather than depletion of sn-2 fatty acids in plasma 
cholesteryl esters. Therefore, synthesis of chylomicron phosphatidylcholine from 
absorbed 2-monoacylglycerols (route C) and subsequent transfer of the sn-2 fatty 
acid to cholesterol esters by LCAT in plasma (route M) is the most likely pathway 
for the observed effects of the dietary fatty acid configuration on the composition 
of plasma cholesteryl esters. 
Alternatively, some of the s/?-2-mono-palmitoyl-glycerols produced by 
lipoprotein lipase action on chylomicrons after a Betapol-rich meal might be 
transported to the liver by albumin or in chylomicron remnants (route F i n f ig. 1) 
[11]. The ensueing higher availability of palmitic acid for cholesterol esterification 
by hepatic cells could enhance production and secretion of cholesteryl palmitate 
in VLDL particles (route L). Increased delivery of palmitic acid to the liver could also 
explain the minimal rises in serum LDL cholesterol seen on Betapol [30] (Chapter 
6), because the low affinity of ACAT for palmitic acid may cause a rise in a pool 
of unesterified (chole)sterol, resulting in down-regulation of the hepatic LDL 
receptor and a rise in plasma LDL concentrations [39]. 
A third possible mechanism is that exogenous 2-monoacylglycerols reaching 
the liver might be converted into phosphatidylcholine (route K in Fig. 1 ). Secretion 
of these phospholipids in VLDL particles and transfer of the sn-2 fatty acids to 
cholesteryl esters by LCAT (route M) might explain the increase in plasma 
cholesteryl palmitate that we observed on the Betapol diet. However, this 
mechanism is less likely because the 2-monoacylglycerol pathway of glycerolipid 
synthesis is probably not active in the adult liver [36,37]. 
In conclusion, we found that the positional distribution of fatty acids in 
dietary fat had a small but distinct and significant influence on the fatty acid 
configuration and composition of fasting plasma triglycerides and cholesteryl esters 
in humans. The most plausible explanation for retention of the sn-2 position in 
dietary triglycerides in fasting plasma lipids is that chylomicron triglycerides with 
the original fatty acid on the sn-2 position are transferred to other lipoproteins and 
in this way escape postprandial lipolysis by lipoprotein lipase. The enrichment of 
cholesteryl esters in dietary sn-2 fatty acids points to formation of phospholipids 
in the intestine from absorbed 2-monoacylglycerols and subsequent transfer of the 
sn-2 fatty acids to cholesteryl esters by LCAT in plasma. However, other 
explanations cannot be excluded. 
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The current thesis embodies three controlled dietary trials in which we studied 
the influence of fatty acids on serum lipoprotein cholesterol levels and some other 
risk factors for CHD. The studies were aimed at investigating effects of the 
cis/trans configuration of the double bonds, the chain length, and the triglyceride 
configuration of fatty acids. The first section of this chapter summarizes the main 
findings and the results are put into perspective with those of other studies. Next, 
some methodological aspects of the trials are discussed. The main conclusions are 
given at the end of this chapter. 
MAIN FINDINGS AND PERSPECTIVE WITH OTHER STUDIES 
Monounsaturated trans fatty acids 
LDL and HDL cholesterol 
The first study in this thesis confirms that monounsaturated trans fatty acids 
from hydrogenated vegetable oils simultaneously raise LDL and lower HDL 
cholesterol as compared with cis unsaturated fatty acids. Several dietary trials on 
trans fatty acids have been reported since our study was published [1-3]. Fig. 1 
shows the effects of monounsaturated trans fatty acids relative to their cis isomer 
oleic acid across five trials. Differences in other fatty acids between the trans 
enriched diets and the reference diets were adjusted for using the meta-analysis 
of Mensink [4]. Thus, the changes we observed for on the Trans-d\et versus the 
Linoleate diet (Chapter 2) are now expressed relative to oleic acid, taking into 
account the modest differences between oleic and linoleic acid. When the data 
from references [1-3,5] and our study are combined in a linear model, every 
additional percent of dietary energy as trans fatty acids results in an increase in 
LDL cholesterol of 0.040 mmol/L or 1.55 mg/dL (R2 = 0.86, P = 0.028) and a 
decrease in HDL cholesterol of 0.013 mmol/L or 0.50 mg/dL (R2 = 0.88, P=0.019). 
These combined data indicate that the effects of monounsaturated trans fatty acids 
on LDL cholesterol is about similar to that of saturated fatty acids [4]. Although 
more studies would be needed to define the true shape of the dose-response 
curves, the available data fit well in linear relations. The regression coefficients are 
in good agreement with the estimates of 0.03 mmol/L for LDL and - 0.015 mmol/L 
for HDL derived from the study of Mensink [5] and ours (Chapter 2). Fig. 1 shows 
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mmol/L mg/dL 
0.5 
8 10 
% of energy intake as trans-C18:1 
Fig. 1. Effects of monounsaturated trans fatty acids ( f ransd8:1) on lipoprotein 
cholesterol levels relative to oleic acid (c/s-C18:1). Data are derived from 6 dietary 
comparisons between trans monounsaturates and cis unsaturated fatty acids [1-3,5] 
(Chapter 2); differences between diets in fatty acids other than trans and cis 
monounsaturates were adjusted for using regression coefficients from a meta-analysis of 
27 controlled trials [4]. The regression lines were forced through the origin because a zero 
change in intake will produce a zero change in lipoprotein levels. Regression coefficients 
per percent contribution of trans to daily energy are 0.040 mmol/L per en% for LDL 
(R2 = 0.86, P= 0.0028) and -0 .013 mmol/L per en% (R2 = 0.88, />=0.0019) for HDL 
cholesterol. 
that the increase in LDL seen in our study was somewhat smaller than predicted 
by the regression line. However, the predicted value fell within the 95% confidence 
interval of the change in LDL as observed by us, and the difference thus may well 
be due to chance. 
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It has been proposed that HDL cholesterol responses to trans fatty acids may 
be dependent on the dietary dose, with a threshold below which trans 
monounsaturates have no effect [1,3]. However, Fig. 1 suggests that the effect 
on HDL increases with the amount of trans fatty acids consumed. It appears that 
to date there is no evidence for a threshold below which trans fatty acids do not 
affect HDL cholesterol. 
Hydrogénation alternatives 
Grundy [6] suggested that stearic acid, a fatty acid known to be 'neutral' in 
its effects on serum lipids [7-12], might be a favorable alternative to trans fatty 
acids for the hardening of edible fats. We followed this lead by comparing stearic 
acid and trans fatty acids with each other, and with linoleic acid, the fatty acid 
from which stearic and trans fatty acids are formed during hydrogénation. The 
Stearate-diet in our study slightly elevated the HDL to LDL cholesterol and the 
apolipoprotein A-l to B ratios as compared with the Trans-diet (Chapter 2), but the 
differences in HDL and LDL cholesterol levels were small and not statistically 
significant. Thus, our data do not support the idea that substituting stearic acid for 
trans fatty acids yields much health benefits. It is possible, however, that our study 
somewhat underestimated the effect of trans monounsaturates on LDL cholesterol 
(Fig. 1 ), and that the true differences between stearic acid and trans fatty acids are 
larger than observed by us. 
Linoleic acid, like stearic acid, has been reported to equal oleic acid in its 
effects on serum lipids [13-18]. Therefore, we hypothesized that the effects of 
stearic acid would be similar to those of linoleic acid. This was not confirmed by 
the results; stearic acid moderately raised total and LDL cholesterol as compared 
with linoleic acid. The average increase in men plus women was 0.15 mmol/L for 
total cholesterol. This is smaller than the 0.25 mmol/L estimated by the equation 
of Keys [7], but slightly larger than the rise of 0.11 mmol/L predicted for stearic 
versus linoleic acid according to the meta-analysis of Mensink [4]. Unfortunately, 
we did not study oleic acid in our trial, and it is thus impossible to tell whether the 
difference between the Stéarate- and the Linoleate-diet was caused by stearic acid 
being slightly cholesterol-raising or linoleic acid being cholesterol-lowering relative 
to oleic acid. In any event, stearic acid increases total and LDL cholesterol less 
than lauric, myristic, and palmitic acid [7-12]. Furthermore, we observed a small 
HDL cholesterol-lowering effect of stearic acid. Others also reported somewhat 
lower HDL cholesterol levels on stearic acid diets than on diets rich in unsaturated 
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fatty acids [9,19]. The differences in these latter studies were not statistically 
significant, but together with our data they suggest that stearic acid may have 
some HDL cholesterol-depressing effect. 
In summary, this study does not support the idea that complete hydrogénation 
of linoleic acid to stearic acid is much more beneficial for the serum lipid profile 
than partial hydrogénation to trans fatty acids. However, the potential of stearic 
acid as a replacer of trans fatty acids in hard fats needs more investigation. 
Blood pressure 
Monounsaturated trans fatty acids did not affect systolic or diastolic blood 
pressure (Chapter 3). This is consistent with findings from the study by Mensink 
and Katan [20]. Lichtenstein and co-workers [2] also reported no effect of trans 
fatty acids on systolic and diastolic blood pressure. Thus, it seems that trans fatty 
acids from hydrogenated vegetable oil do not influence blood pressure in 
normotensive subjects. 
Lipoprotein(a) 
Two dietary trials from our department show that consumption of trans fatty 
acids may increase the serum Lp(a) concentration relative to saturated or cis 
unsaturated fatty acids (Chapter 4). This finding confirms the study of Nestel and 
co-workers [1 ] , in which a trans fatty acid-rich diet led to elevations in Lp(a) levels 
compared with diets rich in palmitic or oleic acid. Lichtenstein et al. [2] did not 
observe a rise in Lp(a) after consumption of trans fatty acids. However, this lack 
of effect might be explained by the lower dose of trans fatty acids, the relatively 
small number of subjects, and the high variability of Lp(a) levels, resulting in a 
limited power. Hornstra and co-workers [21] showed that replacement of the 
habitual fat in a Dutch diet by palm oil lowered Lp(a) levels in healthy men. These 
findings are in line with the notion that trans fatty acids increase Lp(a), as the 
replacement of habitual fat by palm oil decreased the intake of trans fatty acids by 
more than 50% [4]. 
Additional comments 
Consumption of monounsaturated trans fatty acids results in an unfavorable 
lipoprotein risk profile for CHD by concurrently increasing LDL and decreasing HDL 
cholesterol levels relative to cis unsaturated fatty acids. Moreover, trans fatty acids 
might enhance CHD risk by raising the serum Lp(a) concentration. It should be 
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mentioned that, in addition to partially hydrogenated vegetable oils, partially 
hydrogenated fish oils are an important source of trans fatty acids in Western 
Europe. Such hardened fish oils contain mainly polyunsaturated trans isomers with 
a chain length of 20 or 22 rather than 18 carbon atoms. The metabolic effects of 
hardened fish oils in humans have not been studied in depth, and could possibly 
be different from those of fats rich in monounsaturated trans isomers of oleic acid 
(frc3A7S-C18:1). 
The mechanisms by which trans fatty acids raise LDL and lower HDL 
cholesterol are as yet unclear. A report by Abbey and Nestel [22] suggests that the 
activity of cholesterol ester transfer protein (CETP), an enzyme which transfers 
cholesterol from HDL to lower density lipoproteins, is involved. This explanation is 
supported by measurements of the activity levels of CETP in sera from our study. 
The CETP activities after the stearic acid diet and the linoleic acid diet were 
identical, despite the higher (VLDL + LDL) cholesterol on stearic acid. The trans 
fatty acid diet was accompanied by a mean increase of 18% in CETP activity. The 
rise was seen in 52 out of 55 individuals, one subject showed no change, and two 
showed a decrease (van Toi A, Zock PL, van Gent T, Scheek LM, Katan MB. 
Submitted for publication). 
Epidemiologic studies sustain the concept that trans fatty acid intake 
contributes to CHD risk. In a cross-sectional study of 748 men consumption of 
trans fatty acids was positively related to LDL and inversely related to HDL 
cholesterol [23]. In several case-control studies, patients were found to have higher 
intakes of trans fatty acids than controls [24-26]. The most suggestive evidence 
derives from a prospective study of 85,000 women, in which consumption of trans 
fatty acids from partially hydrogenated vegetable oils was significantly associated 
with CHD risk. 
Although not fully conclusive, the metabolic and epidemiologic data together 
provide considerable evidence that a high intake of trans fatty acids has adverse 
health effects. 
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Specific saturated fatty acids 
Myristic versus palmitic acid 
The trial on specific saturated fatty acids clearly showed that myristic as well 
as palmitic acid are dietary constituents that raise serum total and LDL cholesterol 
levels (chapter 5). Myristic acid was about 1.5 times as cholesterol-raising as 
palmitic acid, due to increases in both LDL and HDL cholesterol on the myristic 
versus the palmitic acid diet. Few studies have investigated the relative effects of 
lauric, myristic, and palmitic acid by direct comparison. In three trials lauric acid 
was exclusively exchanged for palmitic acid [27-29]. These studies, however, did 
not produce a conclusive answer; lauric acid resulted in either lower [27], the same 
[28], or higher [29] cholesterol levels than palmitic acid. Our study is the only trial 
next to that by McGandy and co-workers [30] in which myristic acid was directly 
compared with palmitic acid. McGandy et al. concluded that both myristic and 
palmitic acid raise total cholesterol. They did not find a consistent difference 
between these two saturates [30], possibly because the number of subject was 
small. Other human studies on the relative cholesterol-raising potencies of myristic 
and palmitic acid either applied a meta-analytical approach [4,8], or studied the 
effects of coconut oil, rich in both lauric and myristic acid, versus those of palm 
oil, which is rich in palmitic acid [31-33]. Findings from the meta-analyses suggest 
that myristic acid might be 4 to 6 times more cholesterol-raising than palmitic acid 
[4,8]. This large difference, however, may be partly explained by the type of 
studies included in the regression analyses. Butterfat and coconut oil, the main 
sources of myristic acid, were the primary saturated fats studied, the intake of 
lauric acid (coconut oil) and palmitic acid (butterfat) were thus closely linked with 
that of myristic acid. The high correlations of the various fatty acids could 
compromise the ability of regression analysis to accurately assess the relative 
potencies [34]. 
Palmitic acid from palm oil 
The trials in which palm oil was compared with coconut oil found that palmitic 
acid has a much smaller cholesterol-raising effect than a mixture of lauric and 
myristic acid [31-33], and the authors therefore suggested that palmitic acid might 
be neutral (i.e. equivalent to oleic acid). The reasons for the discrepancy with our 
finding on palmitic acid are not entirely clear, but one explanation may be that the 
dietary control in the other trials was less strict than in our study. Hayes and 
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Khosla [35-37] propose that palmitic acid raises serum cholesterol in 
hypercholesterolemic subject (total cholesterol, >5 .8 mmol/L or 225 mg/dL), 
especially in those with a high cholesterol intake, but not in normocholesterolemic 
subjects. This is not confirmed by our study. The subjects in our trial were 
normocholesterolemic and had an average cholesterol intake; yet their cholesterol 
levels were clearly elevated on the palmitic versus the oleic acid diet. Furthermore, 
the magnitude of the individual responses to palmitic acid were not related to the 
subjects' initial cholesterol levels (Chapter 5). Our findings are in accordance with 
a number of other studies in which palmitic acid from palm oil was shown to 
increase total and LDL cholesterol relative to oleic acid [1,9,13,27,38], Table 1 
summarizes the results of three strictly controlled trials and our study. The 
cholesterol-raising effect of palmitic acid ranges from 0.034 to 0.047 mmol/L per 
percent of energy of palmitic acid substituted for oleic acid. The effect does not 
seem to be dependent on the average cholesterol level of the subjects or the 
amount of cholesterol in the diets. However, the average rise of 0.04 mmol/L per 
percent of energy as palmitic acid is lower than the values of 0.055 to 0.065 
mmol/L for C12-C16 saturates estimated in the meta-analyses of Keys [7], Hegsted 
[8], and Mensink [4]. This difference can be partly explained by myristic acid, and 
perhaps also lauric acid [29], being more cholesterol-raising than palmitic acid. It 
is also possible that the consumption of lauric and myristic acid modifies the effect 
of palmitic acid, and that the combined effect of C12-C16 saturates is larger than 
the sum of the indiviual effects of each fatty acid. Moreover, the amount of dietary 
Table 1. Cholesterol intake, average serum total cholesterol level, and the proportional 
change in total cholesterol on strictly controlled diets in which palmitic acid from palm oil 
was iso-energetically substituted for oleic acid. 
Study 
Mattson [13] 
Bonanome [9] 
Denke [27] 
Zock (Chapter 5) 
Cholesterol intake 
very lowa 
<100 mg/day 
very low3 
350 mg/day 
Average cholesterol 
level during the trial 
(mmol/L) 
5.28 
4.79 
4.85 
4.89 
Change 
energy 
in cholesterol per 
% of palmitic acid 
(mmol/L) 
0.046 
0.034 
0.047 
0.043 
a
 Actual cholesterol intake was not reported, but vegetable oils (containing no cholesterol) were the sole fat 
sources in the experimental diets. 
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cholesterol in some of the studies included in the early meta-analyses [7,8] was 
much higher than in the studies in Table 1. A very high cholesterol intake might 
enhance the rise in serum cholesterol induced by saturated fatty acids [35]. It has 
also been claimed - b u t not p roven - that minor constituents in palm oil could 
have effects on cholesterol metabolism in humans [39]. 
Whatever the possible modulating effects, a diet rich in palmitic acid as present 
in palm oil obviously has a cholesterol-raising potential. It is possible, however, that 
the background composition of the diet modulates the magnitude of the effect of 
palmitic acid. 
In conclusion, myristic acid produces a higher cholesterol level than palmitic 
acid. However, the difference is caused by rises in both LDL and HDL cholesterol, 
resulting in similar unfavorable HDL to LDL cholesterol ratios on either saturate. Our 
study indicates that palmitic should remain classified as a cholesterol-raising fatty 
acids. Most epidemiologic studies have not reported the consumption of specific 
saturated fatty acids, and it is thus very difficult to estimate their individual impact 
on CHD risk. More specific intake data would be needed to further investigate this 
point. The available studies indicate the lauric, myristic, and palmitic acid each 
raise total and LDL cholesterol levels. Therefore, it seems prudent to consider a 
high intake of these three fatty acids as an important CHD risk factor. 
Chain length or number of double bonds? 
The common cholesterol-raising fatty acids in the human diet are saturated and 
differ in chain length from 12 to 16 carbon atoms, whereas the predominant 
'neutral' or cholesterol-lowering fatty acids have one or two double bonds and are 
18 carbons in length. A pertinent question is whether the distinctive effects of 
these two classes of fatty acids are primarily due to their differences in chain 
length or to the presence or absence of double bonds. This question is difficult to 
answer because the precise mechanisms by which the molecular structure of fatty 
acids influence cholesterol metabolism are still unknown [40]. Our and other 
studies on 12, 14, and 16 carbon fatty acids indicate that the chain length 
modulates their cholesterol-raising effect. Saturated stearic acid (18 carbon atoms) 
raises serum cholesterol much less than the shorter C12-C16 saturates, which also 
suggests that length is important. Yet, the presence of one or more double bonds 
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also seems to have some metabolic effect, as the 18 carbon stearic, oleic, and 
linoleic acids differ slightly in their effects on lipoprotein cholesterol levels 
[4,7,8](Chapter 2). Recently, Nestel and co-workers [38] directly addressed the 
issue of chain length vs. double bonds. They compared the effects of palmitoleic 
acid, a 16 carbon fatty acid with one double bond (c/s-C16:1n-7), with those of 
palmitic (C16:0) and of oleic acid (c/s-C18:1n-9). Nestel et al. hypothesized that 
palmitoleic acid would be as effective as oleic acid in lowering cholesterol, because 
they expected palmitoleic acid to be elongated to oleic acid in the body. However, 
it was found that palmitoleic acid produced the same total and lipoprotein 
cholesterol levels as palmitic acid, and that both 16 carbon fatty acids raised total 
and LDL cholesterol relative to oleic acid [38]. 
Thus, it appears that chain length is more important than the double bond in 
determining the effects of a fatty acid on cholesterol metabolism. However, the 
modest relative effects of 18 carbon acids with different numbers of double bonds 
remain to be explained. 
Positional distribution of fatty acids 
Fasting serum lipid and lipoprotein cholesterol levels 
Our study on triglyceride configuration suggests that the position of fatty 
acids, specifically palmitic and oleic acid, on the glycerol backbone does not 
influence its effect on fasting serum lipid and lipoprotein levels (Chapter 6). In the 
field of lipid research, possible effects of differences in triglyceride configuration 
have received much less attention than the overall fatty acid composition of dietary 
fats. No other study has directly examined the influence of the positional 
distribution of fatty acids on fasting serum lipids in humans, and thus it is difficult 
compare our findings with those of others. Nevertheless, Zampelas and co-workers 
[41] recently examined the effects on postprandial lipids of the same two dietary 
fats as in our study. They found no differences in lipids and lipoproteins over the 
6 h following their liquid test meals [41]. A tentative conclusion from this and our 
study is that the differences between dietary fats in the positional distribution of 
their component fatty acids have no important consequences for CHD risk. 
However, our findings need to be confirmed by future studies and, in addition, 
positional effects of fatty acids other than palmitic acid should be investigated. 
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Fatty acid composition and configuration of plasma lipids 
The data on the fatty acid composition and configuration of blood lipids 
showed that the position of a fatty acid is partly retained in fasting plasma 
triglycerides and cholesteryl esters. Although small, these effects were distinct and 
statistically significant. 
It is unlikely that the partial conservation of the sn-2 position of dietary 
triglycerides in fasting plasma lipids has any substantial health effect. Yet, our 
study shows that the positional distribution of dietary fatty acids has effects that 
persist beyond fat absorption and clearance. This finding could not be predicted by 
the current knowledge about the pathways of fat metabolism. Several speculations 
about the possible mechanisms can be made. The most plausible explanation for 
retention of the dietary sn-2 position in fasting plasma triglycerides seems the 
following: the chylomicron triglycerides, which enter the blood stream after a meal, 
contain fatty acids on the original dietary sn-2 position. These triglycerides can be 
transferred to higher density lipoproteins and in this way escape postprandial 
lipolysis, resulting in fasting lipoproteins that still contain triglycerides with fatty 
acids in the initial sn-2 position. The enrichment of cholesteryl esters in fatty acids 
from the sn-2 position of dietary fat could be explained by formation of 
phospholipids in the intestinal wall from absorbed 2-monoglycerides and 
subsequent transfer of the sn-2 fatty acids to cholesteryl esters by 
lecithin:cholesterol acyl transferase in plasma. 
Effects of dietary fat on other risk factors for CHD 
Dietary recommendations are not based exclusively on the effects of diet on 
serum lipoprotein and blood pressure levels. Fatty acids may also exert other 
effects that modulate CHD risk. One aspect is the proneness of LDL particles to 
oxidative modification [42]. According to this plausible, although not yet proven 
theory, LDL particles damage the arterial wall once they have become modified by 
certain oxidative agents [43]. Several studies have shown that fatty acids [44-46] 
and other food components [47-49] influence the in vitro susceptibility of LDL to 
oxidative modification. However, the possible role of oxidative damage to LDL does 
by no means discard the importance of the level of circulating LDL cholesterol for 
CHD risk. Another risk factor for CHD that appears to be influenced by dietary fat 
is the blood coagulation tendency and fibrinolysis. Several epidemiologic studies 
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suggest that certain parameters of hemostasis are independent risk factors [50-52], 
and both epidemiologic [53-55] and experimental data [56-59] indicate that these 
parameters might be modified by diet. 
The possible influence of dietary fat on risk factors other than serum 
lipoproteins or blood pressure should be taken into account when evaluating the 
effect of diet on the risk for CHD. 
METHODOLOGY OF THE STUDIES 
The effects of dietary fatty acids on risk factors for CHD were studied by 
means of controlled trials in which we supplied specific diets to healthy volunteers. 
The purpose of this section is to briefly discuss some aspects of the methods used, 
and to indicate the potentials and limitations of extrapolating our findings to public 
health practice. 
Duration 
The subjects in our studies consumed each experimental diet for three weeks. 
The choice of this period is based on experience from trials with longer duration, 
which indicates that lipid and lipoprotein levels stabilize within two weeks after a 
dietary change [7,60-62]. Some studies have suggested that the effects of dietary 
fat on certain serum lipid levels, specifically triglyceride and HDL cholesterol levels, 
might be transient [63-65]. However, others have shown that changes in 
triglyceride and HDL cholesterol after modifying dietary fat are sustained for 
periods of several months [61,66,67] up till one year [68]. These data are 
consistent with epidemiologic observations of free-living subjects who have been 
eating their customary diets for a very long period [69,70]. Moreover, it has never 
been reported that diet-induced changes in total and LDL cholesterol levels might 
be temporary. Thus, the 3-week periods in our trials seem long enough to study 
the relation between fatty acid consumption and serum lipids and lipoproteins in 
the general population. 
We can not rule out the possibility that the dietary periods were too short to 
induce a change in blood pressure, although some studies show that blood 
pressure levels stabilize within 3 weeks after a dietary change [71,72]. Also, we 
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are not sure whether the observed changes in Lp(a) (Chapter 4) were transient or, 
alternatively, underestimated and not yet at their maximum after three weeks. 
Another consequence of the short-term character of our studies is that we can not 
prove whether the dietary changes will indeed modify CHD risk. To this end long-
term intervention studies are needed. Nevertheless, the axiom that lowering the 
LDL cholesterol level - a n endpoint in our s tud ies- reduces CHD risk seems 
legitimate (see Chapter 1). 
Design 
The three studies described in this thesis applied a cross-over design to 
compare the effects of various fatty acids. The feature that distinguishes the cross-
over trial from other trials is that measurements on different treatments - i n our 
case d i e t s - are obtained from each subject. The main advantage is that the diets 
are compared 'wi thin ' subjects, and any variation due to differences between the 
subjects is removed from the comparison. Since the statistical tests of differences 
between diets are based on within-subject variation only, a cross-over design 
provides a much higher power to detect true differences than, for example, a 
parallel design. Another advantage is that differences in measurements between 
periods, for example due to systematic drift of variables over time, are eliminated 
by supplying the diets in different order [73]. If the order of the diets is completely 
balanced, as was the case in our studies, then period effects can not bias the 
comparisons of the diets [74]. A potential disadvantage of a cross-over design is 
the possibility that the effect of a diet given in one period might still be present at 
the end of the following period. This 'carry-over' effect could attenuate the 
estimates of the differences between diets. However, as argued on the previous 
page, it is reasonable to assume that lipid and lipoprotein levels reach a steady 
state within two weeks after a dietary change. Thus it is unlikely that carry-over 
effects biased our findings on total, LDL, and HDL cholesterol. Possible carry-over 
effects on the measurements of Lp(a) and blood pressure levels can not be totally 
excluded. Nevertheless, the absence of significant diet-by-period interactions in 
either of the studies indicates that there were no large carry-over effects [74]. At 
the most, small carry-over effects, if any, could have biased the estimated 
differences in blood pressure and Lp(a) levels to the null hypothesis, i.e. an 
underestimation of the true population effect. 
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Diets 
The study diets consisted of conventional foodstuffs, such as bread, meat, 
vegetables, fruits, dairy products, cookies, etcetera. The differences in fatty acid 
composition between the diets were achieved by using specially designed and 
manufactured margarines. The tailored compositions of these margarines enabled 
us to compose diets in which the fatty acids under study were iso-energetically 
exchanged, while all other nutrients and food components were kept constant. 
Thus, the changes observed between the diets were due to the differences in fatty 
acid composition only, without confounding effects of other food components. 
The supply of a variety of foodstuffs resulted in experimental diets which 
resembled every-day food intake in the normal population. The overall nutrient 
composition came close to that of an average Dutch diet [75]. Some investigators 
applied liquid formula diets to study the influence of fatty acids on serum 
lipoproteins, e.g. [9,13,27]. The advantage of using conventional solid food diets 
rather than liquid formula diets is that effects of fatty acids are studied in the 
context of a more realistic food intake, and that any possible artefact due to the 
use of liquid formula diets is eliminated [76,77]. It must be noted, however, that 
the absolute amount of fat in our diets was quite high (37% to 4 0 % of energy 
intake). We do not know for certain whether the magnitude of the observed dietary 
effects would be different at lower levels of fat intake. 
Body weight influences serum lipid and lipoprotein levels [78,79]. Therefore, 
it was important to keep our subjects at stable weights during the trials. The study 
diets were formulated at different levels of energy intake, so that each subject 
received the amount of food that met his or her energy needs. The subjects' 
weights were closely monitored and the level of energy intake was adjusted when 
necessary. We succeeded in keeping body weights constant, thus weight changes 
could not have affected the results. 
Subjects 
Characteristics of the volunteers 
Our subjects were on average young, lean, healthy men and women with 
normal serum lipid and blood pressure levels. It is reasonable to assume that our 
findings will apply to similar people in the general population. However, one must 
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be cautious in extrapolating our results to other population groups, such as people 
with high lipoprotein levels, overweight, hypertension, or the elderly. For example, 
it has been proposed that a persons cholesterol response to a change in saturated 
fat intake depends on his or her initial cholesterol level [35]. We could not support 
this view. Our subjects' starting cholesterol levels, which ranged from 3 to 6.5 
mmol/L, were not related to cholesterol responses in either of the trials. However, 
our results do not tell whether diet responsiveness of people with moderate to 
severe hyperlipidemia is different from that of normolipidemic subjects. Possibly, 
cholesterol levels of hyperlipidemic subjects are more sensitive to dietary change 
[80-82]. A high body weight has also been associated with a diminished response 
of lipid levels to dietary changes [65,82-84]. Furthermore, some studies suggest 
that older subjects are more diet responsive than younger ones [82,85]. 
Gender differences 
Women are often considered to be less suitable subjects for studying dietary 
effects on serum lipoproteins because of supposed confounding effects of 
menstrual cycle [86,87] or the use of oral contraceptives [88]. As argued in 
Chapter 2 and 5, the design of our studies excluded possible bias due to cyclic 
effects. Thus, the differences in serum lipoproteins observed between the dietary 
treatment were not confounded by hormonal variations. 
It has been questioned whether women and men have similar responses to 
changes in dietary fat [89,90]. Specifically, some studies indicate that the HDL 
cholesterol levels of women are less sensitive to dietary modification than those 
of men [14,62]. However, other studies suggest the opposite [82,85]. In our three 
trials we did not find any substantial gender-specific effect of diet on HDL. We 
therefore think that HDL cholesterol levels of men and women respond similarly to 
changes in dietary fatty acid composition. If anything, the responses of total and 
LDL cholesterol on saturated fat tended to be somewhat larger for the men than 
for the women, although this difference was statistically significant only for the 
changes on stearic versus linoleic acid (Chapter 2). In a number of other trials both 
sexes were equally responsive to saturated fat [3,5,32,91,92]. 
The precise gender differences in diet responsiveness remain unclear. In any 
case, women as well as men show a considerable decrease in the total and LDL 
cholesterol level when saturated fat intake is diminished (Chapter 5). At present, 
there seems to be no need for different dietary treatments of men and women with 
hypercholesterolemia. 
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Compliance 
When dietary effects are investigated in human volunteers, it is of obvious 
importance that the subjects adhere to the study diets. On weekdays during the 
trials, hot meals were served at the department and eaten under our supervision. 
Other foods as well as foods for the weekends were supplied as a package and 
consumed at home. The following actions were taken to maximize dietary 
compliance in this relatively 'free-living' situation. First of all, the recruitment was 
aimed at selecting volunteers who were well aware of the restraints of participating 
in a diet study and who were motivated to adhere to the protocol. No payment 
was offered to ensure that subjects did not participate for personal financial gain. 
One-hundred-seventy-fiveof the 178 participants completed the trials successfully. 
This illustrates that we succeeded in recruiting highly motivated subjects. Also, the 
daily visits to the department ensured frequent contact between the volunteers and 
the dietary staff. Consultancy hours offered ample opportunity to privately discuss 
difficulties with the protocol and to receive personal advice if needed. Subjects 
were encouraged to talk about problems related to the diets, and the importance 
of reporting any deviation was carefully explained. We told the participants to 
contact us whenever they faced problems or were not sure about the protocol. The 
investigators could always be reached, including the evenings and the weekends. 
Probably the most effective way to improve dietary compliance is to provide the 
subjects with high quality foods. Our dietary staff made large efforts to present a 
high variety in the menus and to prepare palatable foods. A large number of 
volunteers indicated that they appreciated the foods and diversity of the diet. 
In order to obtain an estimate of the actual degree of compliance, subjects 
were not only asked to record deviations from the protocol in their diaries, but also 
in anonymous questionnaires which were handed out at the end of the studies 
(Chapter 5 and 6). The anonymously reported deviations were in accordance with 
those recorded in the diaries. Consumption of foods outside the dietary protocol 
was very low. For example, it provided at most 0.2 grams of fat per day in the trial 
on triglyceride configuration (Chapter 6). In the studies on trans fatty acids 
(Chapter 2) and specific saturates (Chapter 5) we also measured the fatty acid 
compositions of serum cholesteryl esters as indicators of compliance. Individual 
changes in cholesteryl ester fatty acids consistently followed the differences in 
fatty acid composition between the diets. These quantative data confirmed that 
dietary adherence was very high. 
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CONCLUSIONS 
Monunsaturated trans fatty acids 
Trans fatty acids as present in hydrogenated vegetable oils produce an 
unfavorable lipoprotein risk profile for CHD by raising LDL and lowering HDL 
cholesterol. Use of stearic acid to produce semi-solid and solid fats does not seem 
to offer much health benefit over trans fatty acids, but more study on this point 
is needed. Monounsaturated trans fatty acids have no substantial effects on blood 
pressure, but they may increase CHD risk by raising serum Lp(a). It should be kept 
in mind that the consumption of trans fatty acids is low compared with that of 
saturates, and that the reduction of saturated fat and cholesterol intake remains 
a primary goal in the dietary prevention of CHD. 
Specific saturated fatty acids 
Myristic acid is about 1.5 times more cholesterol-raising than palmitic acid. 
This difference is due to LDL as well as HDL cholesterol, and as a consequence 
myristic and palmitic acid result in similar unfavorable HDL to LDL cholesterol 
ratios. Both saturated fatty acids strongly raise total and LDL cholesterol. Since 
palmitic acid is the most abundant saturate in our diet, it can be regarded as the 
principle cholesterol-raising fatty acid. 
Positional distribution of fatty acids 
Changing the position of palmitic acid on the glycerol molecule does not 
materially affect fasting serum lipid and lipoprotein levels. However, differences in 
the positional distribution do have small but consistent effects on the fatty acid 
configuration and composition of fasting plasma triglycerides and cholesteryl 
esters. Nevertheless, at present there is no solid evidence that the 'structuring' of 
dietary triglycerides has important health consequences. 
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General conclusion and implication 
The studies in this thesis show that the cis or trans configuration of double 
bonds modulates the effect of dietary fatty acids on serum lipoproteins. Chain 
length modifies the cholesterol-raising properties of saturated fatty acids, but the 
differences are not as large as has been suggested. The positional distribution of 
fatty acids over the triglyceride molecule is probably not an important determinant 
of serum lipid levels. 
We conclude that consumption of monounsaturated trans fatty acids and the 
saturates myristic and palmitic acid has adverse effects on the serum lipoprotein 
risk profile for CHD. Dietary therapy and public health measures to lower total and 
LDL cholesterol levels should aim at reducing the intake of both trans and saturated 
fatty acids. In practical terms, people at increased risk for CHD should replace the 
hard fats in their diets by carbohydrates or unsaturated oils. 
172 
General Discussion 
REFERENCES 
1. Nestel P, Noakes M, Belling B, et al. Plasma lipoprotein lipid and Lp(a) changes w i th 
subst i tut ion of elaidic acid for oleic acid in the diet. J Lipid Res 1992 ; 33 : 1029 -1036 . 
2. Lichtenstein A H , Ausman LM, Carrasco W, Jenner JL, Ordovas J M , Schaefer EJ. 
Hydrogénation impairs the hypolipidemic effect of corn oil in humans. Hydrogénation, trans 
fa t ty acids, and plasma lipids. Arterioscler Thromb 1993 ; 13: 1 5 4 - 1 6 1 . 
3. Judd JT, Clevidence A, Muesing RA, Wittes J , Sunkin ME, Podczasy J J . Dietary trans fat ty 
acids: effects on plasma lipids and lipoproteins of healthy men and women . Am J Clin Nutr 
1994 ; 59 : 861 -868 . 
4 . Mensink RP, Katan MB. Effect of dietary fat ty acids on serum lipids and l ipoproteins: a 
meta-analysis of 27 trials. Arterioscler Thromb 1992 ; 12: 911 -919 . 
5. Mensink RP, Katan MB. Effect of dietary trans fat ty acids on high-density and low-densi ty 
l ipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990 ; 323 : 439 -445 . 
6. Grundy S M . Trans monounsaturated fat ty acids and serum cholesterol levels. N Engl J Med 
1990 ; 323 : 4 8 0 - 4 8 1 . 
7. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. IV. 
Particular saturated fat ty acids in the diet. Metabolism 1965; 14: 776 -787 . 
8. Hegsted D M , McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum 
cholesterol in man. Am J Clin Nutr 1965 ; 17: 281-295 . 
9. Bonanome A , Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein 
levels. NEnglJMed 1988 ; 318 : 1244-1248 . 
10. Denke MA, Grundy SM. Effects of fats high in stearic acid on lipid and l ipoprotein 
concentrat ions in men. Am J Clin Nutr 1 9 9 1 ; 54 : 1036-1040 . 
1 1 . Kris-Etherton PM, Derr J , Mitchell DC, et al. The role of fat ty acid saturation on plasma lipids, 
l ipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oi l , 
soybean oi l , dairy butter, and milk chocolate on the plasma lipids of young men. Metabolism 
1993 ; 4 2 : 121-129. 
12. Derr J , Kris-Etherton PM, Pearson TA, Seligson FH. The role of fat ty acid saturation on plasma 
lipids, l ipoproteins, and apolipoproteins: II. The plasma total and low-density l ipoprotein 
cholesterol response of individual fat ty acids. Metabolism 1993 ; 4 2 : 130-134. 
13. Mat tson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and 
polyunsaturated fa t ty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985 ; 2 6 : 
194 -202 . 
14. Mensink RP, Katan MB. Effect of a diet enriched w i th monounsaturated or polyunsaturated 
fat ty acids on levels of low-density and high-density l ipoprotein cholesterol in healthy women 
and men. N Engl J Med 1989 ; 3 2 1 : 4 3 6 - 4 4 1 . 
15. Wardlaw G M , Snook JT, Lin M-C, Puangco MA, Sook Kwon J . Serum lipid and apolipoprotein 
concentrat ions in healthy men on diets enriched in either canola oil or saff lower oi l . Am J Clin 
Nutr 1 9 9 1 ; 54 : 104-110. 
16. Valsta LM, Jauhiainen M, Aro A , Katan MB, Mutanen M. Effects of monounsaturated rapeseed 
oil and a polyunsaturated sunflower oil diet on lipoprotein levels in humans. Arterioscler 
Thromb 1992 ; 12: 50-57 . 
17. Lichtenstein A H , Ausman LM, Carrasco W, et al. Effects of canola, corn, and olive oils on 
fasting and postprandial plasma lipoproteins in humans as part of a national cholesterol 
education step 2 diet. Arterioscler Thromb 1993 ; 13: 1533 -1542 . 
173 
Chapter 8 
18. Nydahl MC, Gustafsson l-B, Vessby B. Lipid-lowering diets enriched with monounsaturated or 
polyunsaturated fatty acids but low in saturated fatty acids have similar effects on serum lipid 
concentrations in hyperlipidemic patients. Am J Clin Nutr 1994; 59: 115-122. 
19. Becker N, lllingworth DR, Alaupovic P, Connor WE, Sundberg EE. Effects of saturated, 
monounsaturated, and omega-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and 
apoproteins in humans. Am J Clin Nutr 1983; 37: 355-360. 
20. Mensink RP, de Louw MHJ, Katan MB. Effects of dietary trans fatty acids on blood pressure 
in normotensive subjects. Eur J Clin Nutr 1991; 45: 375-382. 
21 . Hornstra G, van Houwelingen AC, Kester ADM, Sundram K. A palm oil-enriched diet lowers 
serum lipoprotein(a) in normocholesterolemic volunteers. Atherosclerosis 1991; 90: 91-93. 
22. Abbey M, Nestel PJ. Plasma cholesteryl ester transfer protein activity is increased when 
rrens-elaidic acid is substituted for c/s-oleic acid in the diet. Atherosclerosis 1994; 106: 
99-107. 
23. Troisi R, Willett WC, Weiss ST. Trans-fatty acid intake in relation to serum lipid concentrations 
in adult men. Am J Clin Nutr 1992; 56: 1019-1024. 
24. Tzonou A, Kalandidi A, Trichopoulou A, et al. Diet and coronary heart disease: a case-control 
study in Athens, Greece. Epidemiology 1993; 4: 511-516. 
25. Siguel EN, Lerman RH. Trans-fatty acid patterns in patients with angiographically documented 
coronary artery disease. Am J Cardiol 1993; 71 : 916-920. 
26. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC. Trans-fatty acids 
intake and risk of myocardial infarction. Circulation 1994; 89: 94-101. 
27. Denke MA, Grundy SM. Comparison of effects of lauric acid and palmitic acid on plasma lipids 
and lipoproteins. Am J Clin Nutr 1992; 56: 895-898. 
28. Dougherty RM, lacono JM. Dietary lauric acid has similar effects on blood cholesterol as 
palmitic acid in natural diets in man. FASEB J 1992; 6: A1680. 
29. Temme EHM, Mensink RP, Hornstra G. Effecten van laurinezuur en palmitinezuur op 
serumlipiden. Voeding 1994; 55: 32. 
30. McGandy RB, Hegsted DM, Myers ML. Use of semisynthetic fats in determining effects of 
specific dietary fatty acids on serum lipids in man. Am J Clin Nutr 1970; 23: 1288-1298. 
31 . Ng TKW, Hassan K, Lim JB, Lye MS, Ishak R. Nonhypercholesterolemic effects of a palm-oil 
diet in Malaysian volunteers. Am J Clin Nutr 1991; 53: 1015S-1020S. 
32. Ng TKW, Hayes KC, DeWitt GF, et al. Dietary palmitic and oleic acids exert similar effects on 
serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. J Am Coll 
Nutr 1992; 11: 383-390. 
33. Sundram K, Hayes KC, Siru OH. Dietary palmitic acid results in lower serum cholesterol than 
does a lauric-myristic acid combination in normolipemic humans. Am J Clin Nutr 1994; 59: 
841-846. 
34. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariabie 
methods. 2nd ed. Boston: PWS-KENT Publishing Company, 1987: 1-718. 
35. Hayes KC, Khosla P. Dietary fatty acid thresholds and cholesterolemia. FASEB J 1992; 6: 
2600-2607. 
36. Khosla P, Hayes KC. Comparison between the effects of dietary saturated (16:0), 
monounsaturated (18:1), and polyunsaturated (18:2) fatty acids on plasma lipoprotein 
metabolism in cebus and rhesus monkeys fed cholesterol-free diets. Am J Clin Nutr 1992; 55: 
51-62. 
37. Khosla P, Hayes KC. Dietary palmitic acid raises plasma LDL cholesterol relative to oleic acid 
only at a high intake of cholesterol. Biochim Biophys Acta 1994; 
174 
General Discussion 
38. Nestel P, Clifton P, Noakes M. Effects of increasing dietary palmitoleic acid compared with 
palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 1994; 35: 
656-662. 
39. Elson CE. Tropical oils: nutritional and scientific issues. Critical Rev Food Sei Nutr 1992; 31: 
79-102. 
40. Spady DK, Woollett LA, Dietschy JM. Regulation of plasma LDL-cholesterol levels by dietary 
cholesterol and fatty acids. Annu Rev Nutr 1993; 13: 355-381. 
4 1 . Zampelas A, Williams CM, Morgan LM, Wright J, Quinlan PT. The effect of triacylglycerol fatty 
acid positional distribution on postprandial plasma metabolite and hormone responses in normal 
adult men. Br J Nutr 1994; 71 : 401-410. 
42. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. 
Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 
320: 915-924. 
43. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 
801-809. 
44. Reaven P, Parthasarathy S, Grasse BJ, et al. Feasibility of using an oleate-rich diet to reduce 
the suspectibility of low-density lipoprotein to oxidative modification in humans. Am J Clin 
Nutr 1991; 54: 701-706. 
45. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich 
and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification 
in mildly hypercholesterolemic subjects. J Clin Invest 1993; 9 1 : 668-676. 
46. Bonanome A, Pagnan A, Biffanti S, et al. Effect of dietary monounsaturated and 
polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to 
oxidative modification. Arterioscler Thromb 1992; 12: 529-533. 
47. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative 
modification of low density lipoprotein. J Lipid Res 1992; 33: 899-906. 
48. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant 
combinations in humans. Protection of LDL by vitamin E but not by /ff-carotene. Arterioscler 
Thromb 1993; 13: 590-600. 
49. Rifici VA, Khachadurian AK. Dietary supplementation with vitamins C and E inhibits in vitro 
oxidation of lipoproteins. J Am Coll Nutr 1993; 12: 631-637. 
50. Renaud S, Morazain R, Godsey F, et al. Nutrients, platelet function and composition in nine 
groups of French and British farmers. Atherosclerosis 1986; 60: 37-48. 
51 . Meade TW. Thrombosis and cardiovascular disease. Ann Epidemiol 1992; 2: 353-364. 
52. Heinrich J, Schulte H, Balleisen L, Assmann G, van de Loo J. Predictive value of haemostatic 
variables in the PROCAM-study. Thromb Haemost 1991; 65: 815-816.(abstract) 
53. Renaud S, Godsey F, Dumont E, Thevenon C, Ortchanian E, Martin JL. Influence of long-term 
diet modification on platelet function and composition in Moselle farmers. Am J Clin Nutr 
1986; 43: 136-150. 
54. Renaud S, Dumont E, Baudier F, Ortchanian E, Symington IS. Effect of smoking and dietary 
saturated fats on platelet functions in Scottish farmers. Cardiovascular Res 1985; 19: 
155-159. 
55. Miller GJ. Environmental influences on hemostasis and thrombosis. Diet and smoking. Ann 
Epidemiol 1992; 2: 387-391. 
56. Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid 
composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 
227-233. 
57. Salomaa V, Rasi V, Pekkanen J, et al. The effects of saturated fat and n-6 polyunsaturated 
fat on postprandial lipemia and hemostatic activity. Atherosclerosis 1993; 103: 1-11. 
175 
Chapter 8 
58. Freese R, Mutanen M, Valsta LM, Salminen I. Comparison of the effects of two diets rich in 
monounsaturated fatty acids differing in their linoleic/c-linolenic acid ratio on platelet 
aggregation. Thromb Haemost 1994; 7 1 : 73-77. 
59. Marckmann P, Sandström B, Jespersen J. Low-fat, high-fiber diet favorably affects several 
independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, 
and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-939. 
60. Connor WE, Hodges RE, Bleier RE. The serum lipids in men receiving high cholesterol and 
cholesterol-free diets. J Clin Invest 1961; 40: 894-900. 
6 1 . Brussaard JH, Katan MB, de Groot PHE, Havekes LM, Hautvast JGAJ. Serum lipoproteins of 
healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. 
Atherosclerosis 1982; 42: 205-219. 
62. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates 
on high-density lipoproteins in healthy men and women. Lancet 1987; i: 122-125. 
63. Antonis A, Bersohn I. The influence of diet on serum-triglycerides in South African White and 
Bantu prisoners. Lancet 1961; i: 3-9. 
64. Berry EM, Eisenberg S, Friedlander Y, et al. Effects of diets rich in monounsaturated fatty 
acids on plasma lipoproteins - the Jerusalem Nutrition Study. II. Monounsaturated fatty acids 
vs carbohydrates. Am J Clin Nutr 1992; 56: 394-403. 
65. Cole TG, Bowen PE, Schmeisser D, et al. Differential reduction of plasma cholesterol by the 
American Heart Association Phase 3 diet in moderately hypercholesterolemic, premenopausal 
women with different body mass indexes. Am J Clin Nutr 1992; 55: 385-394. 
66. Clevidence BA, Judd JT, Schatzkin A, et al. Plasma lipid and lipoprotein concentrations of men 
consuming a low-fat, high-fiber diet. Am J Clin Nutr 1992; 55: 689-694. 
67. Sandström B, Marckmann P, Bindslev N. An eight-month controlled study of a low-fat 
high-fibre diet: effects on blood lipids and blood pressure in healthy young subjects. Eur J Clin 
Invest 1992; 46: 95-109. 
68. Brunner D, Weissbort J, Fischer M, et al. Serum lipid response to a high-caloric, high-fat diet 
in agricultural workers during 12 months. Am J Clin Nutr 1979; 32: 1342-1349. 
69. Knuiman JT, West CE, Katan MB, Hautvast JGAJ. Total cholesterol and high density 
lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. 
Arteriosclerosis 1987; 7: 612-619. 
70. West CE, Sullivan DR, Katan MB, Halferkamps IL, van der Torre HW. Boys from populations 
with high-carbohydrate intake have higher fasting triglyceride levels than boys from 
populations with high-fat intake. Am J Epidemiol 1990; 131: 271-282. 
71 . lacono JM, Judd JT, Marshall MW, et al. The role of dietary essential fatty acids and 
prostaglandins in reducing blood pressure. Prog Lipid Res 1981; 20: 349-364. 
72. lacono JM, Puska P, Dougherty RM, et al. Effect of dietary fat on blood pressure in a rural 
Finnish population. Am J Clin Nutr 1983; 38: 860-869. 
73. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, Iowa: The Iowa State 
University Press, 1980: 1-507. 
74. Jones B, Kenward MG. Monographs on statistics and applied probability. Vol 34. Design and 
analysis of cross-over trials. London, UK: Chapman and Hall, 1989: 25-37. 
75. Ministerie van WVC , Ministerie van LNV . Zo eet Nederland, 1992. Resulaten van de 
Voedselconsumptiepeiling. Den Haag: Voorlichtingsbureau voor de Voeding, 1993: 1-196. 
76. Hayes KC. Fatty acids and liquid-formula diets in cholesterol studies. Am J Clin Nutr 1993; 
57: 231. 
77. Hegsted DM, Nicolosi RJ. Do formula diets attenuate the serum cholesterol response to dietary 
fats? J Vas Med Biol 1990; 2: 68-73. 
176 
General Discussion 
78. Kromhout D. Body weight, diet, and serum cholesterol in 871 middle-aged men during 10 
years of follow-up (the Zutphen Study). Am J Clin Nutr 1983; 38: 591-598. 
79. Leenen R, van der Kooy K, Meyboom S, Seidell JC, Deurenberg P, Weststrate JA. Relative 
effects of weight loss and dietary fat modification on serum lipid levels in the dietary 
treatment of obesity. J Lipid Res 1993; 34: 2183-2191. 
80. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. III. 
Differences among individuals. Metabolism 1965; 14: 765-775. 
8 1 . Denke MA, Frantz ID. Response to a hypercholesterol-lowering diet: efficacy is greater in 
hypercholesterolemic subjects even after adjustment for regression to the mean. Am J Med 
1993; 94: 626-631. 
82. Clifton PM, Nestel PJ. Influence of gender, body mass index, and age on response of plasma 
lipids to dietary fat plus cholesterol. Arterioscler Thromb 1992; 12: 955-962. 
83. Katan MB, Beynen AC. Characteristics of human hypo- and hyperresponders to dietary 
cholesterol. Am J Epidemiol 1987; 125: 387-399. 
84. Goff DC,Jr., Shekelle RB, Moye LA, Katan MB, Gotto AM,Jr., Stamler J. Does body fatness 
modify the effect of dietary cholesterol on serum cholesterol? Results from the Chicago 
western electric study. Am J Epidemiol 1993; 137: 171-177. 
85. Cobb MM, Teitelbaum H. Determinants of plasma cholesterol responsiveness to diet. Br J Nutr 
1994; 71: 271-282. 
86. Barclay M, Barclay RK, Skipski VP, et al. Fluctuations in human serum lipoproteins during the 
normal menstrual cycle. Biochem J 1965; 96: 205-209. 
87. Kim H-J, Kalkhoff RK. Changes in lipoprotein composition during the menstrual cycle. 
Metabolism 1979; 28: 663-668. 
88. Demacker PNM, Schade RWB, Stalenhoef AFH, Stuyt PMJ, van't Laar A. Influence of 
contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol 
concentrations. Br Med J 1982; 284: 1213-1215. 
89. Crouse JR,III. Gender, lipoproteins, diet, and cardiovascular risk. Sauce for the goose may not 
be sauce for the gander. Lancet 1989; i: 318-320. 
90. Mensink RP, Katan MB. Dietary fat guidelines for men and women. Lancet 1989; i: 790-791. 
9 1 . Anderson JW. Diet, lipids and cardiovascular disease in women. J Am Coll Nutr 1993; 12: 
433-437. 
92. Hunninghake DB, Stein EA, Dujovne CA, et al. The efficacy of intensive dietary therapy alone 
or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993; 
328: 1213-1219. 
177 
Summary 
Elevated levels of total or LDL cholesterol, lipoprotein(a) and blood pressure, 
and low levels of HDL cholesterol are known to increase the risk for coronary heart 
disease (Chapter 1). Differences in the chain length and the number and geometry 
of the double bonds in dietary fatty acids may affect these risk factors. Thus, 
coronary heart disease risk might be altered by modifying the amount and type of 
fat in the human diet. 
The aim of the studies described in this thesis was to investigate the effects 
of dietary fatty acids on risk factors for coronary heart disease. In each of three 
trials we fed conventional solid food diets with tailored fatty acid composition to 
about 60 healthy male and female volunteers. The different diets within one trial 
were supplied to every subject for 3 weeks each, in random order (cross-over). 
In the first study we investigated whether stearic acid could be a favorable 
alternative to trans fatty acids for the production of semi-solid and solid fats. We 
compared the effects of 8% of energy intake as monounsaturated trans fatty acids 
with those of linoleic acid, the fatty acid from which trans fatty acids are formed 
upon partial hydrogénation, and with those of stearic acid, a product of complete 
hydrogénation of linoleic acid. As compared with linoleic acid, trans fatty acids 
raised LDL by 0.24 mmol/L and lowered HDL cholesterol by 0.10 mmol/L. Stearic 
acid raised LDL by 0.17 mmol/L and lowered HDL by 0.06 mmol/L relative to 
linoleic acid. Differences between the trans fatty acid and the stearic acid diet were 
not statistically significant. Thus, hydrogénation of linoleic acid to either trans fatty 
acids or stearic acid produced fatty acids that may increase LDL and decrease HDL 
cholesterol relative to linoleic acid itself (Chapter 2). These findings do not support 
the use of stearic acid as a preferable alternative to trans fatty acids for the 
production of hard fats. Systolic and diastolic blood pressure were not affected by 
trans fatty acids or stearic acid (Chapter 3). This and an earlier study from our 
department show that trans fatty acids may produce modest increases in serum 
lipoprotein(a) levels relative to other dietary fatty acids (Chapter 4). 
The second study addressed the relative cholesterol-raising properties of two 
specific saturates. Three diets differed from each other in myristic, palmitic, or 
oleic acid by 10% of energy intake. As compared with oleic acid, myristic acid 
increased LDL by 0.50 mmol/L and HDL cholesterol by 0.15 mmol/L. Palmitic acid 
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raised LDL cholesterol by 0.38 mmol/L, but not HDL. The differences between 
myristic and palmitic acid were statistically significant. Nevertheless, both 
saturates caused high total and LDL cholesterol levels and raised the LDL to HDL 
cholesterol ratio (Chapter 5). Thus, myristic and palmitic acid have 
disadvantageous effects on serum lipids. 
In the third study we examined the effect of the positional distribution of fatty 
acids within dietary triglycerides. Two diets had identical total fatty acid 
composition. One diet, rich in palm oil, contained 82% of its palmitic acid on the 
two outer carbon atoms of glycerol, and 18% on the middle carbon. In the other 
diet, rich in modified palm oil (Betapol), these figures were 35% and 65%, 
respectively. Total, LDL, and HDL cholesterol levels were the same on Betapol and 
on palm oil. Thus, a large contrast in the fatty acid configuration of dietary fat did 
not influence lipid and lipoprotein levels (Chapter 6). However, the positional 
distribution of the fatty acids did have consistent but small effects on the fatty 
acid configuration and composition of fasting plasma triglycerides and cholesteryl 
esters (Chapter 7). Taken together, the positional distribution of fatty acids in 
dietary fat do not seem to have important health effects. 
Trans fatty acids as present in hydrogenated vegetable oils produce an 
unfavorable lipoprotein profile by raising LDL cholesterol and lipoprotein(a) levels 
and by lowering HDL cholesterol levels. Myristic and palmitic acid differ in their 
effects on serum lipids, but they both increase total and LDL cholesterol. The 
position of a fatty acid on the glycerol molecule does not materially affect serum 
lipid and lipoprotein levels. 
In conclusion, consumption of monounsaturated trans fatty acids and of 
saturated fatty acids has adverse effects on the serum lipoprotein risk profile for 
coronary heart disease. The positional distribution of fatty acids over the 
triglyceride molecule is probably not an important determinant of coronary heart 
disease risk. Dietary therapy and public health measures to lower total and LDL 
cholesterol levels should aim at reducing the consumption of both trans and 
saturated fatty acids. In practice, this implies that people at risk for coronary heart 
disease should avoid high intakes of hard fats and incorporate more carbohydrates 
or unsaturated oils in their diets. 
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Een hoog gehalte aan totaal- of LDL-cholesterol en lipoproteïne(a), een 
verhoogde bloeddruk, en een laag HDL-cholesterolgehalte verhogen het risico voor 
coronaire hartziekte (Hoofdstuk 1). Verschillen in de ketenlengte en het aantal en 
de plaats van dubbele bindingen van voedingsvetzuren kunnen deze risicofactoren 
beïnvloeden. De kans op coronaire hartziekte kan dus veranderen wanneer de 
hoeveelheid en de soort vet in de voeding wordt gewijzigd. 
Het doel van het onderzoek in dit proefschrift was de uitwerking van vetzuren 
in de voeding op risicofactoren voor coronaire hartziekte te bestuderen. In drie 
proeven kregen telkens 60 mensen alledaagse voedingen met nauwkeurige vetzuur-
samenstelling te eten. Elk van de verschillende voedingen binnen een proef werd 
gedurende 3 weken verstrekt aan iedere deelnemer, in verschillende volgorde. 
In de eerste proef onderzochten we of stearinezuur een gunstig alternatief 
voor fr-SAis-vetzuren kan bieden bij de produktie van geharde vetten. We vergeleken 
de effecten van enkelvoudig onverzadigde trans-vetzuren met die van linolzuur, het 
vetzuur waaruit trans-vetzuren tijdens gedeeltelijke hydrogenering worden gevormd, 
en met die van stearinezuur, dat bij volledige hydrogenering van linolzuur ontstaat. 
Het verschil in de hoeveelheid van deze vetzuren tussen de drie voedingen bedroeg 
8 % van de dagelijkse energiebehoefte (energie%). Vergeleken met linolzuur 
verhoogden rrans-vetzuren het LDL-cholesterol met 0.24 mmol/L en verlaagden het 
HDL-cholesterol met 0.10 mmol/L. Stearinezuur verhoogde LDL met 0.17 mmol/L 
en verlaagde HDL met 0.06 mmol/L. De verschillen tussen de trans-vetzuur- en de 
stearinezuurvoeding waren niet statistisch significant. Het hydrogeneren van 
linolzuur tot zowel rra/7s-vetzuren als tot stearinezuur levert dus vetzuren op die het 
LDL verhogen en het HDL verlagen vergeleken met linolzuur zelf. Onze resultaten 
kunnen het gebruik van stearinezuur als gunstige keuzemogelijkheid bij het maken 
van harde vetten niet ondersteunen (Hoofdstuk 2). De systolische en diastolische 
bloeddruk werden niet beïnvloed door trans-vetzuren of stearinezuur (Hoofdstuk 3). 
Deze proef laat samen met andere proeven van onze vakgroep zien dat trans-
vetzuren wel het lipoproteïne(a)-gehalte kunnen verhogen (Hoofdstuk 4). 
De tweede proef was gericht op het verschil in cholesterolverhogende werking 
van twee afzonderlijke verzadigde vetzuren. Drie voedingen verschilden 10 
energie% van elkaar in myristine-, palmitine- of oliezuur. Ten opzichte van oliezuur 
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verhoogde myristinezuur het LDL met 0.50 mmol/L en het HDL-cholesterol met 
0.15 mmol/L. Palmitinezuur verhoogde het LDL met 0.38 mmol/L, maar niet het 
HDL. De verschillen tussen myristine- en palmitinezuur waren statistisch significant. 
Beide verzadigde vetzuren veroorzaakten echter een hoog totaal- en LDL-cholesterol 
en verhoogden de LDL / HDL verhouding. Zowel myristinezuur als palmitinezuur 
hebben dus een ongunstige uitwerking op de bloedlipiden (Hoofdstuk 5). 
In de derde proef onderzochten we de invloed van de positie van vetzuren in 
het triglyceridemolecuul. Twee voedingen hadden precies dezelfde totale vetzuur-
samenstelling. Eén voeding was rijk aan palmolie, en bevatte 8 2 % van het 
palmitinezuur op de twee buitenste koolstofatomen van het glycerol, en 18% op 
het middelste koolstofatoom. In de andere voeding, rijk aan gewijzigde palmolie, 
was dit 35% en 65%, respectievelijk. De totaal-, LDL- en HDL- cholesterolgehalten 
waren op beide voedingen gelijk. Een groot verschil in de vetzuurconfiguratie van 
voedingsvet had dus geen invloed op de lipidengehalten (Hoofdstuk 6). De positie 
van het vetzuur had echter wel duidelijke, zij het kleine, effecten op de vetzuur-
configuratie en -samenstelling van nuchtere triglyceriden en cholesterolesters in 
plasma (Hoofdstuk 7). Over het geheel gezien hebben verschillen in positionele 
verdeling van voedingsvetzuren geen grote invloed op de serumlipiden. 
Trans-vetzuren in gehydrogeneerde plantaardige oliën veroorzaken een 
ongunstig lipoproteïnebeeld doordat ze het LDL-cholesterol en lipoproteïne(a)-
gehalte verhogen en het HDL-cholesterolgehalte verlagen. Myristinezuur en 
palmitinezuur hebben verschillende effecten, maar beide verhogen het totaal- en 
LDL-cholesterol. De positie van een vetzuur op het glycerolmolecuul is van weinig 
betekenis voor de lipoproteïnegehalten. 
De conclusie is dat de consumptie van enkelvoudig onverzadigde trans-
vetzuren en van verzadigde vetzuren een ongunstige uitwerking heeft op het 
risicobeeld van de lipoproteïnen voor coronaire hartziekte. De positionele verdeling 
van vetzuren over het triglyceridenmolecuul heeft waarschijnlijk geen belangrijke 
invloed op het risico. Dieetbehandeling en algemene maatregelen om het totaal- en 
LDL-cholesterolgehalte te verlagen zouden gericht moeten zijn op verminderde 
consumptie van zowel trans- als verzadigde vetzuren. In de praktijk betekent dit dat 
mensen met een hoge kans op coronaire hartziekte het gebruik van harde vetten 
dienen te vermijden en meer koolhydraten of onverzadigde oliën in hun voeding 
moeten opnemen. 
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